<SEC-DOCUMENT>0001161697-24-000156.txt : 20240318
<SEC-HEADER>0001161697-24-000156.hdr.sgml : 20240318
<ACCEPTANCE-DATETIME>20240318164426
ACCESSION NUMBER:		0001161697-24-000156
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240318
DATE AS OF CHANGE:		20240318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KORU Medical Systems, Inc.
		CENTRAL INDEX KEY:			0000704440
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				133044880
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39086
		FILM NUMBER:		24759697

	BUSINESS ADDRESS:	
		STREET 1:		100 CORPORATE DRIVE
		CITY:			MAHWAH
		STATE:			NJ
		ZIP:			07430
		BUSINESS PHONE:		845-469-2042

	MAIL ADDRESS:	
		STREET 1:		100 CORPORATE DRIVE
		CITY:			MAHWAH
		STATE:			NJ
		ZIP:			07430

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REPRO MED SYSTEMS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>schedule_14a.htm
<DESCRIPTION>SCHEDULE 14A PRELIMINARY PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<DIV STYLE="width: 7.5in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Amendment No.&nbsp;&nbsp;&nbsp;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Filed by the Registrant&nbsp;&nbsp; [X]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Filed by a Party other than the Registrant&nbsp;&nbsp; [&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Check the appropriate box:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="width: 7in; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material under &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7.5in; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>KORU Medical Systems, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Registrant as Specified In Its Charter)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Payment of Filing Fee (Check the appropriate box):</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">[X]</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules&nbsp;14a-6(i)(1)&nbsp;and&nbsp;0-11.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 0.5in; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="vertical-align: top; width: 6.5in; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title of each class of securities to which transaction applies:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Aggregate number of securities to which transaction applies:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&nbsp;0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2)&nbsp;and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form&nbsp;or Schedule and the date of its filing.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Amount Previously Paid:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Form, Schedule or Registration Statement No.:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Filing Party:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify"><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; padding-top: 1.3pt; padding-bottom: 0.85pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="koru_logo.jpg"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">KORU Medical Systems, Inc.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">100 Corporate Drive</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Mahwah, NJ 07430</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">800-624-9600</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Notice of Annual Meeting of Shareholders</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050">to be held on May 9, 2024</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The 2024 Annual Meeting of Shareholders
(the &ldquo;Annual Meeting&rdquo;) of KORU Medical Systems, Inc. (the &ldquo;Company&rdquo;) will be held on May 9, 2024 at 8:00 a.m.
Eastern Time at the Company&rsquo;s offices at 100 Corporate Drive, Mahwah, NJ 07495.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Annual Meeting is to vote
on the following matters:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 17.9pt; text-align: justify">1.</TD>
    <TD STYLE="width: 6.75in; text-align: justify"><A HREF="#Election">Election of directors</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">2.</TD>
    <TD STYLE="text-align: justify"><A HREF="#Advisory">Advisory approval of the compensation of the Company&rsquo;s executive officers</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">3.</TD>
    <TD STYLE="text-align: justify"><A HREF="#Ratification">Ratification of the appointment of independent registered public accountants</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">4.</TD>
    <TD STYLE="text-align: justify"><A HREF="#Approval">Approval of the 2024 Omnibus Equity Incentive Plan</A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">5.</TD>
    <TD STYLE="text-align: justify">Transaction of any other business that may properly come before the meeting</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Company will also transact
any other business that may properly come before the meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">All shareholders are invited to attend the Annual Meeting. Only those shareholders
of record at the close of business on March 11, 2024 are entitled to notice of and to vote at the Annual Meeting and any postponements
or adjournments thereof. A complete list of shareholders entitled to vote at the Annual Meeting will be available for inspection by any
shareholder at the Annual Meeting and during normal business hours at the Company&rsquo;s corporate headquarters during the 10-day period
immediately prior to the date of the Annual Meeting. &nbsp;Officers of the Company will be present at the Annual Meeting and available
to respond to questions from shareholders.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><B>YOUR VOTE IS IMPORTANT.</B>&nbsp;
Whether or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the
methods described in the proxy materials for the Annual Meeting. Shareholders who attend the Annual Meeting may revoke any previously
submitted proxies and vote in person, by internet or by mobile device up until the polls close during the Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>How to Vote:</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 7.5in; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33.3%">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_mail.jpg"></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Mail</B></P></TD>
    <TD STYLE="width: 33.4%">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_internet.jpg"></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Internet</B></P></TD>
    <TD STYLE="width: 33.3%">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_mobile.jpg"></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Mobile Device</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Sign, complete and return the proxy card in the postage paid envelope provided</TD>
    <TD STYLE="text-align: center">www.cstproxy.com - have your proxy card available when logging in</TD>
    <TD>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Scan this QR code:</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">[INSERT QR CODE]</P></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><B>Important Notice Regarding
the Availability of Proxy Materials for the Meeting to be Held on May 9, 2024:</B> This Proxy Statement, along with our Annual Report on Form 10-K for the
fiscal year ended December 31, 2023 is available at https://www.cstproxy.com/KORUMEDICAL/2024.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">By order of the Board of Directors,</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_signature.jpg"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Thomas Adams</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Chief Financial Officer, Treasurer and Corporate
Secretary</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="koru_logo.jpg"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">KORU Medical Systems, Inc.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">100 Corporate Drive</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Mahwah, NJ 07430</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">800-624-9600</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">This Proxy Statement is furnished in connection with the solicitation of
proxies by the Board of Directors of KORU Medical Systems, Inc. (the &ldquo;Company&rdquo; or &ldquo;KORU Medical&rdquo; and, as the context
requires, &ldquo;we&rdquo;, &ldquo;us&rdquo; or &ldquo;our&rdquo;) to be used at the Company&rsquo;s 2024 Annual Meeting of Shareholders
to be held on May 9, 2024 at the time and place and for the purposes set forth in the accompanying Notice of Annual Meeting of Shareholders,
and at any postponements or adjournments thereof. All proxies will be voted in accordance with the shareholders&rsquo; instructions, and
if no choice is specified, the proxies will be voted in favor of the matters specified in the accompanying Notice of Annual Meeting of
Shareholders and each of the director nominees specified herein. Any proxy may be revoked by a shareholder before its exercise by delivery
of written revocation or a subsequently dated proxy to our Corporate Secretary by the close of business on May 8, 2024 or by voting again
by internet or mobile device prior to or at the Annual Meeting before the polls close.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Notice of Electronic Availability
of Proxy Materials</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On or about March 28, 2024, we mailed to our shareholders of record and
beneficial owners a Notice of Internet Availability of Proxy Statement (&ldquo;Notice&rdquo;) containing instructions on how to access
this proxy statement and our 2023 Annual Report on Form 10-K via the Internet and how to vote online or by mobile device. <B>This Proxy
Statement, along with our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 is available at http://www.cstproxy.com/KORUMEDICAL/2024.
</B>As a result, you will not receive a paper copy of the proxy materials unless you request one. All shareholders are able to access
the proxy materials on the website referred to in the Notice and in this proxy statement and to request to receive a set of the proxy
materials by mail or electronically, in either case, free of charge. If you would like to receive a paper or electronic copy of our proxy
materials, you should follow the instructions for requesting such materials in this proxy statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Questions and Answers about the
Annual Meeting</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What is the record date?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The record date for the determination of shareholders entitled to notice
of and to vote at the Annual Meeting is the close of business on March 11, 2024. The record date is established by the Board of Directors
as required by Delaware law. On the record date, 46,560,500 shares of the Company&rsquo;s common stock, par value $0.01 per share (&ldquo;shares&rdquo;
or &ldquo;common stock&rdquo;) (including 850,000 shares of unvested restricted common stock entitled to vote) were issued and outstanding.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Who is entitled to vote?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">All record holders of shares
as of the close of business on the record date are entitled to vote.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What are the voting rights of shareholders?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Each holder of shares is entitled to one vote per common share on all matters
to be acted upon at the Annual Meeting. Neither the Company&rsquo;s Certificate of Incorporation, nor Bylaws allow for cumulative voting
rights.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 1 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What constitutes a quorum for the Annual Meeting?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">A majority of the outstanding
shares of common stock entitled to vote, represented at the meeting in person or by proxy, constitutes a quorum. Broker non-votes, votes
withheld and abstentions will be counted for purposes of determining whether a quorum is present.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>How do I vote my shares?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">KORU Medical offers registered
shareholders these ways to vote:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="width: 6.75in; text-align: justify">By mail (if you received your proxy materials by mail), using the enclosed proxy card and return envelope;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">By Internet or mobile device, following the instructions on the Notice or the proxy card, prior to or at the Annual Meeting; or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">By submitting a ballot in person at the Annual Meeting.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>How do I attend the Annual Meeting? What do I need
to bring?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In order to be admitted to the Annual Meeting, you must bring documentation
showing that you owned shares as of March 11, 2024, the record date. Acceptable documentation includes (i) your Notice of Internet Availability
of Proxy Materials, (ii) the admission ticket attached to your proxy card (if you received your proxy materials by mail), or any other
proof of ownership (such as a brokerage or bank statement) reflecting your KORU Medical holdings as of March 11, 2024. All attendees must
also bring valid photo identification. Shareholders who do not bring this documentation will not be admitted to the Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Can I vote my shares during the Annual Meeting?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Yes. If you are a shareholder of record, you may vote your shares during
the Annual Meeting by accessing https://www.cstproxy.com/KORUMEDICAL/2024 until the polls close or by completing a ballot at the meeting.
However, if your shares are held in &ldquo;street name,&rdquo; you may vote your shares in person only if you obtain a nominee-issued
proxy from your broker or nominee giving you the right to vote the shares. Even if you currently plan to attend the Annual Meeting, we
recommend that you also submit your proxy as described above so that your vote will be counted if you later decide not to attend the meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What is the difference between a shareholder of
record and a &ldquo;street name&rdquo; holder?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If your shares are registered
directly in your name with Continental Stock Transfer &amp; Trust Company, the Company&rsquo;s transfer agent, you are considered the
shareholder of record with respect to those shares. The Notice and proxy card have been sent directly to you by the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If your shares are held in a
stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of these shares, and your shares are held
in &ldquo;street name.&rdquo; The Notice and proxy card have been forwarded to you by your broker, bank or nominee who is considered,
with respect to those shares, the shareholder of record.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>How do I vote shares that are held by my broker?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If you have shares held by a
broker or other nominee, you may instruct your broker or other nominee to vote your shares by following instructions that your broker
or nominee provides to you. Most brokers offer voting by mail and the Internet.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What if I do not specify how I want my shares voted?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If you return a signed proxy card and do not specify on your proxy card
(or when giving your proxy over the Internet or mobile device) how you want to vote your shares, your shares will be voted FOR each of
the directors nominated in Proposal 1, and FOR each of the proposals set forth in Proposals 2, 3 and 4.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 2 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Broker non-votes occur when nominees, such as banks and brokers holding
shares on behalf of beneficial owners, do not receive voting instructions from the beneficial holders. If that happens, the banks and
brokers who are registered with the New York Stock Exchange (NYSE) may vote those shares only on matters deemed &ldquo;routine&rdquo;
by the NYSE, such as the ratification of the appointment of the Company&rsquo;s independent registered public accounting firm. On &ldquo;non-routine&rdquo;
matters nominees cannot vote unless they receive voting instructions from beneficial owners, resulting in so called &ldquo;broker non-votes.&rdquo;
The items being considered at the Annual Meeting, except for the ratification of the appointment of the Company&rsquo;s independent registered
public accounting, are considered &ldquo;non-routine&rdquo; matters. &nbsp;Therefore, it is important that you provide voting instructions
to your broker as to how you want your shares voted on the proposals being submitted at the Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>How do I find out the voting results?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Preliminary results are typically
announced at the Annual Meeting. Final voting results will be reported on a Form 8-K filed with the Securities and Exchange Commission
following the Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What are my choices when voting?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Shareholders may vote &ldquo;for,&rdquo; &ldquo;against&rdquo; or abstain
from voting with respect to each of Proposals 2, 3 and 4 described in the Notice and this Proxy Statement. &nbsp;Shareholders may vote
&ldquo;for&rdquo; or &ldquo;against&rdquo; all or some of the nominees, or vote &ldquo;withhold&rdquo; with respect to one or more of
the nominees with respect to Proposal 1 (Election of Directors).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What are the recommendations of the Board of Directors
on how I should vote my shares?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Board of Directors recommends that you vote your shares FOR each of
the director nominees in Proposal 1 and FOR each of Proposals 2, 3 and 4.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Can I change my vote?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Yes. You may revoke your proxy
at any time by any of the following means:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="width: 6.75in; text-align: justify">Attending the Annual Meeting and voting by one of the methods described in the proxy materials for the Annual Meeting. Your attendance at the Annual Meeting will not by itself revoke a proxy. You must vote your shares at the meeting to revoke your proxy. If your shares are held in &ldquo;street name,&rdquo; you will need a nominee-issued proxy from your broker to vote your shares at the meeting.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">Completing and submitting a new valid proxy bearing a later date by Internet, mobile device or mail before 11:59 pm on May 8, 2024.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">Giving written notice of revocation to the Company addressed to Corporate Secretary, at the Company&rsquo;s address above, which notice must be received before the close of business on May 8, 2024.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What percentage of the vote is required to elect
the nominees to the Board of Directors?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">To be elected as a director (Proposal
1), each director nominee must receive a plurality of the votes cast at the Annual Meeting by the shareholders entitled to vote in the
election of directors. Should any director nominee become unable or unwilling to accept nomination or election, the proxy holders may
vote the proxies for the election, in his or her stead, of any other person the Board of Directors may nominate or designate. &nbsp;Each
director nominee has expressed his intention to serve the entire term for which election is sought. &nbsp;Broker non-votes and votes &ldquo;withheld&rdquo;
will have no impact on the outcome of Proposal 1.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What percentage of the vote is required to approve
the advisory vote regarding executive compensation?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The affirmative vote of a majority
of the votes cast for or against at the Annual Meeting by the shareholders entitled to vote thereon is required to approve, by advisory
vote, the Company&rsquo;s executive compensation described in this proxy statement (Proposal 2). &nbsp;This is a non-binding advisory
vote. &nbsp;Broker non-votes and abstentions will have no effect on the outcome of Proposal 2.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 3 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What percentage of the vote is required to ratify
the appointment of independent registered accountants?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The affirmative vote of a majority
of the votes cast in favor of or against such action at the Annual Meeting by the shareholders entitled to vote thereon is required to
ratify the appointment of the independent registered accountants (Proposal 3). This is a non-binding advisory vote. &nbsp;Broker non-votes
and abstentions will have no effect on the outcome of Proposal 3.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What percentage of the vote is required to approve
the 2024 Omnibus Equity Inventive Plan (the &ldquo;2024 Equity Plan&rdquo;)?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The affirmative vote of a majority of the votes cast
in favor of or against such action at the Annual Meeting by the shareholders entitled to vote thereon is required to approve the 2024
Equity Plan (Proposal 4). Broker non-votes and abstentions will have no effect on the outcome of Proposal 4.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Is this proxy statement the only way that proxies
are being solicited?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">No. In addition to the solicitation
of proxies by use of the mail, officers and employees of the Company may solicit the return of proxies by mail, telephone, facsimile or
e-mail or through personal contact. These officers and employees will not receive additional compensation but will be reimbursed for out-of-pocket
expenses. Brokerage houses and other custodians, nominees and fiduciaries, in connection with shares registered in their names, will be
requested to forward solicitation materials to the beneficial owners of shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Are there any other matters to be acted upon at
the Annual Meeting?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Management does not intend to
present any business for a vote at the Annual Meeting other than the matters set forth in the Notice and has no information that others
will do so. If other matters requiring a vote of the shareholders properly come before the Annual Meeting, it is the intention of the
persons named in the accompanying form of proxy to vote the shares represented by the proxies held by them in accordance with applicable
law and their discretion on such matters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What does it mean to vote by proxy?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">It means that you give someone else the right to vote your shares in accordance
with your instructions. In this way, you ensure that your vote will be counted even if you are unable to attend the Annual Meeting. If
you give your proxy but do not include specific instructions on how to vote, the individuals named as proxies will vote your shares &ldquo;FOR&rdquo;
each of the director nominees and FOR Proposals 2, 3 and 4.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>What is &ldquo;householding&rdquo; and how does
it affect me?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">KORU Medical has adopted &ldquo;householding,&rdquo;
a procedure under which shareholders of record who have the same address and last name will receive a single Notice of Internet Availability
of Proxy Materials or set of proxy materials, unless one or more of these shareholders notifies the Company that they wish to continue
receiving individual copies. Shareholders who participate in householding will continue to receive separate proxy cards. This procedure
can result in significant savings to the Company by reducing printing and postage costs.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">If you participate in householding
and wish to receive a separate Notice of Internet Availability of Proxy Materials or set of proxy materials, or if you wish to receive
separate copies of future notices, special reports and proxy materials, please contact Continental Transfer &amp; Trust Company at 1 State
Street 30th floor, New York, NY 10004, phone (212) 509-4000. The transfer agent will deliver the requested documents to you promptly upon
your request.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Any shareholders of record who
share the same address and currently receive multiple copies of proxy materials who wish to receive only one copy of these materials per
household in the future may contact Continental Transfer &amp; Trust Company at the address or telephone number listed above. If you hold
your shares through a broker, bank or other nominee, however, please contact your broker, bank, or other nominee to request information
about householding.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Are there rights of dissent or appraisal for the
proposals submitted at the Annual Meeting?</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">None of the matters to be acted
on at the Annual Meeting give rise to any statutory right of a shareholder to dissent and obtain the appraisal of or payment for such
shareholder&rsquo;s shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 4 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="Election"></A>&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proposal 1: Election of Directors</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
The Board recommends a vote &ldquo;FOR&rdquo; each of the nominees for director.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;)
currently has 7 members, and all of our current directors are standing for election at the 2024 Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Members of the Board are elected to serve a term of
one year and until their successors have been elected and qualified. All of the nominees for director have consented to being named in
this proxy statement and to serve if elected. Shareholders will be unable to vote their proxies for more than 7 persons.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not know of any reason why any nominee
would be unable to serve as director. If any nominee is unable to serve, the shares represented by valid proxies will be voted for the
election of such other person as the Board may nominate, or the size of the Board may be reduced.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&rsquo;s directors have a variety of backgrounds,
which reflects the Board&rsquo;s continuing efforts to achieve a diversity of viewpoints, insights and perspectives on the Board. As more
fully discussed below, director nominees are considered on the basis of a range of criteria, including their business knowledge and background,
prominence and reputation in their fields and commitment to strong corporate governance and citizenship. They must also have experience
and ability that is relevant to the Board&rsquo;s oversight of the Company&rsquo;s business and affairs. Each nominee&rsquo;s biography
starting on page 7 includes the particular experience and qualifications that led the Board to conclude that the nominee should serve
on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; background-color: #00B050; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Committee Membership*</B></FONT></TD></TR>
  <TR STYLE="background-color: #00B050">
    <TD STYLE="width: 3.8in; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Nominee</B></FONT></TD>
    <TD STYLE="width: 0.55in; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Age</B></FONT></TD>
    <TD STYLE="width: 1.2in; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Director Since</B></FONT></TD>
    <TD STYLE="width: 0.65in; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>AC</B></FONT></TD>
    <TD STYLE="width: 0.65in; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>CC</B></FONT></TD>
    <TD STYLE="width: 0.65in; border-bottom: black 1pt solid; border-right: black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>NGC</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>R. John Fletcher</B></FONT><FONT STYLE="font-size: 11pt"><BR>
Chairman of the Board<FONT STYLE="color: #00B050"><B><BR>
</B></FONT>Managing Partner Emeritus, Fletcher Spaght Inc.</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">78</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2019</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">C</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Robert A. Cascella</B></FONT><FONT STYLE="font-size: 11pt"><BR>
Former CEO of Precision Diagnostics, Royal Phillips</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">69</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2022</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">C</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Donna French, PhD</B></FONT><FONT STYLE="font-size: 11pt"><BR>
VP Dosage Form Design and Development, AstraZeneca</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">59</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2021</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Joseph M. Manko, Jr.</B></FONT><FONT STYLE="font-size: 11pt"><BR>
Senior Principal, Horton Capital Management LLC</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">58</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2016</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">C</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Shahriar (Shar) Matin</B></FONT><FONT STYLE="font-size: 11pt"><BR>
Former CEO, Cordis Corporation</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">49</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2021</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">M</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Edward Wholihan</B></FONT><FONT STYLE="font-size: 11pt"><BR>
Former CFO Medical Specialties Distributors</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">64</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2023</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 3pt"><FONT STYLE="font-size: 11pt; color: #00B050"><B>Linda Tharby</B></FONT><FONT STYLE="font-size: 11pt"><BR>
President and CEO, KORU Medical</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">55</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">2022</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">* As of March 25, 2024</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AC - </B>Audit Committee</FONT></TD>
    <TD STYLE="width: 2.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>C</B> - Chair</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CC</B> &ndash; Compensation Committee</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>M - </B>Member</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NGC </B>&ndash;Nominating &amp; Corporate Governance Committee</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 5 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Skills &amp; Experience</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below summarizes the key qualifications,
skills and attributes of the nominees for director that served as the basis for the Board&rsquo;s decision to nominate these individuals
for election.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="background-color: #00B050">
    <TD STYLE="width: 51%; border: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Skills &amp; Experience &amp; Attributes</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Fletcher</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Cascella</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>French</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Manko</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Matin</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Tharby</B></FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt; color: white"><B>Wholihan</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Market Knowledge - Distribution</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Market Knowledge - Specialty Pharma</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Market Knowledge - Biopharma</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Medtech Industry Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Medtech Operational Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Healthcare Growth Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">International Healthcare Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&nbsp;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Product Development</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Capital Markets Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Financial Expertise/Audit Committee Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">C-level Expertise</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Other Public Company Director Experience</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Prior Knowledge of the Company</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Independent</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 0.15in 0.1in; text-align: center"><FONT STYLE="font-size: 11pt">Female</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&#10004;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.15in 0.1in; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt; color: #00B050"><B>&nbsp;</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 6 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Nominees for Director</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">R. John Fletcher</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Mr. Fletcher brings more than 40 years of healthcare and medical device
experience to KORU. He currently serves as Managing Partner Emeritus of Fletcher Spaght Inc., a healthcare-focused strategy consulting
firm which he founded in 1983, and Managing Partner of Fletcher Spaght Ventures, a venture capital firm which he founded in 2001. Mr.
Fletcher joined the Board of Directors of publicly-traded medical device company Spectranetics Corporation in 2002 and served as Chairman
of the Board from 2010-2017. Mr. Fletcher was named 2018 Director of the Year by The National Association of Corporate Directors (NACD)
for his work at Spectranetics and Axcelis. Mr. Fletcher currently serves as Chairman of ClearPoint Neuro (formerly MRI Interventions)
and is Chairman of Metabolon, Inc., as well as, Chairman of the Board of Optinose, Inc. He is Chairman Emeritus of the Corporate Collaboration
Council at the Thayer School of Engineering/Tuck School of Business at Dartmouth College and serves on the Board of Advisors of Beth Israel
Deaconess Medical Center and the Whitehead Institute at MIT. Mr. Fletcher received his MBA from Southern Illinois University, a BBA in
Marketing from George Washington University and an MS in international finance from Central Michigan University. Mr. Fletcher was also
an instructor and PhD candidate at the Wharton School, University of Pennsylvania.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Robert A. Cascella</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Over more than 30 years, Mr. Cascella has supported value creation in the
healthcare industry, with a strong focus on innovation and integrated solutions. Mr. Cascella retired from Philips on December 31, 2021,
after working for the company since 2015. The last position he held before retiring was Executive Vice President and Strategic Business
Development Leader and was also a member of the company&rsquo;s Executive Committee. Prior to that role, Mr. Cascella was the CEO for
the Precision Diagnosis Segment, responsible for the integration of smart systems, software, informatics and services dedicated to delivering
on the promise of precision medicine. Prior to that role, Mr. Cascella was the CEO of the Diagnosis and Treatment Segment, where he was
responsible for the development and growth of modality-based diagnostics and interventional treatment and therapy. Before joining Philips,
Mr. Cascella spent 11 years at Hologic, a global leader in Women&rsquo;s Health, as its president, and later, its CEO. Under his leadership,
Hologic broadly diversified its product portfolio and substantially grew revenues through a combination of innovative product development
and acquisition, as well as the building of strong customer relationships. Mr. Cascella serves as a board director for Celestica (NYSE:
CLS), Mirion Technologies (NYSE: MIR) and Neuronetics (Nasdaq: STIM). He is also a NACD certified director. Mr. Cascella holds a Bachelor
of Arts in accounting from Fairfield University.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #00B050"><B>Donna French</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Dr. French, Ph.D.,
is a pharmaceutical industry veteran with over 25 years of experience in pharmaceutical sciences and drug-device combination products.
Dr. French, has been Vice President of Dosage Form Design and Development at AstraZeneca since June 2017. Prior to joining AstraZeneca,
Dr. French was Senior Director of Device Development at Genentech from January 2009 to May 2017. She was Executive Director of Drug Delivery
Engineering at Amgen, Inc. before joining Genentech. For her entire career, Dr. French has been developing and commercializing drug products,
drug delivery systems and devices. She has led the development and commercialization of numerous products with delivery devices worldwide,
including auto-injectors, pen injectors, needle stick prevention devices, prefilled syringes, needle-free injectors, subcutaneous infusion
devices, intraocular delivery devices, inhalation drug delivery systems, and patient aids and tools for drug preparation and administration.
Dr. French earned her B.S. in Pharmacy from Albany College of Pharmacy, and her Ph.D. in Pharmaceutical Sciences from the University of
Nebraska.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Joseph M. Manko, Jr.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Mr. Manko has been
the Senior Principal in Horton Capital Management LLC, the investment manager for the Horton Capital Partners Fund, LP (&ldquo;Horton
Fund&rdquo;) since 2013. The Horton Fund is a significant shareholder in the Company. Mr. Manko has over 20 years of investment experience
in the asset management, investment banking, private equity and corporate securities markets. From 2005 to 2010, Mr. Manko was a Partner
and Chief Executive Officer of Switzerland-based BZ Fund Management Limited, where he was responsible for corporate finance, private equity
investments, three public equity funds and the firm&rsquo;s Special Situations and Event-Driven strategies. Prior to that Mr. Manko was
a Managing Director with Deutsche Bank in London. He began his investment banking career at Merrill Lynch as a Vice President in Hong
Kong and prior to that, Mr. Manko was a corporate finance attorney at Skadden, Arps, Slate, Meagher &amp; Flom LLP. Mr. Manko has served
on the board of several companies in the bio-pharmaceutical industry and has advised numerous companies in the pharmaceutical, biotech
and medtech industries and currently serves as a director and Chairman of Safeguard Scientifics, Inc., and previously served as a director
of Wireless Telecom Group, Inc., and Creative Realities, Inc. Mr. Manko earned both his B.A. and Juris Doctor from the University of Pennsylvania.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 7 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shahriar (Shar) Matin</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Matin has over 25 years of medical technology experience and was mostly
recently the Chief Executive Officer of Cordis Corporation, a leading cardiovascular medical device company, from 2021 to 2023. Previously,
he was the Chief Operating Officer at ViewRay Technologies Inc., an early-stage radiation oncology medical technology firm, from July
2018 to March 2021. Prior to that, he served as Chief Operating Officer of Spectranetics from January 2014 until its sale to Royal Philips
in November 2017. From 2007 &ndash; 2014, Mr. Matin held commercial and operation leadership roles of increasing responsibilities at Spectranetics.
Mr. Matin started his career in several commercial and engineering leadership roles at Boston Scientific and Guidant Corporation. He earned
a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Edward Wholihan</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Edward Wholihan joins KORU Medical&rsquo;s Board of Directors with over 25 years of experience as Chief Financial
Officer driving growth and shareholder value for public, private equity-sponsored, and venture capital-funded life sciences and healthcare
businesses. Most recently, he has leveraged his strategic management, financial, and operational expertise consulting for various companies.
Prior, he served as the Chief Financial Officer for Rarebreed Veterinary Partners, Inc, a community of veterinary hospitals; CFO of Allena
Pharmaceuticals, Inc., a development stage biopharmaceutical company; and CFO of Medical Specialties Distributors, a leading solution
provider to the specialty pharmacy, home infusion, and oncology practice markets that was acquired by McKesson Corp (NYSE: MCK) in 2018.
Ed also held two other CFO roles within the life science sector earlier in his career and, prior to that, spent seven years as a management
strategy consultant for McKinsey &amp; Company. He earned his MBA from Stanford University&rsquo;s Graduate School of Business and a BA
in economics from Yale University.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Linda Tharby</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Ms. Tharby was
appointed as President and CEO in April 2021. Ms. Tharby has over 25 years of executive leadership experience building and leading
strong performing global organizations that develop and commercialize products and service innovations, while delivering solutions
to patients in the home setting. Prior to joining KORU, Ms. Tharby spent the last 24 years working in various roles of increased
responsibility at Becton Dickinson (&ldquo;BD&rdquo;). Ms. Tharby was a member of the Executive Leadership team of BD. From 1998 to
2016, she held numerous senior global business leadership roles at BD, including Executive Vice President and President of Life
Sciences, Group President of Pre-Analytical Systems and Biosciences, Worldwide President of Diabetes Care, and Vice
President/General Manager of Pharmaceutical Systems. Ms. Tharby&rsquo;s last role was as Chief Customer Experience Officer from July
2018 through December 2020. Prior to that she served as BD&rsquo;s Chief Human Resources Officer, from October 2016 through July
2018. Ms. Tharby has an Honors Bachelor of Business Administration from Wilfrid Laurier University in Waterloo, Ontario
Canada.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Ms. Tharby has entered
into an agreement with the Company whereby she will be deemed to have automatically resigned from the Board simultaneously with the termination
of her employment as the Company&rsquo;s Chief Executive Officer.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Board Assessment, Nomination &amp;
Diversity</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Board members have extensive experience in business,
finance, healthcare and enterprise growth, as well as developing successful Company strategies. The Board strives to obtain and retain
the right mix of skills and experiences on the Board to drive the Company&rsquo;s success. To that end, the Board performs annual self-assessments
and engages in a thorough director nomination process.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">Board Self-Evaluation Process</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board and its committees conduct an annual self-evaluation
of their respective performances that allows directors to provide individual and confidential feedback on the Board&rsquo;s composition,
structure, committee structure, effectiveness, relationship with management, meetings, and other Board-related topics. The results of
the self-evaluation are presented by the chair of the Nominating and Corporate Governance Committee (the &ldquo;Nominating and Governance
Committee&rdquo;) to the full Board. The Board then assesses progress made in areas targeted for improvement from the prior year&rsquo;s
self-evaluation and develops an action plan in response to the current year&rsquo;s self-evaluation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 8 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">Director Nomination Process</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">The Nominating and
Governance Committee makes its recommendations of director candidates to the full Board, after considering candidates&rsquo; depth of
experience, availability and potential contributions to the Board, as well as their qualification as &ldquo;independent&rdquo; under the
standards applicable to the Board and its committees. With respect to incumbent members of the Board, the committee will also consider
the prior performance of each incumbent director.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">In selecting qualified
candidates to serve as directors of the Company, a wide range of diversity criteria are considered, including without limitation, gender,
race, ethnicity, religion, sexual orientation, physical ability and age, with the objective that the Board, as a whole, reflects a range
of viewpoints, backgrounds, skills and experience. In the process of searching for qualified persons to serve on the Board, the Nominating
and Governance Committee strives for the inclusion of diverse groups, knowledge, and viewpoints. To accomplish this, the Committee may
retain an executive search firm to help meet the Board&rsquo;s diversity objectives.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Candidates may come
to the attention of the Nominating and Governance Committee from current or former directors, shareholders, officers or other sources,
and the committee reviews all candidates in the same manner regardless of the source of the recommendation. In addition to those candidates
identified through its own internal processes, the Nominating and Governance Committee will consider nominees recommended by shareholders
who submit their recommendations in accordance with the notice, information and consent requirements set forth in our Bylaws.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">Director Diversity</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board believes having Board members with a diverse
mix of viewpoints, insights and perspectives is critical to board effectiveness. The Company seeks to have its Board composed of directors
that collectively possess a wide range of relevant business and financial expertise, industry knowledge, management experience and prominence
in areas of importance to the Company. The Board believes that gender and minority representation is an important element in achieving
the broad range of perspectives that the Board seeks among its members. To that end, consideration of the overall gender and ethnic diversity
of our Board is an important factor in our Board candidate selection and succession planning. Our Board currently includes two female
directors.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">The Board and Committees of the
Board</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is governed by the Board. The Board held four regular and no
special meetings in 2023. All directors attended at least 75% of the total number of meetings of the Board and the Committees on which
he or she served. The Company&rsquo;s non-employee directors, all of whom are independent, met in executive session at or shortly after
each of the Board meetings held during 2023. All directors and director nominees attended the Company&rsquo;s 2023 Annual Meeting. In
addition to its formal meetings, the Board met regularly with management in 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board has established three operating committees (the &ldquo;Committees&rdquo;)
that meet regularly: the Audit Committee; the Compensation Committee; and the Nominating and Governance Committee (the &ldquo;Governance
Committee&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Committee Membership and Function</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Set forth below are the members of each Committee
and a summary of each Committee&rsquo;s areas of oversight. Each Committee operates under a formal charter adopted by the Board that governs
its duties and conduct. Copies of the Committee charters can be obtained free of charge from the Company&rsquo;s website at www.korumedical.com.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 9 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: #00B050">Audit Committee</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33.3%; border: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Members</B></FONT></TD>
    <TD STYLE="width: 33.3%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Meetings in 2023 (#)</B></FONT></TD>
    <TD STYLE="width: 33.4%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Principal Responsibilities</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: left; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Robert A. Cascella (Chair)*</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">R. John Fletcher</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Joseph M. Manko, Jr.</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">9</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 3pt 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Recommends
    appointment of independent registered public accountants</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews internal
    accounting procedures and financial statements</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Consults with
    and reviews services provided by independent registered public accountants, including the results and scope of their audit</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews and
    discusses with management and the independent auditor annual reports on Form 10-K and makes recommendations to the Board with respect
    thereto</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews and
    discusses with management quarterly reports on Form 10-Q, earnings releases and any earnings guidance</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 3pt 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews financial
    strategies regarding currency, interest rates and use of derivatives and reviews our insurance program</P></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">* The Board has designated Mr. Cascella as the Audit
Committee&rsquo;s &ldquo;audit committee financial expert&rdquo; under the rules of the SEC.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: #00B050">Compensation Committee</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33.3%; border: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Members</B></FONT></TD>
    <TD STYLE="width: 33.3%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Meetings in 2023 (#)</B></FONT></TD>
    <TD STYLE="width: 33.4%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Principal Responsibilities</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: left; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Joseph M. Manko, Jr. (Chair)</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">R. John Fletcher</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Shahriar Matin</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">8</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 3pt 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Recommends
    compensation of our CEO to the independent members of the Board and approves the compensation of our other executive officers</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Approves all
    employment, severance and change in control agreements with our executive officers</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Serves as the
    granting and administrative committee for our equity compensation plans</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Administers
    our Annual Incentive Compensation Plan</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Oversees our
    policies relating to employee compensation and benefits</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 3pt 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews and
    recommends to the Board director compensation, including equity awards</P></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 10 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: left; color: #00B050">Nominating and Governance Committee</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33.3%; border: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Members</B></FONT></TD>
    <TD STYLE="width: 33.3%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Meetings in 2023 (#)</B></FONT></TD>
    <TD STYLE="width: 33.4%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><FONT STYLE="color: #00B050"><B>Principal Responsibilities</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: left; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">R. John Fletcher (Chair)</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Donna French</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">Shariar Matin</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">4</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 3pt 0 0 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Identifies
    and recommends candidates for election to the Board;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Reviews and
    recommends the composition, structure and function of the Board and its Committees;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Recommends a
    chair of the Board</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 8.3pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Monitors our
    corporate governance and Board practices, and oversees the Board&rsquo;s self-evaluation process;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 3pt 8.65pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;Identifies,
    evaluates and mitigates operational, strategic and external environment risks, with overall responsibility for monitoring our risk policies
    and practices</P></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Director Independence</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Governance Committee annually reviews the independence of all directors
and nominees for director and reports its findings to the full Board. The Board has determined that all of our non-employee directors
serving on the Board and on each of its three Committees are independent under the rules of the Nasdaq Stock Market, except for Mr. Wholihan
who previously served as a consultant for the Company. As an employee of the Company, Ms. Tharby is not independent.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In determining that these non-employee directors are independent, the Board
reviewed any transactions or other dealings by the Company with organizations with which a director has a relationship, such as service
as an employee of an organization or as a member of its governing or advisory board. Based on its review, the Board determined that, in
each instance, the relationship met the safe harbor provision of the Nasdaq rules, or that the nature of the relationship, the degree
of the director&rsquo;s involvement with the organization or transaction, and the amount involved did not otherwise constitute a relationship
that would impair the director&rsquo;s independence. The Board considered, among other things, the level of Mr. Manko&rsquo;s beneficial
ownership of Company&rsquo;s common stock.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 11 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050">Corporate Governance</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of KORU Medical&rsquo;s
significant corporate governance practices:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="width: 6.75in; padding-bottom: 6pt; text-align: justify">Annual election of directors</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Majority voting standard for election of directors</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">5 out of 7 director nominees (all except Company CEO and former consultant) are independent</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Lead director structure</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Annual board and committees self-evaluation</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Shareholder right to call special meetings</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Shareholder right to act by written consent</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Director and executive officer stock ownership requirements</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Independent Board Committees</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">No poison pill</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Anti-hedging and pledging policies</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">&#9679;</TD>
    <TD STYLE="padding-bottom: 6pt; text-align: justify">Annual say-on-pay shareholder vote</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify">National Association of Corporate Directors membership and director education</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Board Leadership</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Our governing documents enable the Board to determine the appropriate Board
leadership structure for the Company and allow the roles of Chairman of the Board and Chief Executive Officer to be filled by the same
or different individuals. This approach allows the Board flexibility to determine whether the two roles should be separate or combined
based upon the Company&rsquo;s needs and circumstances and the Board&rsquo;s assessment of the Company&rsquo;s leadership from time to
time. Our Bylaws provide that, in the event the roles of Chairman of the Board and Chief Executive Officer are filled by the same individual,
or if the Chairman is not considered by the Board to be an independent director, the independent directors will elect an independent director
to serve as Lead Director. The Lead Director, if any, will chair meetings of independent directors, will facilitate communications between
other members of the Board and the Chief Executive Officer and the Chairman, and will assume other duties which the independent directors
as a whole may designate from time to time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">Our Bylaws provide
that the primary officers of the Company shall be a Chairman of the Board, Chief Executive Officer and a Treasurer, each of whom shall
be appointed by the Board of Directors and have such powers and duties as provided in the Bylaws or as the Board otherwise deems appropriate.
Any two offices or more may be held by one person. Our Bylaws further provide that the Chairman of the Board shall preside at all meetings
of the Board of Directors and shareholders, when present, and perform other such duties as the Board may designate. In the Chief Executive
Officer&rsquo;s absence or inability to act, the Chairman of the Board shall perform the duties and may exercise the powers of the Chief
Executive Officer.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">The Board believes
the current separation of the Chairman of the Board and Chief Executive Officer roles is appropriate at this time because it enables the
Chief Executive Officer to focus on strategic leadership, execution and day-to-day management of our business, while the Chairman focuses
on board-level leadership and facilitating the Board&rsquo;s ability to be a strategic partner with management and provide oversight and
monitoring. The Board will continue to review its leadership structure.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 12 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Code of Ethics</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KORU Medical maintains a Code of Ethics that is applicable
to all directors, officers and employees. It sets forth our policies and expectations on several topics, including conflicts of interest,
confidentiality, compliance with laws, protection of Company assets (including proprietary information), and business ethics. The Code
of Ethics also sets forth procedures for addressing any potential conflict of interest (or the appearance of a conflict of interest).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company also maintains
an Ethics Hotline, which is accessible via telephone number for all our employees as a means of raising concerns or seeking advice. Employees
using the Ethics Hotline may choose to remain anonymous (unless prohibited by local law) and all inquiries are kept confidential to the
extent practicable in connection with the investigation of an inquiry. All Ethics Hotline inquiries are forwarded to the Chairman of the
Nominating and Governance Committee for investigation. In accordance with our complaint handling procedures, the Audit Committee is informed
of any significant matters, whether reported through the Ethics Hotline or otherwise, including accounting, internal control or auditing
matters, or any reported fraud involving senior management or persons who have a significant role in our internal controls. Retaliation
for submissions to the Ethics Hotline is prohibited.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any waivers from any provisions of the Code of Ethics
for executive officers and directors will be promptly disclosed to shareholders. In addition, certain amendments to the Code of Ethics,
as well as any waivers from certain provisions of the Code of Ethics given to the Company&rsquo;s CEO, CFO or principal accounting officer,
will be posted at the website address set forth below.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Code of Ethics is available on the Company&rsquo;s
website at www.korumedical.com. Printed copies of the Code of Ethics may be obtained, without charge, by contacting the Corporate Secretary,
KORU Medical Systems, Inc., 100 Corporate Drive, Mahwah, NJ 07430; telephone 800-624-9600.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Risk Oversight</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The full Board has the ultimate responsibility for,
and is actively engaged in, overseeing the Company&rsquo;s risk management. The Board receives and reviews periodic reports from management,
auditors, legal counsel and others, as considered appropriate regarding the Board&rsquo;s assessment of risks, and ensures that risks
undertaken by the Company are consistent with the Board&rsquo;s tolerance for risk.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Nominating and Governance Committee has been appointed
by the Board to assist the Board with regard to the identification, evaluation and mitigation of operational, strategic and external environment
risks, and has overall responsibility for monitoring the risk policies and associated practices of the Company. The other Board committees
are responsible for monitoring and reporting to the full Board on risks associated with their respective areas of oversight.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board and its committees actively engage with
management to provide guidance on and oversight of the Company&rsquo;s business strategy throughout the year. The Board dedicates at least
one meeting annually to focus on management&rsquo;s long-term strategic plan that guides the Company&rsquo;s actions to manage risk and
deliver shareholder value. In addition, various elements of strategy are discussed at every Board meeting, as well as at many meetings
of the Board&rsquo;s Committees. In order to assess performance against our strategic plans, the Board receives regular updates on progress
and execution, and provides direction to senior management throughout the year.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&rsquo;s senior leadership team works together
to identify, assess, manage and mitigate a broad range of risks across the Company's business. These risks are shared with the full Board
at its regular meetings and, when appropriate, with committees of the Board. The Company's Senior Vice President, Operations has been
tasked with designing and implementing a more formal enterprise risk management (&ldquo;ERM&rdquo;) process and to align our risk assessment
and mitigation efforts with our corporate strategy. The results of management&rsquo;s ERM activities will be shared with the Nominating
and Governance Committee at least annually, including the process used within the organization to identify risks (including consulting
with outside advisors and experts), management&rsquo;s assessment of the significant categories of risk faced by the Company (including
any changes in such assessment since the last review), and management's plans to mitigate potential exposures. The significant risks identified
through the Company's ERM activities and the related mitigation plans will also be reviewed with the full Board at least once a year.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 13 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Shareholder engagement and communication</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We take the views of our shareholders seriously, and
members of our management team and our Board have actively engaged many of our shareholders to gain a better understanding of their views.
Our process for shareholder outreach and engagement occurs throughout the year. Prior to our annual meeting of shareholders, we review
any report published by Institutional Shareholder Services to gain an initial understanding of areas of focus, and after the meeting,
we review the voting results and reach out to shareholders to invite feedback and discussion to ensure an understanding of the areas of
greatest interest to our shareholders.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shareholders may communicate with the entire Board
or individual directors by sending an email to directors@korumedical.com. Each communication should specify the applicable director or
directors to be contacted, as well as the general topic of the communication. Management will initially receive and process communications
before forwarding them to the director(s). Management generally will not forward to the directors a communication that they determine
to be primarily commercial in nature or related to an improper topic, or that requests general information about the Company.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Diversity, equity and inclusion</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is committed to fostering, cultivating,
and preserving a culture of diversity, equity, and inclusion. We value our employees for their unique talents and abilities. We embrace
and encourage our employee&rsquo;s differences in backgrounds, experiences, race, color, religious creed, sex, national origin, ancestry,
citizenship status, family or marital status, physical, mental and/or intellectual abilities, age, military, or veteran status, registered
domestic partner or civil union status, gender and gender identity, sexual orientation, political affiliation, and socio- economic status.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Through our diversity, equity, and inclusion policy,
KORU Medical seeks to create a positive work environment where all employees can reach their full potential and maximize their contributions.
We are committed to our employees&rsquo; dignity and well-being and make every effort to provide all employees with a safe and professional
work environment. We continuously seek to ensure a respectful and dignified workplace, and to foster diversity, equity, and inclusion
in our business. Among other things, the Company requires all of its employees to attend annual training to promote a greater understanding
and enhance employee knowledge in our diversity, equity, and inclusion initiatives.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Corporate Responsibility</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We remain fully dedicated to improving quality of
life for patients through the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery
systems. We are passionate about serving patients and committed to our dedicated employees, our community and running our business in
an ethical and compliant manner.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize the importance of embedding environmental
and social priorities within our business operations and are committed to developing an ESG strategy. We intend to establish an ESG working
group to be responsible for leading our ESG strategy and monitoring our corporate social responsibility and sustainability initiatives.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We address environmental risks by maintaining sustainable
practices throughout our business, including identifying and assessing financial risks associated with climate change, energy, waste,
pollution, and natural resource conservation. We plan to engage best practices to measure and manage environmental impacts in order to
conserve resources, reduce costs, and promote ethical sourcing practices.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are passionate about the culture we have created
of openness, trust and mutual respect in our work environment. We are committed to a strong &lsquo;pay for performance&rsquo; environment
where each person is accountable and rewarded for not only building the Company but developing themselves and those around them.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">It is the Company&rsquo;s policy to provide a healthy
and safe workplace for our employees and to observe applicable federal and state laws and regulations. The health and safety of our associates
is our top priority and in recognition of this, we aim to provide a robust health and wellness package. We continually evolve our benefits
plans to remain competitive and to meet the needs of our workforce to include medical benefits, dependent care, survivor benefits, disability
coverage, parental leave and a 401(k) program.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 14 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Non-employee director compensation</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board believes that providing competitive compensation is necessary
to attract and retain qualified non-employee directors. The key elements of KORU Medical&rsquo;s non-employee director compensation are
a cash retainer, stock compensation and Committee chair fees. Of the base compensation paid to non-employee directors (cash retainer and
stock), slightly more than half is paid in shares of common stock. Ms. Tharby does not receive compensation for her service as a director.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee reviews the annual compensation of our non-employee
directors and makes recommendations to the Board. The following table summarizes the Company&rsquo;s non-employee director compensation
plan in effect in 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; margin-left: 0.25pt; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 73.28%; border-bottom: #70AD47 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify"><B>Annual Compensation<SUP>(1)</SUP></B></TD>
    <TD STYLE="width: 26.72%; border-bottom: #70AD47 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify"><B>Amount</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Cash Retainer</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$50,000</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Common Stock Award</TD>
    <TD STYLE="vertical-align: bottom; border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$60,000<SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Additional Common Stock Award for Chairman</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$40,000<SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Audit Committee Chair Retainer</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$15,000</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Compensation Committee Chair Retainer</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$11,500</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #70AD47 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">Nominating and Corporate Governance Committee Chair Retainer</TD>
    <TD STYLE="border-bottom: #70AD47 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify">$7,500</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><SUP>(1)</SUP> Paid in quarterly installments.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><SUP>(2)</SUP> Number of shares of common stock issued
determined by the average of the high and low prices of the Company&rsquo;s common stock on the last day of the quarter as reported by
the Nasdaq Capital Market.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board believes that directors should hold meaningful
equity ownership positions in the Company. To that end, a significant portion of non-employee director compensation is in the form of
equity awards to further align the interests of our non-employee directors with our shareholders. Under the Board&rsquo;s stock ownership
guidelines, each non-employee director is required to own shares of KORU Medical common stock valued at four times the annual cash retainer
and must comply with the guidelines within five years of joining the Board. All of our non-employee directors have achieved the required
share ownership or are on track to meet their ownership target.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the compensation earned
or received by our non-employee directors during fiscal year 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40.24%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: justify"><B>Name</B></TD>
    <TD STYLE="width: 14.38%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><B>Fees earned or paid in cash <BR>
($)</B></TD>
    <TD STYLE="width: 0.54%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 14.34%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><B>Stock awards <BR>
($)</B></TD>
    <TD STYLE="width: 0.5%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 14.38%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><B>All other compensation <BR>
($)</B></TD>
    <TD STYLE="width: 0.52%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 14.34%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><B>Total <BR>
($)</B></TD>
    <TD STYLE="width: 0.74%; border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left">
R. John Fletcher<BR>
Chairman of the Board<BR>
Nominating and Governance Committee Chair</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">50,000</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">90,000</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">140,000</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: left">
Robert A. Cascella<BR>
Audit Committee Chair</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">65,000</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">60,000</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">125,000</TD>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left">Donna French</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">50,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">60,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">110,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-right: -15.75pt; padding-bottom: 1pt; text-align: left">Joseph M. Manko, Jr.<BR>
Compensation Committee Chair</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 9pt; text-align: right">61,500</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">60,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">121,500</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-right: -15.75pt; padding-bottom: 1pt; text-align: left">Shahriar (Shar) Matin</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; padding-left: 9pt; text-align: right">50,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">60,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">110,000</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left">Edward Wholihan<SUP>(1)</SUP></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">12,772</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">15,326</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">--</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">28,098</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; background-color: white; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<SUP>(1)</SUP> Joined Board in Sept 2023</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KORU Medical reimburses non-employee directors for
travel and other business expenses incurred in the performance of their services for the Company. Our insider trading policy prohibits
all of our directors from, among other things, margining or pledging any Company shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 15 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="Advisory"></A>&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proposal 2: Advisory vote to approve
named executive officer compensation</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>&#10004;</B>
The Board recommends a vote &ldquo;FOR&rdquo; Proposal 2.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Dodd-Frank Wall Street Reform and Consumer Protection
Act added Section 14A to the Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;), which requires that we provide
shareholders with the opportunity to vote to approve, on an advisory basis, the compensation of our named executive officers. Commonly
known as a &ldquo;say-on-pay&rdquo; vote, this proposal gives our shareholders the opportunity to express their views on our executive
compensation policies and programs and the compensation paid to the named executive officers. At the Company&rsquo;s 2020 Annual Meeting
of Shareholders, 95% of the votes cast were in favor of the Board of Directors&rsquo; recommendation to hold an advisory vote on executive
compensation every year. The Board of Directors and the Governance Committee (then, our compensation committee) reviewed these results
and determined that the Company&rsquo;s shareholders should hold an advisory vote on executive compensation every year. Accordingly, a
say-on-pay vote is being taken at the 2023 Annual Meeting.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe that the most effective compensation program
is one that is designed to reward all of our employees, including but not limited to, our named executive officers, for the achievement
of our short-term and long-term strategic goals using a pay for performance system to ultimately drive toward the achievement of increased
total shareholder return. Through this strategy, we seek to closely align the interests of our named executive officers with the interests
of our shareholders. Our named executive officers&rsquo; total compensation is comprised of a mix of base salary, performance-based cash
bonus, long-term incentive compensation, retirement and other benefits intended to fulfill these objectives.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are asking our shareholders to indicate their support
for the compensation of our named executive officers as described in this proxy statement by approving the following resolution at the
Annual Meeting:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 1.5in 0 1in; text-align: justify">&ldquo;RESOLVED, that the Company&rsquo;s
shareholders approve, on an advisory basis, the compensation paid to the named executive officers, as disclosed in the Company&rsquo;s
proxy statement for the 2024 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange
Commission, including the compensation tables and accompanying narrative disclosure.&rdquo;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We strongly encourage shareholders to read &ldquo;Compensation
of Named Executive Officers&rdquo; in this proxy statement, including the tabular and narrative disclosure regarding executive compensation,
for additional details.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The vote on this proposal is advisory and therefore
not binding on the Company, the Board of Directors or the Compensation Committee. However, the Board of Directors and the Compensation
Committee will review and consider the voting results in future decisions regarding executive compensation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 16 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">Executive Compensation</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our goal is to provide an executive compensation program
that best serves the long-term interests of our shareholders. We believe that attracting and retaining superior talent and rewarding performance
is key to delivering long-term shareholder returns, and that a competitive compensation program is critical to that end<FONT STYLE="color: teal">.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #00B050">
    <TD STYLE="width: 54%; border: Black 1pt solid; padding-top: 8pt; padding-bottom: 8pt; text-align: center"><FONT STYLE="color: white"><B>What We Do</B></FONT></TD>
    <TD STYLE="width: 46%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 8pt; padding-bottom: 8pt; text-align: center"><FONT STYLE="color: white"><B>What We Don&rsquo;t Do</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 8pt 0; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Use a balanced mix of cash and equity compensation and annual and long-term incentives</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Tie a significant portion of executive pay to performance against targets, both short- and long-term</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Align performance goals with shareholder value</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Ensure undue weight is not given to any single performance metric</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Consider peer groups</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Engage an independent compensation consultant</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Solicit annual say on pay vote</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Stock ownership guidelines</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    Clawback provisions for performance-based compensation</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="color: #00B050"><B>&#10004;</B></FONT>
    &ldquo;Double trigger&rdquo; for accelerated equity vesting upon change in control</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 8pt 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Encourage excessive risk-taking by management</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Grant discounted stock options</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Reprice stock options</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Allow hedging or pledging of Company shares</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Tax gross-ups on severance or change in control</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>x</B></FONT>
    Provide excessive executive perquisites</P></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Setting our executive compensation</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee annually reviews and approves
all compensation paid to our executive officers, including our named executive officers, subject to Board approval in the case of CEO
compensation. The CEO evaluates and provides to the Compensation Committee performance assessments and compensation recommendations. While
the CEO discusses her recommendations with the Compensation Committee, she does not participate in the deliberations concerning, or the
determination of, her own compensation. From time to time, various other members of management and other employees as well as outside
advisors or consultants may be invited by the Compensation Committee to make presentations, provide financial or other background information
or advice or otherwise participate in the Compensation Committee meetings.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee meets periodically throughout
the year to manage and evaluate executive compensation; however, decisions may be made at other times for new hires, promotions or other
special circumstances as our Compensation Committee determines appropriate. The Compensation Committee will continue to monitor and evaluate
our executive compensation in light of our shareholders&rsquo; views, before making any appropriate adjustments, and continue to consider
the outcome of our say-on-pay votes and our shareholders&rsquo; views when making future compensation decisions for our named executive
officers.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 17 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee has the authority to retain compensation consultants
to assist in its evaluation of executive compensation, including the authority to approve the consultant&rsquo;s reasonable fees and other
retention terms. The Compensation Committee has retained The Burke Group and AON plc as its compensation consultants to, among other things,
provide competitive market assessments of the compensation of our executive officers, as well as provide support on other matters as requested
by the Compensation Committee from time to time. The Compensation Committee has analyzed whether the work of The Burke Group and AON plc
as compensation consultants raises any conflict of interest, taking into account relevant factors in accordance with SEC guidelines. Based
on its analysis, the Compensation Committee determined that the work of The Burke Group and AON plc and the individual compensation advisors
employed by them do not create any conflict of interest pursuant to the SEC rules and applicable Nasdaq listing standards.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Principal elements of our executive
compensation</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our 2023 executive compensation program consisted
of the following principal elements:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #00B050"><B>Base
Salary</B></FONT>, which provides a baseline level of compensation set forth in an employment agreement that is reviewed and subject to
adjustment annually. Base salary is fixed cash compensation based on performance, scope of responsibilities, experience and competitive
pay practices.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #00B050"><B>Annual
Incentive Compensation Program (&ldquo;AICP&rdquo;)</B></FONT>, which provides an annual variable cash payment tied to company and individual
performance during the fiscal year. AICP cash bonus drives business performance towards achievement of annual goals and rewards individual
contributions to the Company&rsquo;s performance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #00B050"><B>Stock
Options</B></FONT>, which reward creation of shareholder value and promote executive retention. Stock options are exercisable for shares
upon payment of the exercise price fixed at fair market value at the time of the award, and generally vest ratably over four years. Stock
options are generally issued at the time of hire.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #00B050"><B>Time-Based
Restricted Stock</B></FONT>, which increases executive ownership to align with shareholder interests and promotes executive retention.
Time-based restricted stock generally vests ratably over four years.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #00B050"><B>Performance-Based
Restricted Stock</B></FONT>, which also increases executive ownership to align with shareholder interests and promotes executive retention.
Performance-based restricted stock ties vesting to the performance of the Company and/or the individual over a period of time.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The compensation of our named executive officers includes
substantial performance-based compensation, where the amount received by an executive varies based on Company and individual performance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Annual Incentive Compensation
Plan</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of the Company&rsquo;s pay-for-performance philosophy, the Company
has an Annual Incentive Compensation Plan (&ldquo;AICP&rdquo;) applicable to all full-time employees, including the named executive officers,
in the form of an annual cash bonus award potential. Target AICP awards are expressed as a percentage of base salary and, for the named
executive officers, set forth in their respective employment agreements.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An employee&rsquo;s bonus award is made from a pool established by the
Board for all employees under the AICP, based on achievement and over-achievement of any one or more measures of the Company&rsquo;s financial
or other performance for the year as determined in the discretion of the Board. The Company performance targets may include any one or
more of the following criteria, measured on an absolute basis or relative to a pre-established target, in each case as specified and weighted
by the Board: (i) revenues, (ii) earnings before one or more of interest, taxes, depreciation, and amortization, (iii) return on equity,
(iv) income or net income, (v) operating income or net operating income, (vi) gross margin, operating margin, or profit margin, (vii)
strategic plan progress; (viii) market segment share, (ix) new product innovation, (x) minimum cash balance, or (xi) such other criteria
as the Board may determine are appropriate to measure the Company&rsquo;s performance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 18 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An employee&rsquo;s individual bonus award is calculated based the Company
performance as described above, and in part, on the extent to which they meet expectations in their individual annual performance review,
as determined by the Board for the CEO and the Compensation Committee for her direct reports, and as determined by the CEO for other employees.
Such expectations are based on individual annual performance goals and objectives established by the Compensation Committee for the CEO
and by the CEO in her sole discretion for her direct reports and all other employees. Different employees may have different individual
performance goals and objectives. In no event does an employee&rsquo;s individual bonus award exceed the total of the funded performance
target pool, which may include over-achievement for Company over-performance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board (and the independent directors in the case
of our CEO), upon recommendation of the Compensation Committee, has the discretion to determine what it believes is an appropriate AICP
award to recognize the Company&rsquo;s performance and a particular executive&rsquo;s contribution to that performance. Actual awards
are in the discretion of the Board and awards may be more or less than the target. The Board may also amend any financial or other targets
or goals based on the Company&rsquo;s market performance or any other criteria it deems appropriate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee seeks to reward what it
deems to be superior performance by management in light of current industry conditions and growth trends. The Compensation Committee sets
what it believes are challenging performance targets in light of the Company operating plans reviewed by the Board, and structures payouts
so that they are aligned with the Company&rsquo;s performance against those targets.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Change in control</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain of our unvested equity grants provide for
double-trigger vesting upon a change in control. Under this provision, the awards will automatically vest upon a change in control only
if the executive is terminated without &ldquo;cause&rdquo; or terminates employment for &ldquo;good reason&rdquo; (as such terms are defined
in the executive&rsquo;s employment agreement) within the specified period of the change in control.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Clawback</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have adopted a Clawback Policy in compliance with
Nasdaq listing standards that applies to all of the Company&rsquo;s current and former executive officers. In the event of an accounting
restatement, the Company shall recoup of all incentive-based compensation received by such executive officers that exceeds the amount
of incentive-based compensation that would have been received by the executive officer had it been determined based on the restated amounts.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, our Annual Incentive Compensation Plan
(&ldquo;AICP&rdquo;) provides that if the Company&rsquo;s financial statements are the subject of a restatement (i) due to material non-compliance
with any financing reporting requirement under the federal securities laws, even if such restatement was not the result of any misconduct
or error of the participant, (ii) in order to correct errors that were immaterial to previously issued financial statements but would
result in a material misstatement if the errors were left uncorrected in future filings under the federal securities laws; or (iii) to
correct errors that are recognized in the current period covered by the financial statements, then the Company will seek reimbursement
of excess incentive cash compensation paid under the AICP for the relevant year(s). In addition, if the Company&rsquo;s financial statements
are the subject of a restatement or correction of error due, in whole or in part, to a participant&rsquo;s misconduct, to the extent permitted
by governing law, the Company may seek reimbursement of all incentive cash compensation paid under the AICP to such participant for the
relevant year(s). Finally, the Company may seek reimbursement of any or all incentive cash compensation paid under the AICP to a participant
in the event the Board or Compensation Committee determines, in its reasonable judgment, that the participant has, or has been negligent
in connection with the supervision of someone who has, engaged in fraud, misrepresentation, theft or embezzlement, engaged in other misconduct
(including harassment), or been grossly negligent in connection with the performance of their duties, in each case resulting in Company
reputational or financial harm.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the Company&rsquo;s employment agreement with our Chief Executive
Officer provides that if the Company&rsquo;s financial results are subsequently restated and such restatement shows any bonus, option
or restricted stock award was incorrectly paid or vested, she will be required to forfeit the portion of such compensation that was incorrectly
paid and, to the extent her fraud or other misconduct resulted in the receipt or vesting of such compensation, she shall will be required
to forfeit such improperly paid or vested compensation. The Company may also recover any bonus paid and cancel outstanding equity awards
and recover any shares received upon the exercise or vesting of such awards (or any gain realized on the sale of such shares) to the extent
she breaches certain restrictive covenants in her employment agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 19 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Stock ownership guidelines</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To increase executive share ownership and promote
a long-term perspective when managing our business, our Chief Executive Officer and certain other executives identified by the Board are
required to achieve the required ownership level set forth below within 5 years of becoming subject to the guidelines and to maintain
such ownership while they are employed by the Company. Shares subject to unvested stock options or otherwise subject to a right to acquire
are not included in the ownership level for this purpose.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 7.5in; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3.75in; border-bottom: #00B050 1pt solid; padding: 1.5pt 1pt; text-align: justify"><B>Position</B></TD>
    <TD STYLE="width: 3.75in; border-bottom: #00B050 1pt solid; padding: 1.5pt 1pt; text-align: justify; text-indent: 1.25in"><B>Multiple</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt 1pt; text-align: justify">CEO</TD>
    <TD STYLE="padding: 1.5pt 1pt; text-align: justify; text-indent: 1.25in">5x base salary</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt 1pt; text-align: justify">Certain Other Executives</TD>
    <TD STYLE="padding: 1.5pt 1pt; text-align: justify; text-indent: 1.25in">3x base salary</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #00B050 1pt solid; padding: 1.5pt 1pt; text-align: justify">Nonemployee Directors</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding: 1.5pt 1pt; text-align: justify; text-indent: 1.25in">4x annual cash fees</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pledging and hedging</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our insider trading policy prohibits all of our directors,
officers and employees (including the named executive officers) from margining or pledging any Company shares or other Company securities,
entering into hedging or monetization transactions or similar arrangements with respect to Company securities, selling the Company&rsquo;s
securities short, or buying or selling puts or calls or other derivative securities on the Company's securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Equity award timing</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Compensation Committee has adopted a policy that
prohibits the backdating of any equity compensation award and requires our annual equity compensation awards and any &ldquo;off-cycle&rdquo;
awards to be made on certain fixed dates.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Compensation of named executive
officers</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">Summary Compensation Table</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table shows the compensation provided by the Company to each
of the named executive officers in fiscal years 2023 and 2022:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 104.75pt; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>Name and Position</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 36.1pt; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Year</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 45.35pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Salary<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 45.35pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bonus<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 55.9pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Stock<BR>
Awards<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 56pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option<BR>
Awards<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 69.9pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Nonequity<BR>
Incentive Plan<BR>
Compensation<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 69.9pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>All Other<BR>
Compensation<BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 53.15pt; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total<BR>
($)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD STYLE="white-space: nowrap; text-align: left">Linda Tharby<BR>
President &amp; CEO</TD>
    <TD STYLE="white-space: nowrap; text-align: center">2023</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">563,063</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">137,106</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">13,200</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">713,369</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">2022</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">550,000</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">440,400</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">12,200</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">962,600</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD STYLE="white-space: nowrap; text-align: left">Brian Case<BR>
Chief Technology Officer</TD>
    <TD STYLE="white-space: nowrap; text-align: center">2023</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">350,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">12,994</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">8,163</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">371,157</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">2022</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">247,917</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">945,215</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">101,981</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">6,417</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">1,301,529</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD STYLE="white-space: nowrap; text-align: left">Thomas Adams<BR>
Chief Financial Officer</TD>
    <TD STYLE="white-space: nowrap; text-align: center">2023</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">302,917</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">174,937</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">64,350</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">13,200</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">555,404</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">2022</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">240,000</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">50,000</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">81,900</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">10,000</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">381,900</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD STYLE="white-space: nowrap; text-align: left">Kenneth Miller<BR>
Chief Commercial Officer</TD>
    <TD STYLE="white-space: nowrap; text-align: center">2023</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">45,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">590,686</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">19,800</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">61,737</TD>
    <TD STYLE="white-space: nowrap; padding-right: 0.05in; padding-left: 0.05in; text-align: right">717,224</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">2022</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: right">&mdash;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 20 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Narrative disclosure to Summary Compensation Table</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Employment Agreements.</I> Each of our named executive
officers had a written employment with the Company during 2023. Under each of the employment agreements, the employment of the named executive
officer may be terminated by either party upon written notice to the other party.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Salary.</I> As of December 31, 2023, the base salaries
for our named executive officers then employed by the Company were as follows: Ms. Tharby, $566,500; Mr. Case, $350,000; Mr. Adams, $325,000;
and Mr. Miller, $360,000.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Bonus.</I> In 2022, Mr. Adams received a discretionary
bonus of $50,000 in recognition of his additional contributions in the role of Interim Chief Financial Officer.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Non-Equity Incentive Plan Compensation.</I>
Pursuant to her employment agreement, Ms. Tharby is eligible to receive an annual bonus of up to 80% of her base salary in
accordance with the AICP. Any annual bonus paid to Ms. Tharby under her employment agreement has been and will be paid 70% in cash
and 30% in shares of common stock. Pursuant to their employment agreements, Mr. Adams, Mr. Case and Mr. Miller were eligible to receive
an annual bonus of up to 30%, 45% and 50%, respectively, of their annual base salaries in accordance with the AICP.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Option Awards</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Adams received an option to purchase 100,000 shares
of our common stock at $2.54 per share upon his appointment as our Chief Executive Officer. Each of Mr. Case and Mr. Miller received on
the respective start dates of their employments an option to purchase 475,000 shares of our common stock at $2.67 per share, and 400,000
shares of our common stock at $2.18 per share, respectively. Each of these options are subject to vesting on each of the four anniversary
dates of their award, subject to continued employment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>All Other Compensation.</I> Each named executive
officer was entitled to participate in any benefit plan from time to time in effect for our executives and/or employees generally, subject
to the eligibility provisions of that plan. Each named executive officer received matching contributions under our 401(k) savings plan
for all executives.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding equity awards at 2023 fiscal year
end</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the outstanding equity
awards held by our named executive officers at the end of fiscal year 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Option Awards<SUP>(1)</SUP></B></TD>
    <TD COLSPAN="4" STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><B>Stock Awards</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 89.8pt; border-bottom: black 1pt solid"><B>Name</B></TD>
    <TD STYLE="width: 69.45pt; border-bottom: black 1pt solid; text-align: center"><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable</B></TD>
    <TD STYLE="width: 60pt; border-bottom: black 1pt solid; text-align: center"><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable</B></TD>
    <TD STYLE="width: 39pt; border-bottom: black 1pt solid; text-align: center"><B>Option<BR>
Exercise<BR>
Price ($)</B></TD>
    <TD STYLE="width: 46.15pt; border-bottom: black 1pt solid; text-align: center"><B>Option<BR>
Expiration<BR>
Date</B></TD>
    <TD STYLE="width: 53.4pt; border-bottom: black 1pt solid; text-align: center"><B>Number of<BR>
Shares or<BR>
Units of<BR>
Stock That<BR>
Have Not<BR>
Vested (#)</B></TD>
    <TD STYLE="width: 52.75pt; border-bottom: black 1pt solid; text-align: center"><B>Market<BR>
Value of<BR>
Shares or<BR>
Units of<BR>
Stock That<BR>
Have Not<BR>
Vested ($)<SUP>(2)</SUP></B></TD>
    <TD STYLE="width: 70.55pt; border-bottom: black 1pt solid; text-align: center"><B>Equity<BR>
Incentive<BR>
Plan Awards:<BR>
Number of<BR>
Unearned<BR>
Shares, Units<BR>
or Other<BR>
Rights that<BR>
Have Not<BR>
Vested (#)</B></TD>
    <TD STYLE="width: 71.05pt; border-bottom: black 1pt solid; text-align: center"><B>Equity<BR>
Incentive<BR>
Plan Awards:<BR>
Market or<BR>
Payout Value<BR>
of Unearned<BR>
Shares, Units<BR>
or Other<BR>
Rights that<BR>
Have Not<BR>
Vested ($)</B></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: #E6E6E6">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 11pt">Linda Tharby</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right"><FONT STYLE="font-size: 11pt">500,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right"><FONT STYLE="font-size: 11pt">500,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in"><FONT STYLE="font-size: 11pt">3.875</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 11pt">3/15/31</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">850,000</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">2,091,000</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 11pt">Thomas Adams</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right"><FONT STYLE="font-size: 11pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right"><FONT STYLE="font-size: 11pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in"><FONT STYLE="font-size: 11pt">3.34</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 11pt">11/29/31</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  <TR STYLE="background-color: #E6E6E6">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 11pt">Thomas Adams</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right"><FONT STYLE="font-size: 11pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in"><FONT STYLE="font-size: 11pt">2.54</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 11pt">7/30/33</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 11pt">Brian Case</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right"><FONT STYLE="font-size: 11pt">118,750</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right"><FONT STYLE="font-size: 11pt">356,250</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in"><FONT STYLE="font-size: 11pt">2.67</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 11pt">4/30/32</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  <TR STYLE="background-color: #E6E6E6">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 11pt">Kenneth Miller</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 13.5pt; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 6pt; text-align: right"><FONT STYLE="font-size: 11pt">400,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in"><FONT STYLE="font-size: 11pt">2.18</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 11pt">11/13/33</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">__________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27pt"><FONT STYLE="font-size: 11pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 513pt; text-align: justify"><FONT STYLE="font-size: 11pt">Non-qualified stock options that vest 25% annually commencing on the first anniversary following the date of award.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 11pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Based on a closing price of our common stock on December 30, 2023 of $2.46.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 21 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pay versus performance</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following tables and related
disclosures provide information about (i)&nbsp;the &ldquo;total compensation&rdquo; of our CEO, and our other named executive officers
(the &ldquo;<U>Other NEOs</U>&rdquo; or the &ldquo;<U>Non-CEO NEOs</U>&rdquo;) as presented in the Summary Compensation Table above, (ii)&nbsp;the
&ldquo;compensation actually paid&rdquo; to our CEO and our Other NEOs, as calculated pursuant to the SEC&rsquo;s pay-versus-performance
rules, (iii)&nbsp;certain financial performance measures, and (iv) the relationship of the &ldquo;compensation actually paid&rdquo; to
those financial performance measures.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This disclosure has been prepared
in accordance with Item 402(v) of Regulation S-K under the Exchange Act, and does not necessarily reflect value actually realized by the
executives or how our Compensation Committee evaluates compensation decisions in light of Company or individual performance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Summary<BR>
Compensation<BR>
Table Total<BR>
for CEO<SUP>(1)</SUP></B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Compensation<BR>
Actually Paid<BR>
to CEO<SUP>(1)(2)(3)</SUP></B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Average<BR>
Summary<BR>
Compensation<BR>
Table Total<BR>
for Non-CEO<BR>
NEOs<SUP>(1)</SUP></B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Average<BR>
Compensation<BR>
Actually Paid<BR>
to Non-CEO<BR>
NEOs<SUP>(1)(2)(3)</SUP></B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Value of Initial<BR>
Fixed $100<BR>
Investment<BR>
Based On Total<BR>
Shareholder<BR>
Return<SUP>(4)</SUP></B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Net Income/<BR>
(Loss) (in<BR>
thousands)</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-size: 11pt">2023</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 11pt">713,369</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-size: 11pt">(1,193,861</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 11pt">547,298</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 11pt">359,612</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-size: 11pt">53.25</FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-size: 11pt">(13,741,062</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2022</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">962,600</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">1,446,209</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">841,715</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">1,019,809</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">118.55</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">(8,661,142</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">7,052,291</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">5,179,379</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">602,560</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">535,540</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">49.83</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">(4,562,823</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">__________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 11pt">(1)</FONT></TD>
    <TD STYLE="width: 7.25in; text-align: justify"><FONT STYLE="font-size: 11pt">The CEO for 2023 and 2022 is Linda Tharby. The Non-CEO NEOs for whom the average compensation is presented in this table are for 2023, Thomas Adams, Brian Case and Kenneth Miller, and for 2022, Thomas Adams and Brian Case. Brian Case joined the Company in April 2022.</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 11pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">The amounts shown as Compensation Actually Paid have been calculated in accordance with Item&nbsp;402(v)&nbsp;of Regulation S-K and do not reflect compensation actually realized or received by the Company&rsquo;s CEO and Non-CEO NEOs. These amounts reflect total compensation as set forth in the Summary Compensation Table for each&nbsp;year, adjusted as described in footnote 3 below.</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 11pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">Compensation Actually Paid reflects the exclusions and inclusions for the CEO and the Non-CEO NEOs set forth below. Amounts excluded, which are set forth in the &ldquo;Minus Stock and Option Awards from Summary Compensation Table&rdquo; columns below, represent the stock awards and option awards reported in the Stock Awards and Option Awards columns of the Summary Compensation Table for each applicable year. See - Narrative Disclosure to Summary Compensation Table &ndash; Options and Restricted Stock Awards on page 21. Amounts added back to determine Compensation Actually Paid are made up of the following components which are set forth in the table below, as applicable: (i) the fair value as of the end of the fiscal year of outstanding and unvested equity awards granted in that year; (ii) the change in fair value during the year of equity awards granted in prior years that remained outstanding and unvested at the end of the year; (iii) the fair value as of the vesting date of equity awards that were granted and vested in that year; and (iv) the change in fair value during the year through the vesting date of equity awards granted in prior years that vested during that year. The fair value at the end of the prior year of awards granted in any prior year that failed to meet applicable vesting conditions during the covered year are subtracted, although there were no such awards for the CEO or the Non-CEO NEOs in 2022 or 2023. Equity values are calculated in accordance with ASC Topic 718.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Summary<BR>
Comp. Table<BR>
Total for<BR>
CEO</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Minus</I> Stock<BR>
and Option<BR>
Awards from<BR>
Summ. Comp.<BR>
Table</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Year-<BR>
End Equity<BR>
Value of<BR>
Unvested<BR>
Awards<BR>
Granted<BR>
During Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Change<BR>
in Value of<BR>
Unvested<BR>
Awards<BR>
Granted in<BR>
Prior Years</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Value of<BR>
Awards<BR>
Granted and<BR>
Vested<BR>
During<BR>
Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Change<BR>
in Value of<BR>
Prior Years&rsquo;<BR>
Awards<BR>
Vested<BR>
During<BR>
Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Comp.<BR>
Actually Paid<BR>
to CEO</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 11pt">2023</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">713,369</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">(1,810,232</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">(96,998</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">(1,193,861</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2022</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">962,600</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">554,102</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">(70,493</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">1,446,209</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">7,052,291</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">6,327,122</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">4,454,210</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">5,179,379</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 22 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><B>Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Avg.<BR>
Summary<BR>
Comp. Table<BR>
Total for<BR>
Other NEOs</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Minus</I> Avg.<BR>
Stock and<BR>
Option<BR>
Awards from<BR>
Summ. Comp.<BR>
Table</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Avg.<BR>
Year-End<BR>
Equity Value<BR>
of Unvested<BR>
Awards<BR>
Granted<BR>
During Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Avg.<BR>
Change in<BR>
Value of<BR>
Unvested<BR>
Awards<BR>
Granted in<BR>
Prior Years</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Avg.<BR>
Value of<BR>
Awards<BR>
Granted and<BR>
Vested<BR>
During<BR>
Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B><I>Plus</I> Avg.<BR>
Change in<BR>
Value of Prior<BR>
Years&rsquo;<BR>
Awards<BR>
Vested<BR>
During<BR>
Year</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><B>Average<BR>
Comp.<BR>
Actually Paid<BR>
to Other<BR>
NEOs</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 11pt">2023</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">547,928</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">255,208</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">270,931</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">(192,609</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">(11,430</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 11pt">359,612</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2022</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">841,715</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">472,607</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">640,287</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">15,607</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">(5,193</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">1,019,809</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">602,560</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">532,560</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">465,540</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 11pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">535,540</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">__________</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) Total Shareholder Return illustrates the value,
as of the last day of the indicated fiscal year, of an investment of $100 in KORU Medical common stock on <FONT STYLE="background-color: white">December
31, 2020.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Description of Relationship Between NEO Compensation
Actually Paid and Company Total Shareholder Return (&ldquo;<U>TSR</U>&rdquo;)</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The following chart sets forth the relationship between Compensation Actually
Paid to our CEO, the average of Compensation Actually Paid to our Non-CEO NEOs, and the Company&rsquo;s TSR over the fiscal three&nbsp;year
period from 2021 through 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_chart-1.jpg"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 23 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><I>Description of Relationship Between NEO Compensation
Actually Paid and Net Loss</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The following chart sets forth the relationship between Compensation Actually
Paid to our CEO, the average of Compensation Actually Paid to our Non-CEO NEOs, and the Company&rsquo;s Net Loss over the fiscal three
year period from 2021 through 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="proxy_chart-2.jpg"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 24 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="Ratification"></A>&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proposal 3: Ratification of selection
of independent registered public accounting firm</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>&#10004;</B>
The Board recommends a vote &ldquo;FOR&rdquo; Proposal 3.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">McGrail Merkel Quinn &amp; Associates, P.C. has been
selected by the Audit Committee as the Company&rsquo;s independent auditors for fiscal year 2024. The Audit Committee is solely responsible
for the appointment, compensation, retention and oversight of its independent auditors. Shareholders are being asked to ratify the Audit
Committee&rsquo;s selection of McGrail Merkel Quinn &amp; Associates, P.C. If ratification is withheld, the Audit Committee will reconsider
its selection.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A representative of McGrail Merkel Quinn &amp; Associates,
P.C. is expected to attend the 2024 Annual Meeting to respond to appropriate questions and will have the opportunity to make a statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Listed below are the fees billed to the Company by
McGrail Merkel Quinn &amp; Associates, P.C. for services rendered during fiscal years 2023 and 2022.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in; margin-left: 0.25pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #00B050 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: center"><B>2023</B></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: #00B050 1pt solid; text-align: center"><B>2022</B></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18.3%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">Audit Fees</TD>
    <TD STYLE="width: 1.5%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 2.06%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="width: 8.34%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">50,000</TD>
    <TD STYLE="width: 2.04%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1.92%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="width: 7.68%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">45,250</TD>
    <TD STYLE="width: 2.4%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 55.76%; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&ldquo;Audit Fees&rdquo; consist of aggregate fees billed for professional services rendered for the audit of our annual financial statements and review of the interim financial statements included in quarterly reports or services that are normally provided by the independent auditors in connection with statutory and regulatory filings or engagements for the fiscal years ended December 31, 2023 and December 31, 2022, respectively.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">Audit Related Fees</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">Tax Fees</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-top: #D1D3D4 1pt solid; border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">All Other Fees</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">$</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">&mdash;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #D1D3D4 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left"><B>Total</B></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left"><B>$</B></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">50,000</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left"><B>$</B></TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">45,250</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: #00B050 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Audit Committee of the Board of Directors is responsible
for the appointment, compensation, and oversight of the work of the independent auditors and has approved in advance any services to be
performed by the independent auditors, whether audit-related or not. The Audit Committee has reviewed each proposed engagement to determine
whether the provision of services is compatible with maintaining the independence of the independent auditors. All of the Audit Fees shown
above were pre-approved by the Audit Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 25 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="Approval"></A>&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><B>Proposal 4: Approval of 2024 Omnibus
Equity Incentive Plan</B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&#10004;</B></FONT>
The Board recommends a vote &ldquo;FOR&rdquo; Proposal 4.</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; color: #00B050">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Board of Directors has adopted, and is seeking
shareholder approval, for a new equity incentive plan, the <A HREF="#Koru2024OmnibusEquityIncentivePlan">2024 Omnibus Equity Incentive Plan</A> (the &ldquo;2024 Equity Plan&rdquo;), which,
if approved by our shareholders, will replace the 2021 Omnibus Equity Incentive Plan (the &ldquo;2021 Equity Plan&rdquo;), the 2015 Stock
Option Plan (the &ldquo;2015 Plan&rdquo;), and the Nonemployee Director Compensation Plan (the &ldquo;Nonemployee Director Plan&rdquo;)
for future grants.&nbsp;&nbsp;The terms and conditions of outstanding awards previously granted under the 2021 Equity Plan, the 2015 Plan
and the Nonemployee Director Plan will not be affected by the adoption or approval of the 2024 Equity Plan.&nbsp;&nbsp;If the 2024 Equity
Plan is approved by our shareholders, no new awards will be granted under the terms of the 2021 Equity Plan, the 2015 Plan and the Nonemployee
Director Plan.&nbsp;&nbsp;If the 2024 Equity Plan is not approved by our shareholders, no awards will be granted pursuant to the 2024
Equity Plan, and the Company will continue to grant awards to employees, officers, directors, consultants and advisors under the 2021
Equity Plan or the 2015 Plan and to non-employee directors under the Nonemployee Director Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The material features of the 2024 Equity Plan are
summarized below. This summary is qualified in its entirety by reference to the full text of the 2024 Equity Plan, which is set forth
in <U><A HREF="#Appendix_A">Appendix A</A></U> to this proxy statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 2024 Equity Plan covers the grant of awards to
our employees (including officers), non-employee consultants and non-employee directors and those of our affiliates. For purposes of the
2024 Equity Plan, our affiliates include any corporation, partnership, limited liability company, joint venture or other entity, with
respect to which we, directly or indirectly, own either (i) stock of a corporation possessing at least fifty percent (50%) of the total
combined voting power of all classes of stock entitled to vote, or at least fifty percent (50%) of the total value of all shares of all
classes of stock of such corporation, or (ii) an aggregate of at least fifty percent (50%) of the profits interest or capital interest
of any non-corporate entity.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect that the Compensation Committee of our Board
(the &ldquo;Plan Committee&rdquo;) will administer the 2024 Equity Plan. The Board or the Plan Committee may delegate certain of its administrative
authority to our Chief Executive Officer or to a management committee except with respect to awards to executive officers, non-employee
directors and others who are subject to Section 16 of the Exchange Act. In addition, the full Board must serve as the Plan Committee with
respect to any awards to our non-employee directors.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon approval by the shareholders, the 2024 Equity
Plan will provide for the issuance of up to 2,300,000 shares of our common stock, plus any unissued shares reserved and available for
issuance under the 2021 Equity Plan, 2015 Equity Plan and Non-Employee Director Compensation Plan (an aggregate 844,687 shares as of March
25, 2024).&nbsp;&nbsp;In the event that any outstanding option previously granted under the 2021 Equity Plan, the 2015 Plan, or the Nonemployee
Director Plan or the 2024 Equity Plan for any reason expires or is terminated prior to the exercise thereof, the shares reserved for the
unexercised portion of such option shall also be available for future option&nbsp;awards under the 2024 Equity Plan.&nbsp; If the 2024
Equity Plan is approved by our shareholders, no new awards will be granted under the terms of the 2021 Equity Plan, the 2015 Plan and
the Nonemployee Director Plan. The total number of shares available for issuance under the 2024 Equity Plan (including for this purpose
those from the 2021 Equity Plan, the 2015 Plan and the Nonemployee Director Plan) are subject to adjustment of such number in the event
of future increases or decreases in the number of outstanding shares of our common stock effected as a result of stock splits, stock dividends,
combinations of shares or similar transactions in which the Company receives no consideration. Up to all shares of our common stock reserved
under the 2024 Equity Plan may be issued under the 2024 Equity Plan pursuant to the exercise of incentive stock options (&ldquo;ISOs&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 26 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stock delivered to settle awards made under the
2024 Equity Plan may be authorized and unissued shares or treasury shares, including shares repurchased by us for purposes of the 2024
Equity Plan. Shares subject to any award granted under the 2024 Equity Plan (other than a substitute award as described below) that is
forfeited or otherwise terminated without delivery of such shares (or if such shares are returned to us due to a forfeiture restriction
under such award), the shares subject to such award will again be available for issuance under the 2024 Equity Plan. However, any shares
that are withheld or applied as payment for shares issued upon exercise of an award or for the withholding or payment of taxes due upon
exercise of the award will continue to be treated as having been delivered under the 2024 Equity Plan and will not again be available
for grant under the 2024 Equity Plan. Upon settlement of any stock appreciation rights (&ldquo;SARs&rdquo;), the number of shares underlying
the portion of the SARs that is exercised will be treated as having been delivered for purposes of determining the maximum number of shares
available for grant under the 2024 Equity Plan and shall not again be treated as available for issuance under the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If a dividend or other distribution (whether in cash,
shares of common stock or other property), recapitalization, forward or reverse stock split, subdivision, consolidation or reduction of
capital, reorganization, merger, consolidation, scheme of arrangement, split-up, spin-off or combination involving us or repurchase or
exchange of our shares or other securities, or other rights to purchase shares of our securities or other similar transaction or event
affects our common stock such that the Plan Committee determines that an adjustment is appropriate in order to prevent dilution or enlargement
of the benefits (or potential benefits) provided to grantees under the 2024 Equity Plan, the Plan Committee will make an equitable change
or adjustment as it deems appropriate in the number and kind of securities subject to awards (whether or not then outstanding) and the
related exercise price relating to an award in order to prevent dilution or enlargement of the benefits or potential benefits intended
to be made available under the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Types of Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 2024 Equity Plan permits the granting of any or
all of the following types of awards:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 7.5in; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="width: 7in; text-align: justify"><FONT STYLE="font-size: 11pt">stock options, including non-qualified options and incentive stock options, or ISOs;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">stock appreciation rights, or SARs;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">restricted shares;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">deferred stock and restricted stock units;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">performance units and performance shares;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">dividend equivalents;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">bonus shares; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">&bull; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 11pt">other stock-based awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Generally, awards under the 2024 Equity Plan are granted
for no consideration other than prior and future services. Awards granted under the 2024 Equity Plan may, in the discretion of the Plan
Committee, be granted alone or in addition to, in tandem with or in substitution for, any other award under the 2024 Equity Plan or other
plan of ours; provided, however, that if a SAR is granted in tandem with an ISO, the SAR and ISO must have the same grant date and term
and the exercise price of the SAR may not be less than the exercise price of the ISO. The material terms of each award will be set forth
in a written award agreement between the grantee and us.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 27 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Stock Options and SARs</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee is authorized to grant stock options
(including ISOs except that an ISO may only be granted to an employee of ours) and SARs. A stock option allows a grantee to purchase a
specified number of shares of our common stock at a predetermined price per share (the &ldquo;exercise price&rdquo;) during a fixed period
measured from the date of grant. A SAR entitles the grantee to receive the excess of the fair market value of a specified number of shares
on the date of exercise over a predetermined exercise price per share. The exercise price of an option or a SAR will be determined by
the Plan Committee and set forth in the award agreement but the exercise price may not be less than the fair market value of a share of
common stock on the grant date. The term of each option or SAR is determined by the Plan Committee and set forth in the award agreement,
except that the term may not exceed ten (10) years. Options may be exercised by payment of the purchase price through one or more of the
following means: payment in cash (including personal check or wire transfer), or with the approval of the Plan Committee, by delivering
shares of our common stock previously owned by the grantee, or by delivery of shares of our common stock acquired upon the exercise of
such option. The Plan Committee may also permit a grantee to pay the exercise price of an option through the sale of shares acquired upon
exercise of the option through a broker-dealer to whom the grantee has delivered irrevocable instructions to deliver sales proceeds sufficient
to pay the purchase price and any applicable withholding taxes to us. The grant of ISOs is contingent upon shareholder approval of the
2024 Plan within twelve (12) months of its adoption by our Board.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Restricted Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee may award restricted shares consisting
of shares of our common stock which remain subject to a risk of forfeiture and may not be disposed of by grantees until certain restrictions
established by the Plan Committee lapse. The vesting conditions may be service-based (i.e., requiring continuous service for a specified
period) or performance-based (i.e., requiring achievement of certain specified performance objectives) or both. A grantee receiving restricted
shares will have all of the rights of a stockholder, including the right to vote the shares and the right to receive any dividends, except
as otherwise provided in the award agreement. Upon termination of the grantee&rsquo;s affiliation with us during the restriction period
(or, if applicable, upon the failure to satisfy the specified performance objectives during the restriction period), the restricted shares
will be forfeited as provided in the award agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Restricted Stock Units and Deferred Stock</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee may also grant restricted stock
unit awards and/or deferred stock awards. A deferred stock award is the grant of a right to receive a specified number of shares of our
common stock at the end of specified deferral periods or upon the occurrence of a specified event, which satisfies the requirements of
Section 409A of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;). A restricted stock unit award is the grant of
a right to receive a specified number of shares of our common stock upon lapse of a specified forfeiture condition (such as completion
of a specified period of service or achievement of certain specified performance objectives). If the service condition and/or specified
performance objectives are not satisfied during the restriction period, the award will lapse without the issuance of the shares underlying
such award.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Restricted stock units and deferred stock awards carry
no voting or other rights associated with stock ownership until the shares underlying the award are delivered in settlement of the award.
The award agreement will provide whether grantees may receive dividend equivalents with respect to restricted stock units or deferred
stock, and if so, whether such dividend equivalents are distributed when credited or deemed to be reinvested in additional shares of restricted
stock units or deferred stock.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Performance Units</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee may grant performance units, which
entitle a grantee to cash and/or shares conditioned upon the fulfillment of certain performance conditions and other restrictions as specified
by the Plan Committee and reflected in the award agreement. The initial value of a performance unit will be determined by the Plan Committee
at the time of grant. The Plan Committee will determine the terms and conditions of such awards, including performance and other restrictions
placed on these awards, which will be reflected in the award agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 28 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Performance Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee may grant performance shares, which
entitle a grantee to a certain number of shares of common stock, conditioned upon the fulfillment of certain performance conditions and
other restrictions as specified by the Plan Committee and reflected in the award agreement. The Plan Committee will determine the terms
and conditions of such awards, including performance and other restrictions placed on these awards, which will be reflected in the award
agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Bonus Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee may grant shares of our common
stock as bonus shares on such terms and conditions as specified in the award agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Dividend Equivalents</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Plan Committee is authorized to grant dividend
equivalents which provide a grantee the right to receive payment equal to the dividends paid on a specified number of shares of our common
stock. Dividend equivalents may be paid directly to grantees or may be deferred for later delivery under the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Other Stock-Based Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to enable us to respond to material developments
in the area of taxes and other legislation and regulations and interpretations thereof, and to trends in executive compensation practices,
the 2024 Equity Plan authorizes the Plan Committee to grant awards that are valued in whole or in part by reference to or otherwise based
on our securities. The Plan Committee determines the terms and conditions of such awards, including consideration paid for awards granted
as share purchase rights and whether awards are paid in shares or cash.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Nonemployee Director Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board may grant awards under the 2024 Equity Plan
to any non-employee director, provided that (except in the context of a merger of the Company) non-employee directors may not be granted
any award to the extent the fair market value (determined as of the date of grant) of the applicable shares, when combined with all other
compensation payable to such non-employee directors in the calendar year the sward is made, exceeds $750,000 (or $1,000,000 in the case
of a newly appointed non-employee director).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Merger, Consolidation or Similar Corporate Transaction</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If there is a merger or consolidation of us with or
into another corporation or a sale of substantially all of our stock (any of which is considered a &ldquo;Corporate Transaction&rdquo;),
and the outstanding awards are not assumed by surviving company (or its parent company) or replaced with economically equivalent awards
granted by the surviving company (or its parent company), the Plan Committee will cancel any outstanding awards that are not vested and
nonforfeitable as of the consummation of such Corporate Transaction (unless the Plan Committee accelerates the vesting of any such awards)
and with respect to any vested and nonforfeitable awards, the Plan Committee may either (i) allow all grantees to exercise options and
SARs within a reasonable period prior to the consummation of the Corporate Transaction and cancel any outstanding options or SARs that
remain unexercised upon consummation of the Corporate Transaction, or (ii) cancel any or all of such outstanding awards (including options
and SARs) in exchange for a payment (in cash, or in securities or other property) in an amount equal to the amount that the grantee would
have received (net of the exercise price with respect to any options or SARs) if the vested awards were settled or distributed or such
vested options and SARs were exercised immediately prior to the consummation of the Corporate Transaction. If an exercise price of the
option or SAR exceeds the fair market value of our common stock and the option or SAR is not assumed or replaced by the surviving company
(or its parent company), such options and SARs will be cancelled without any payment to the grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 29 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Amendment to and Termination of the 2024 Equity
Plan</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 2024 Equity Plan may be amended, altered, suspended,
discontinued or terminated by our Board without further stockholder approval, unless such approval of an amendment or alteration is required
by law or regulation or under the rules of any stock exchange or automated quotation system on which the common stock is then listed or
quoted. Thus, stockholder approval will not necessarily be required for amendments which might increase the cost of the 2024 Equity Plan
or broaden eligibility. Stockholder approval will not be deemed to be required under laws or regulations that condition favorable treatment
of grantees on such approval, although our Board may, in its discretion, seek stockholder approval in any circumstance in which it deems
such approval advisable. No ISOs may be awarded after any amendment to the 2024 Equity Plan that either broadens eligibility or increase
the number of shares available for delivery in the form of ISOs unless such amendment is approved by our stockholders within 12 months
of the date the Board approves the adoption of such amendment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, subject to the terms of the 2024 Equity
Plan, no amendment or termination of the 2024 Equity Plan may materially and adversely affect the right of a grantee under any award granted
under the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless earlier terminated by our Board, the 2024 Equity
Plan will terminate when no shares remain reserved and available for issuance or, if earlier, on the tenth anniversary of the effective
date of the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Federal Tax Information</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a general summary of the U.S. federal
income tax consequences to the Company and to recipients of awards granted under the 2024 Equity Plan. The U.S. federal tax laws may change
and the federal, state and local tax consequences for any participant will depend upon his or her individual circumstances. Tax consequences
for any particular individual may be different. This summary is not intended to be exhaustive and does not discuss the tax consequences
of a participant&rsquo;s death or provisions of income tax laws of any municipality, state or other country. We advise participants to
consult with a tax advisor regarding the tax implications of their awards under the 2024 Equity Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Incentive Stock Options</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A grantee who receives an incentive stock option grant
will not recognize any taxable income either at the time of grant or exercise of the option, although the exercise may subject the grantee
to the alternative minimum tax. Upon the sale or other disposition of the shares more than two years after the grant of the option and
one year after the exercise of the option, any gain or loss will be treated as a long-term capital gain or loss. If these holding periods
are not satisfied, the grantee will recognize ordinary income at the time of sale or disposition equal to the lesser of (a) the fair market
of the shares at the date of the option exercise minus the exercise price or (b) the sale price of the shares minus the exercise price.
Any gain or loss recognized on such a premature disposition of the shares in excess of the amount treated as ordinary income will be characterized
as long-term or short-term capital gain or loss, depending on the holding period. The Company will be entitled to a deduction in the same
amount as the ordinary income recognized by the grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Nonstatutory Stock Options</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All options that do not qualify as incentive stock
options are referred to as nonstatutory options. A grantee will not recognize any taxable income at the time he or she receives a nonstatutory
option grant. However, upon exercise of the nonstatutory option, the grantee will recognize ordinary taxable income generally measured
as the excess of the fair market value of the shares purchased on the date of exercise over the purchase price. Any taxable income recognized
in connection with an option exercise by a grantee who is also an employee of the Company will be subject to tax withholding by the Company.
Upon the sale of such shares by the grantee, any difference between the sale price and the fair market value of the shares on the date
of exercise of the option will be treated as long-term or short-term capital gain or loss, depending on the holding period. The Company
will be entitled to a tax deduction in the same amount as the ordinary income recognized by the grantee with respect to shares acquired
upon exercise of a nonstatutory option, except to the extent the deduction limits of Section 162(m) of the Code apply.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 30 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Stock Appreciation Rights, Restricted Stock, Performance
Shares, Stock Units, and Other Stock-Based Awards</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A grantee will not recognize taxable income at the
time SARs are granted and the Company will not be entitled to a tax deduction at that time. Upon exercise, the grantee will recognize
compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) in an amount equal to the fair
market value of any shares delivered and the amount of cash paid by the Company, and the Company will be entitled to a corresponding deduction,
except to the extent the deduction limits of Section 162(m) of the Code apply.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A grantee will not recognize taxable income at the
time restricted stock is granted and the Company will not be entitled to a tax deduction at that time, unless the grantee makes an election
to be taxed at that time. If such election is made, the grantee will recognize compensation taxable as ordinary income (and subject to
income tax withholding in respect of an employee) at the time of the grant in an amount equal to the excess of the fair market value for
the shares at such time over the amount, if any, paid for those shares. If such election is not made, the grantee will recognize compensation
taxable as ordinary income (and subject to income tax withholding in respect of an employee) at the time the restrictions constituting
a substantial risk of forfeiture lapse in an amount equal to the excess of the fair market value of the shares at such time over the amount,
if any, paid for those shares. The amount of ordinary income recognized by making the above-described election or upon the lapse of restrictions
constituting a substantial risk of forfeiture is deductible by the Company as compensation expense, except to the extent the deduction
limits of Section 162(m) of the Code apply. In addition, a participant receiving dividends with respect to restricted stock for which
the above-described election has not been made and prior to the time the restrictions constituting a substantial risk of forfeiture lapse
will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee), rather than
dividend income, in an amount equal to the dividends paid and the Company will be entitled to a corresponding deduction, except to the
extent the deduction limits of Section 162(m) of the Code apply.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A grantee will not recognize taxable income at the
time a stock unit is granted and the Company will not be entitled to a tax deduction at that time. Upon settlement of stock units, the
grantee will recognize compensation taxable as ordinary income (and subject to income tax withholding in respect of an employee) in an
amount equal to the fair market value of any shares delivered and the amount of any cash paid by the Company, and the Company will be
entitled to a corresponding deduction, except to the extent the deduction limits of Section 162(m) of the Code apply. The tax treatment
with respect to other stock-based awards will depend on the structure of such awards.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Income Tax Effects for the Company</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a general rule, the Company will be entitled to
a deduction in the same amount and at the same time as the compensation income is received by the participant, except to the extent the
deduction limits of Section 162(m) of the Code apply. Section 162(m) of the Code denies a deduction to any publicly held corporation for
compensation paid to any &ldquo;covered employee&rdquo; in a taxable year to the extent that compensation to such covered employee exceeds
$1,000,000. It is possible that compensation attributable to awards under the 2021 Plan may cause this limitation to be exceeded in any
particular year.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Internal Revenue Code Section 409A</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any award that is deemed to be a deferral arrangement
(that is, not excluded or exempted under the tax regulations) will be subject to Section 409A of the Code. Elections by the grantee to
defer compensation under such awards and the timing of distributions relating to such awards must meet the applicable requirements under
Section 409A of the Code in order for income taxation to be deferred upon vesting of the award and tax penalties avoided by the grantee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 31 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Equity Compensation Plan Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>as of December 31, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 7.5in; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 44%; border-bottom: black 1pt solid; text-align: center"><B>Plan Category</B></TD>
    <TD STYLE="width: 20%; border-bottom: black 1pt solid; text-align: center"><B>Number of securities to be issued upon exercise of outstanding options, warrants and rights</B></TD>
    <TD STYLE="width: 17%; border-bottom: black 1pt solid; text-align: center"><B>Weighted-average exercise price of outstanding options, warrants and rights</B></TD>
    <TD STYLE="width: 19%; border-bottom: black 1pt solid; text-align: center"><B>Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</B></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>(a)</B></TD>
    <TD STYLE="text-align: center"><B>(b)</B></TD>
    <TD STYLE="text-align: center"><B>(c)</B></TD></TR>
  <TR STYLE="background-color: #ECECEC">
    <TD><B>Equity compensation plans approved by security holders</B></TD>
    <TD STYLE="text-align: center">3,056,250</TD>
    <TD STYLE="text-align: center">$3.75</TD>
    <TD STYLE="text-align: center">857,274</TD></TR>
  <TR>
    <TD><B>Equity compensation plans not approved by security holders&nbsp;<SUP>(1)</SUP></B></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center">1,400,000</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center">$2.99</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 11pt">&mdash;</FONT></TD></TR>
  <TR STYLE="background-color: #ECECEC">
    <TD><B>Total</B></TD>
    <TD STYLE="text-align: center">4,456,250</TD>
    <TD STYLE="text-align: center">$3.51&nbsp;</TD>
    <TD STYLE="text-align: center">857,274</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">__________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1) Represents unvested shares of restricted stock
and options issued as inducement to employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Report of the Audit Committee</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Audit Committee of the Board has been responsible
for the oversight of the integrity of the Company&rsquo;s consolidated financial statements, our internal accounting and financial controls,
our compliance with legal and regulatory requirements, the organization and performance of our internal audit function and the qualifications,
independence and performance of our independent registered public accounting firm.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management of the Company is responsible for establishing
and maintaining internal controls and for preparing the Company&rsquo;s consolidated financial statements. The independent registered
public accounting firm is responsible for auditing the financial statements. It is the responsibility of the Audit Committee to oversee
these activities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Audit Committee reviewed and discussed the Company&rsquo;s
audited financial statements with management.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Audit Committee discussed with McGrail Merkel
Quinn &amp; Associates, P.C. the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight
Board.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Audit Committee also received written disclosures
and the letter from McGrail Merkel Quinn &amp; Associates, P.C. required by applicable requirements of the Public Company Accounting Oversight
Board regarding McGrail Merkel Quinn &amp; Associates, P.C. communications with the Audit Committee concerning independence and has discussed
with McGrail Merkel Quinn &amp; Associates, P.C. their independence from the Company. The Audit Committee also reviewed and discussed the
selection, application and disclosure of the critical accounting policies of the Company with McGrail Merkel Quinn &amp; Associates, P.C.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the review and discussions referred to above,
the Audit Committee recommended to the Board of Directors that the Company&rsquo;s audited financial statements be included in the Company&rsquo;s
Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #00B050">Audit Committee</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Robert A. Cascella</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">R. John Fletcher</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Joseph M. Manko, Jr.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 32 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050">Securities owned by certain beneficial
owners and management</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below sets forth, as of March 24, 2024,
the number of shares of common stock beneficially owned by each person owning more than 5% of the outstanding shares, by each named executive
officer, director and director nominee, and by all executive officers and directors as a group. Except as otherwise noted, the address
of each person is c/o KORU Medical Systems, Inc., 100 Corporate Drive, Mahwah, NJ, 07430.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have determined beneficial ownership in accordance
with the rules of the Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Except as indicated by the footnotes below, we believe,
based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power
with respect to all shares of common stock that they beneficially own, subject to applicable community property laws. We are not aware
of any arrangements, including any pledge by any person of the Company&rsquo;s securities, which may result in a change in control of
the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Percentage ownership is based on 46,573,087 shares
of common stock outstanding (including 850,000 shares of unvested restricted common stock entitled to vote) at March 24, 2024. In computing
the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, except as indicated by
the footnotes below, we deemed outstanding shares of common stock subject to options held by that person that are currently exercisable
or exercisable within 60 days of March 24, 2024, to be outstanding ignoring the withholding of shares of common stock to cover applicable
taxes. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. We
did not deem outstanding shares of common stock issuable as directors&rsquo; fees within 60 days after March 24, 2024, as the number of
shares is not able to be calculated at this time. Beneficial ownership representing less than 1% is denoted with an asterisk (*).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information provided in the table is based on
our records, information filed with the SEC, and information provided to us, except where otherwise noted.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 7.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%; border-bottom: Black 1pt solid; text-align: center"><B>Name of Principal Shareholders and Identity of Group</B></TD>
    <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><B>Shares<BR>
Beneficially<BR>
Owned</B></TD>
    <TD STYLE="width: 5%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><B>Percent of<BR>
Class</B></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Joseph M. Manko, Jr.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">7,753,632</TD>
    <TD STYLE="text-align: left">&nbsp;<SUP>(1)</SUP></TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">16.7%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Linda Tharby</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">1,819,263</TD>
    <TD STYLE="text-align: left">&nbsp;<SUP>(4)</SUP></TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">3.9%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">R. John Fletcher </TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">164,860</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: left">Tom Adams</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">100,000</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Brian Case</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">118,750</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Shahriar (Shar) Matin</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">56,280</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Donna French</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">53,650</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Robert Cascella</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">53,291</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Edward Wholihan</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">6,448</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Kenneth Miller</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&mdash;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">*</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">All Directors and Executive Officers as a Group</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">10,126,174</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">21.7%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Horton Capital Management, LLC</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">7,753,632</TD>
    <TD STYLE="text-align: left">&nbsp;<SUP>(1)</SUP></TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">16.7%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">First Light Asset Management, LLC</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">5,158,444</TD>
    <TD STYLE="text-align: left">&nbsp;<SUP>(2)</SUP></TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">11.1%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E6E6E6">
    <TD STYLE="text-align: left">Archon Capital Management, LLC</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">3,720,876</TD>
    <TD STYLE="text-align: left">&nbsp;<SUP>(3)</SUP></TD>
    <TD STYLE="padding-right: 22.5pt; text-align: right">8.0%</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 33 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">__________</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
solely upon a Form 4 filed with the SEC on February 16, 2024 and other information provided to us by Horton Capital Management, LLC, a
Delaware limited liability company (&ldquo;HCM&rdquo;), each of Mr. Manko and HCM may be deemed to beneficially own 7,753,632 shares of
common stock, including 7,588,380 shares of common stock held directly by Horton Capital Partners Fund, LP, a Delaware limited partnership
(&ldquo;HCPF&rdquo;) and 165,252 shares held directly by Mr. Manko. HCM maintains discretionary investment and voting authority with respect
to all of such shares and may be deemed to be the beneficial owner of such shares because, in the event HCM&rsquo;s investment advisory
agreements with respect to such shares are terminated, Horton Capital Partners LLC (&ldquo;HCP&rdquo;), a Delaware limited liability company,
has the right to assume HCM&rsquo;s discretionary investment and voting authority with respect to such shares. HCP is the general partner
of HCPF. Mr. Manko is the managing member of HCM and may be deemed to be the beneficial owner of the shares of common stock held by HCPF.
The address of Mr. Manko, HCM, HCP, HCPF and HFF is 1717 Arch Street, 39th Floor, Philadelphia, PA 19103.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based solely upon
an Amendment to Schedule 13G filed with the SEC on February 14, 2024, First Light Asset Management, LLC (&ldquo;First Light&rdquo;), each
of First Light and Mathew P. Arens may be deemed to be the beneficial owner of 5,158,444 of shares of common stock. First Light acts as
an investment adviser to certain persons holding separately managed accounts with First Light, each of whom has the right to receive or
the power to direct the receipt of dividends from, or the proceeds from the sale of, those shares. First Light may also be deemed to be
the beneficial owner of these shares because it acts as an investment adviser to certain private funds. Mr. Arens may also be deemed to
be the beneficial owner of these shares because he controls First Light in his position as managing member and majority owner of First
Light. Mr. Arens also directly holds 10,000 shares in an individual capacity with sole control and 99,967 shares in a joint account over
which he shares control. The address of First Light and Mr. Arens is 3300 Edinborough Way #201, Edina, MN 55435.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
solely upon an Amendment No. 2 to Schedule 13G filed with the SEC on February 13, 2024 by Archon Capital Management, LLC, a Washington
limited liability company (&ldquo;Archon&rdquo;), and Constantinos Christofilis, Mr. Christofilis may be considered a control person with
respect to Archon.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Includes
850,000 unvested shares of restricted stock that are deemed beneficially owned because the holder has sole voting power with
respect to such shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="color: #00B050; font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">Delinquent Section 16(a) reports</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Section 16(a) of the Exchange Act requires that our directors and executive
officers, and persons who own more than ten percent (10%) of our common stock, file with the SEC reports of initial ownership of our common
stock and subsequent changes in that ownership and furnish to us copies of all forms they file pursuant to Section 16(a). Based solely
on a review of Forms 3, 4, and 5 furnished to us or filed with the SEC in fiscal year 2023, we believe all Section 16(a) filing requirements
were timely made in the fiscal year ended December 31, 2023, except for one late Form 4 for Brian Case and a late Form 3 for Tom Adams.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 34 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050">2025 Annual Meeting of Shareholders</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any shareholder proposals intended to be presented
at our 2025 Annual Meeting of shareholders and considered for inclusion in our proxy materials must be received by November 30, 2024 and
must comply with the procedures of Rule 14a-8 under the Exchange Act. Shareholder proposals failing to comply with the procedures of Rule
14a-8 under the Exchange Act will be excluded. If the date of our 2025 Annual Meeting is more than 30 days from the anniversary of the
date of the 2024 Annual Meeting, we will publicly announce a different submission deadline from that set forth above, in compliance with
SEC rules.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Bylaws establish an advance notice procedure with
regard to shareholder proposals that a shareholder wishes to present at an annual meeting of shareholders. To be properly brought before
the 2025 Annual Meeting, a notice of the matter the shareholder wishes to present at the meeting must be delivered to the Chairman of
the Board at the Company&rsquo;s principal offices in Mahwah, NJ (see below) not less than 90 nor more than 120 days prior to the first
anniversary of the date of this year&rsquo;s Annual Meeting. As a result, any notice given by or on behalf of a shareholder pursuant to
these provisions of the Bylaws (and not pursuant to Rule 14a-8) must be received no later than February 15, 2025 and no earlier than January
16, 2025. However, if the 2025 Annual Meeting is more than 30 days before or after the first anniversary of the date of this year&rsquo;s
Annual Meeting, such notice must be received no later than the close of business on the 10th day following the date public disclosure
of the meeting date was made. All shareholder proposals must comply with the requirements of the Bylaws. The chairman of the Annual Meeting
may refuse to acknowledge or introduce any such matter at the Annual Meeting if notice of the matter is not received within the applicable
deadlines or does not comply with the Bylaws. If a shareholder does not meet these deadlines or does not satisfy the requirements of Rule
14a-4 of the Exchange Act, the persons named as proxies will be allowed to use their discretionary voting authority when and if the matter
is presented at the Annual Meeting. In addition to satisfying the foregoing requirements under our Bylaws, to comply with the universal
proxy rules, stockholders who intend to solicit proxies in support of director nominees other than management&rsquo;s nominees must provide
notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 17, 2025.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shareholder proposals should be sent to us at KORU
Medical Systems, Inc., 100 Corporate Drive, Mahwah, NJ 07430, Attention: Corporate Secretary.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #00B050"><FONT STYLE="background-color: white">Other
matters</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board is not aware of any matters to be presented
at the 2024 Annual Meeting other than those set forth in the accompanying notice. If any other matters properly come before the meeting
(or any adjournment or postponement thereof), the persons named in the proxy card will vote on such matters in their discretion in accordance
with their best judgment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="FONT: 10PT TIMES NEW ROMAN, TIMES, SERIF; MARGIN: 0; TEXT-ALIGN: CENTER">- 35 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

</DIV><DIV STYLE="width: 6.5in">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="Appendix_A"></A>&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Appendix A</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: left"><A NAME="Koru2024OmnibusEquityIncentivePlan"></A></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>KORU MEDICAL SYSTEMS, INC.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2024 OMNIBUS EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 6.5in; font: 12pt Times New Roman, Times, Serif">
  <TR>
    <TD STYLE="width: 6in">&nbsp;</TD>
    <TD STYLE="width: 0.5in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 1. Effective Date, Objectives and Duration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 2. Definitions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 3. Administration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 4. Shares Subject to the Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 5. Eligibility and General Conditions of Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 6. Stock Options</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 7. Stock Appreciation Rights</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 8. Restricted Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 9. Performance Units and Performance Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 10. Deferred Stock and Restricted Stock Units</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 11. Dividend Equivalents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 12. Bonus Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 13. Other Stock-Based Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 14. Non-Employee Director Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 15. Amendment, Modification, and Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 16. Section&nbsp;409A</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 17. Withholding</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E6E6E6">
    <TD><FONT STYLE="font-size: 11pt">Article 18. Additional Provisions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 11pt">23</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 2 -</P>


<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>KORU MEDICAL SYSTEMS, INC.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2024 OMNIBUS EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 1.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Effective Date, Objectives and Duration</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective
Date of the Plan</U>. The Board of Directors of KORU Medical Systems, Inc., a Delaware corporation (the &ldquo;Company&rdquo;),
adopted the 2024 Omnibus Equity Incentive Plan (the &ldquo;Plan&rdquo;) effective as of March [*],
2024 (the &ldquo;Effective Date&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Objectives
of the Plan</U>. The Plan is intended (a)&nbsp;to allow selected employees of and consultants to the Company and its Affiliates to acquire
or increase equity ownership in the Company, thereby strengthening their commitment to the success of the Company and stimulating their
efforts on behalf of the Company, and to assist the Company and its Affiliates in attracting new employees, officers and consultants and
retaining existing employees and consultants, (b)&nbsp;to optimize the profitability and growth of the Company and its Affiliates through
incentives which are consistent with the Company&rsquo;s goals, (c)&nbsp;to provide Grantees with an incentive for excellence in individual
performance, (d)&nbsp;to promote teamwork among employees, consultants and Non-Employee Directors, and (e)&nbsp;to attract and retain
highly qualified persons to serve as Non-Employee Directors and to promote ownership by such Non-Employee Directors of a greater proprietary
interest in the Company, thereby aligning such Non-Employee Directors&rsquo; interests more closely with the interests of the Company&rsquo;s
stockholders.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Duration
of the Plan</U>. The Plan shall commence on the Effective Date and shall remain in effect, subject to the right of the Board to amend
or terminate the Plan at any time pursuant to Article 15 hereof, until the earlier of the tenth anniversary of the Effective Date, or
the date all Shares subject to the Plan shall have been purchased or acquired and the restrictions on all Restricted Shares granted under
the Plan shall have lapsed, according to the Plan&rsquo;s provisions.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 2.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Definitions</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Whenever used in the Plan, the
following terms shall have the meanings set forth below:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Affiliate</U>&rdquo;
means, with respect to a Person, any Person that directly or indirectly Controls, or is Controlled by, or is under common Control with
such Person. &ldquo;Control&rdquo;, &ldquo;Controlled by&rdquo; and &ldquo;under common Control with&rdquo; shall mean to have a &ldquo;controlling
interest&rdquo; within the meaning of section 1.409A-1(b) (5) (iii) (E) (1) of the regulations under the Code.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Award</U>&rdquo;
means Options (including non-qualified options and Incentive Stock Options), SARs, Restricted Shares, Performance Units (which may be
paid in cash), Performance Shares, Deferred Stock, Restricted Stock Units, Dividend Equivalents, Bonus Shares or Other Stock-Based Awards
granted under the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Award
Agreement</U>&rdquo; means either (a)&nbsp;a written agreement entered into by the Company and a Grantee setting forth the terms and provisions
applicable to an Award granted under this Plan, or (b)&nbsp;a written statement issued by the Company to a Grantee describing the terms
and provisions of such Award, including any amendment or modification thereof. The Committee may provide for the use of electronic, internet
or other non-paper Award Agreements and the use of electronic, internet or other non-paper means for the acceptance thereof and actions
thereunder by the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 3 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Board</U>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Bonus
Shares</U>&rdquo; means Shares that are awarded to a Grantee with or without cost and without restrictions either in recognition of past
performance, as an inducement to become an Eligible Person or, with the consent of the Grantee, as payment in lieu of any cash remuneration
otherwise payable to the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>CEO</U>&rdquo;
means the Chief Executive Officer of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Change
in Control</U>&rdquo; shall mean a change in ownership of the Company or a substantial portion of its assets within the meaning of Treasury
Regulation Section 1.409A-3(i)(5) or (vii), or change in effective control of the Company within the meaning of Treasury Regulation
Section 1.409A(3)(i)(5)(vi).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended from time to time. References to a particular section of the Code include references
to regulations and rulings thereunder and to successor provisions.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Committee</U>&rdquo;
or &ldquo;<U>Incentive Plan Committee</U>&rdquo; has the meaning set forth in Section&nbsp;3.1(a).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Compensation
Committee</U>&rdquo; means the compensation committee of the Board.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Common
Stock</U>&rdquo; means the common stock, $0.01 par value, of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Corporate
Transaction</U>&rdquo; shall have the meaning set forth in Section&nbsp;4.2(b).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Deferred
Stock</U>&rdquo; means a right, granted under Article 10, to receive Shares at the end of a specified deferral period.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Disability</U>&rdquo;
or &ldquo;<U>Disabled</U>&rdquo; means, unless otherwise defined in an Award Agreement, or as otherwise determined under procedures established
by the Committee for purposes of the Plan:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a) Except as provided
in (b)&nbsp;below, a disability within the meaning of Section&nbsp;22(e) (3) of the Code; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b) In the case of any
Award that constitutes deferred compensation within the meaning of Section&nbsp;409A of the Code, a disability as defined in regulations
under Code Section&nbsp;409A. For purpose of Code Section&nbsp;409A, a Grantee will be considered Disabled if:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) the Grantee is unable
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected
to result in death or can be expected to last for a continuous period of not less than twelve (12)&nbsp;months, or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) the Grantee is, by
reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last
for a continuous period of not less than twelve (12)&nbsp;months, receiving income replacement benefits for a period of not less than
three (3)&nbsp;months under an accident and health plan covering employees of the Grantee&rsquo;s employer.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 4 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Dividend
Equivalent</U>&rdquo; means a right to receive payments equal to dividends or property, if and when paid or distributed, on a specified
number of Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Effective
Date</U>&rdquo; has the meaning set forth in Section&nbsp;1.1.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Eligible
Person</U>&rdquo; means any individual who is an employee (including any officer) of, a non-employee consultant to, or a Non-Employee
Director of, the Company or any Affiliate; provided, however, that solely with respect to the grant of an Incentive Stock Option, an Eligible
Person shall be any employee (including any officer) of the Company or any Subsidiary Corporation. Notwithstanding the foregoing, an Eligible
Person shall also include an individual who is expected to become an employee to, non-employee consultant of or Non-Employee Director
of the Company or any Affiliate within a reasonable period of time after the grant of an Award (other than an Incentive Stock Option);
provided that any Award granted to any such individual shall be automatically terminated and cancelled without consideration if the individual
does not begin performing services for the Company or any Affiliate within twelve (12)&nbsp;months after the Grant Date. Solely for purposes
of Section&nbsp;5.6(b), current or former employees or non-employee directors of, or consultants to, of an Acquired Entity who receive
Substitute Awards in substitution for Acquired Entity Awards shall be considered Eligible Persons under this Plan with respect to such
Substitute Awards.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended from time to time. References to a particular section of the Exchange
Act include references to successor provisions.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Exercise
Price</U>&rdquo; means (a)&nbsp;with respect to an Option, the price at which a Share may be purchased by a Grantee pursuant to such Option
or (b)&nbsp;with respect to a SAR, the price established at the time a SAR is granted pursuant to Article 7, which is used to determine
the amount, if any, of the payment due to a Grantee upon exercise of the SAR.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Fair
Market Value</U>&rdquo; of a Share means (i) if the Shares principally trade on a national securities exchange other than the Nasdaq Capital
Market, the closing sale price of a Share, and (ii) if the Shares principally trade on the Nasdaq Capital Market or an over-the counter
marketplace, the arithmetic mean of the high and low prices of a Share (and if the mean results in a fractional cent, rounded up to the
nearest cent), in each case as reported on the last trading day before the Grant Date, provided that such quotations shall have been made
within the ten (10) business days preceding the applicable Grant Date. In the event Shares are not so traded at the time a determination
of their value is required to be made hereunder, the determination of their Fair Market Value shall be made by the Committee in such manner
as it deems appropriate provided such manner is consistent with Treasury Regulation Section&nbsp;1.409A-1(b)(5)(iv).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Grant
Date</U>&rdquo; means the date on which an Award is granted or such later date as specified in advance by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Grantee</U>&rdquo;
means a person who has been granted an Award.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Incentive
Stock Option</U>&rdquo; means an Option that is intended to meet the requirements of Section&nbsp;422 of the Code.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Including</U>&rdquo;
or &ldquo;<U>includes</U>&rdquo; means &ldquo;including, without limitation,&rdquo; or &ldquo;includes, without limitation,&rdquo; respectively.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Management
Committee</U>&rdquo; has the meaning set forth in Section&nbsp;3.1(b).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 5 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Non-Employee
Director</U>&rdquo; means a member of the Board who is not an employee of the Company or any Affiliate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Option</U>&rdquo;
means an option granted under Article 6 of the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.28 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Other
Stock-Based Award</U>&rdquo; means a right, granted under Article 13 hereof, that relates to or is valued by reference to Shares or other
Awards relating to Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.29 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Performance
Period</U>&rdquo; means, with respect to an Award of Performance Shares or Performance Units, the period of time during which the performance
vesting conditions applicable to such Award must be satisfied.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Performance
Share</U>&rdquo; and &ldquo;<U>Performance Unit</U>&rdquo; have the respective meanings set forth in Article 9.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Period
of Restriction</U>&rdquo; means the period during which Restricted Shares are subject to forfeiture if the conditions specified in the
Plan and the Award Agreement are not satisfied.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Person</U>&rdquo;
means any individual, sole proprietorship, partnership, joint venture, limited liability company, trust, unincorporated organization,
association, corporation, institution, public benefit corporation, entity or government instrumentality, division, agency, body or department.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Restricted
Shares</U>&rdquo; means Shares, granted under Article 8, that are both subject to forfeiture and are nontransferable if the Grantee does
not satisfy the conditions specified in the Plan and the Award Agreement applicable to such Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Restricted
Stock Units</U>&rdquo; are rights, granted under Article 10, to receive cash and/or Shares if the Grantee satisfies the conditions specified
in the Plan and the Award Agreement applicable to such rights.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Rule
16b-3</U>&rdquo; means Rule 16b-3 promulgated by the SEC under the Exchange Act, as amended from time to time, together with any successor
rule.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>SEC</U>&rdquo;
means the United States Securities and Exchange Commission, or any successor thereto.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Section&nbsp;16
Non-Employee Director</U>&rdquo; means a member of the Board who satisfies the requirements to qualify as a &ldquo;non-employee director&rdquo;
under Rule 16b-3.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Section&nbsp;16
Person</U>&rdquo; means a person who is subject to potential liability under Section&nbsp;16(b) of the Exchange Act with respect to transactions
involving equity securities of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Separation
from Service</U>&rdquo; means, with respect to any Award that constitutes deferred compensation within the meaning of Code Section&nbsp;409A,
a &ldquo;separation from service&rdquo; as defined in Treasury Regulation Section&nbsp;1.409A-1(h). For this purpose, a &ldquo;separation
from service&rdquo; is deemed to occur on the date that the Company and the Grantee reasonably anticipate that the level of bona fide
services the Grantee would perform for the Company and/or any Affiliates after that date (whether as an employee, Non-Employee Director
or consultant or independent contractor) would permanently decrease to a level that, based on the facts and circumstances, would constitute
a separation from service; provided that a decrease to a level that is 50% or more of the average level of bona fide services provided
over the</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 6 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">prior 36 months shall not be a separation from service,
and a decrease to a level that is 20% or less of the average level of such bona fide services shall be a separation from service. The
Committee retains the right and discretion to specify, and may specify, whether a separation from service occurs with respect to those
individuals who are performing services for the Company or an Affiliate immediately prior to an asset purchase transaction in which the
Company or an Affiliate is the seller and who continue to perform services for the buyer (or an affiliate thereof) immediately following
such asset purchase transaction; provided, such specification is made in accordance with the requirements of Treasury Regulation Section&nbsp;1.409A-1(h)(4).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Share</U>&rdquo;
means a share of Common Stock, and such other securities of the Company, as may be substituted or resubstituted for Shares pursuant to
Section&nbsp;4.2 hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Stock
Appreciation Right</U>&rdquo; or &ldquo;<U>SAR</U>&rdquo; means an Award granted under Article 7 of the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Subsidiary
Corporation</U>&rdquo; means a corporation other than the Company in an unbroken chain of corporations beginning with the Company if,
at the time of granting the Option, each of the corporations other than the last corporation in the unbroken chain owns stock possessing
50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Surviving
Company</U>&rdquo; means (a)&nbsp;the surviving corporation in any merger, consolidation or similar transaction, involving the Company
(including the Company if the Company is the surviving corporation), (b) or the direct or indirect parent company of such surviving corporation
or (c)&nbsp;the direct or indirect parent company of the Company following a sale of substantially all of the outstanding stock of the
Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Term</U>&rdquo;
of any Option or SAR means the period beginning on the Grant Date of an Option or SAR and ending on the date such Option or SAR expires,
terminates or is cancelled. No Option or SAR granted under this Plan shall have a Term exceeding 10 years.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Termination
of Affiliation</U>&rdquo; occurs on the first day on which an individual is for any reason no longer performing services for the Company
or any Affiliate in the capacity of an employee of, a non-employee consultant to, or a Non-Employee Director of, the Company or any Affiliate
or with respect to an individual who is an employee of, a non-employee consultant to or a Non-Employee Director of an Affiliate, the first
day on which such entity ceases to be an Affiliate of the Company unless such individual continues to perform Services for the Company
or another Affiliate without interruption after such entity ceases to be an Affiliate. Notwithstanding the foregoing, if an Award constitutes
deferred compensation within the meaning of Code Section&nbsp;409A, Termination of Affiliation with respect to such Award shall mean the
Grantee&rsquo;s Separation from Service.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 3.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Administration</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Committee</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to Article 14, and to Section&nbsp;3.2, the Plan shall be administered by a Committee (the &ldquo;Incentive Plan Committee&rdquo; or the
&ldquo;Committee&rdquo;) of directors of the Company appointed by the Board from time to time. Notwithstanding the foregoing, the Board
may at any time and in one or more instances reserve administrative powers to itself as the Committee or exercise any of the administrative
powers of the Committee. The number of members of the Committee may from time to time be increased or decreased as the Board deems appropriate.
To</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 7 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">the extent the Board considers it desirable
to comply with Rule 16b-3, the Committee shall consist of two or more directors of the Company, all of whom qualify as Section&nbsp;16
Non-Employee Directors.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board or the Incentive Plan Committee may appoint and delegate to another committee (&ldquo;Management Committee&rdquo;), or to the CEO,
any or all of the authority of the Board or the Committee, as applicable, with respect to Awards to Grantees other than Grantees who are
executive officers, Non-Employee Directors, or Section&nbsp;16 Persons at the time any such delegated authority is exercised, provided
that the Board shall fix the terms of the Awards to be granted by the Management Committee for the CEO (including the exercise price of
such Awards) and the maximum number of shares subject to Awards that the Management Committee or the CEO may grant; provided further,
however, that the Management Committee and the CEO shall not be authorized to grant Awards to himself/herself/themselves, or to any other
&ldquo;executive officer&rdquo; of the Company (as defined by Rule 3b-7 under the Exchange Act) or to any other &ldquo;officer&rdquo;
of the Company as defined by Rule 16a-1 under the Exchange Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
the context requires otherwise, any references herein to &ldquo;Committee&rdquo; include references to the Incentive Plan Committee, or
the Board to the extent the Incentive Plan Committee, or the Board, as applicable, has assumed or exercises administrative powers
itself as the Committee pursuant to subsection (a), and to the Management Committee or the CEO to the extent either has been delegated
authority pursuant to subsection (b), as applicable; provided that (i)&nbsp;for purposes of Awards to Non-Employee Directors, &ldquo;Committee&rdquo;
shall include only the full Board, and (ii)&nbsp;for purposes of Awards intended to comply with Rule 16b-3, the &ldquo;Committee&rdquo;
shall include only the Incentive Plan Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers
of Committee</U>. Subject to and consistent with the provisions of the Plan (including Article 14), the Committee has full and final authority
and sole discretion as follows; provided that any such authority or discretion exercised with respect to a specific Director shall be
approved by the affirmative vote of a majority of the members of the Board, even if not a quorum, but excluding the Director with respect
to whom such authority or discretion is exercised:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine when, to whom and in what types and amounts Awards should be granted;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
grant Awards to Eligible Persons in any number and to determine the terms and conditions applicable to each Award (including the number
of Shares or the amount of cash or other property to which an Award will relate, any Exercise Price or purchase price, any limitation
or restriction, any schedule for or performance conditions relating to the earning of the Award or the lapse of limitations, forfeiture
restrictions, restrictions on exercisability or transferability, any performance goals including those relating to the Company and/or
an Affiliate and/or any division thereof and/or an individual, and/or vesting based on the passage of time, based in each case on such
considerations as the Committee shall determine);</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine the benefit payable under any Award and to determine whether any performance or vesting conditions have been satisfied;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine whether specific Awards shall be granted in connection with other specific Awards, and if so, whether they shall be exercisable
cumulatively with, or alternatively to, such other specific Awards and all other matters to be determined in connection with an Award;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 8 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine the Term of any Option or SAR;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine the amount, if any, that a Grantee shall pay for Restricted Shares, whether to allow voting rights with respect thereto, or
to permit or require the payment of cash dividends thereon, whether such dividends are to be deferred and the terms related thereto, when
Restricted Shares (including Restricted Shares acquired upon the exercise of an Option) shall be forfeited and whether such shares shall
be held in escrow;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine whether, to what extent and under what circumstances an Award may be settled in, or the exercise price of an Award may be paid
in, cash, Shares, other Awards or other property (including by &ldquo;net&rdquo; exercise), or an Award may be accelerated, vested, canceled,
forfeited or surrendered or any terms of the Award may be waived, and to accelerate the exercisability of, and to accelerate or waive
any or all of the terms and conditions applicable to, any Award or any group of Awards for any reason and at any time;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine with respect to Awards granted to Eligible Persons whether, to what extent and under what circumstances cash, Shares, other
Awards, other property and other amounts payable with respect to an Award will be deferred, either at the election of the Grantee or automatically
pursuant to the terms of the Award Agreement;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
offer to exchange or buy out any previously granted Award for a payment in cash, Shares or other Award;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
construe and interpret the Plan and to make all determinations, including factual determinations, necessary or advisable for the administration
of the Plan;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
make, amend, suspend, waive and rescind rules and regulations relating to the Plan;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
appoint such agents as the Committee may deem necessary or advisable to administer the Plan;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
determine the terms and conditions of all Award Agreements applicable to Eligible Persons (which need not be identical) and, with the
consent of the Grantee, to amend any such Award Agreement at any time, among other things, to permit transfers of such Awards to the extent
permitted by the Plan; provided that the consent of the Grantee shall not be required for any amendment (i)&nbsp;which does not adversely
affect the rights of the Grantee, or (ii)&nbsp;which is necessary or advisable (as determined by the Committee) to carry out the purpose
of the Award as a result of any applicable law or (iii)&nbsp;to the extent the Award Agreement specifically permits amendment without
consent;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
cancel, with the consent of the Grantee, outstanding Awards and to grant new Awards in substitution therefor;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
impose such additional terms and conditions upon the grant, exercise or retention of Awards as the Committee may, before or concurrently
with the grant thereof, deem appropriate, including limiting the percentage of Awards which may from time to time be exercised by a Grantee;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 9 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
make adjustments in the terms and conditions of, and the criteria in, Awards in recognition of unusual or nonrecurring events (including
events described in Section&nbsp;4.2) affecting the Company or an Affiliate or the financial statements of the Company or an Affiliate,
or in accordance with applicable laws, regulations or accounting principles;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
correct any defect or supply any omission or reconcile any inconsistency, and to construe and interpret the Plan, rules and regulations
under the Plan, and Award Agreements or any other instruments entered into or relating to an Award under the Plan; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
take any other action with respect to any matters relating to the Plan for which it is responsible and to make all other decisions and
determinations as may be required under the terms of the Plan or as the Committee may deem necessary or advisable for the administration
of the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Any action of the Committee with
respect to the Plan shall be final, conclusive and binding on all persons, including the Company, its Affiliates, any Grantee, any person
claiming any rights under the Plan from or through any Grantee, and stockholders, except to the extent the Committee may subsequently
modify, or take further action whether or not consistent with, its prior action. If not specified in the Plan, the time at which the Committee
must or may make any determination shall be determined by the Committee, and any such determination may thereafter be modified by the
Committee. The express grant of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed
as limiting any power or authority of the Committee. Subject to Section&nbsp;3.1(b), the Committee may delegate to officers of the Company
or any Affiliate the authority, subject to such terms as the Committee shall determine, to perform specified functions under the Plan.
No Director or member of the Committee, nor any delegate thereof, shall be liable for any act, omission, interpretation, construction
or determination made in good faith in connection with the Plan, and each of the foregoing shall be entitled in all cases to indemnification
and reimbursement by the Company in respect of any claim, loss, damage or expense (including without limitation reasonable attorneys&rsquo;
fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any directors&rsquo; and officers&rsquo; liability
insurance coverage which may be in effect from time &nbsp;to time.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Repricing</U>. &nbsp;Notwithstanding any provision in Section&nbsp;3.2 to the contrary, the terms of any outstanding Option or SAR may
not be amended to reduce the Exercise Price of such Option or SAR or cancel any outstanding Option or SAR in exchange for other Options
or SARs with an Exercise Price that is less than the Exercise Price of the cancelled Option or SAR or for any cash payment (or Shares
having with a Fair Market Value) in an amount that exceeds the excess of the Fair Market Value of the Shares underlying such cancelled
Option or SAR over the aggregate Exercise Price of such Option or SAR or for any other Award, without stockholder approval; provided,
however, that the restrictions set forth in this Section&nbsp;3.3, shall not apply (i)&nbsp;unless the Company has a class of stock that
is registered under Section&nbsp;12 of the Exchange Act or (ii)&nbsp;to any adjustment allowed under to Section&nbsp;4.2.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 10 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 4.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shares Subject to the Plan</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Number of Shares Available for Grants.</U> The number of Shares hereby reserved
for issuance under this Plan is (i) two million three hundred thousand (2,300,000) Shares, plus (ii) any unissued Shares reserved and
available for issuance under the Company&rsquo;s 2021 Omnibus Equity Incentive Plan (the &ldquo;2021 Plan&rdquo;) and the Company&rsquo;s
2015 Stock Option Plan (the &ldquo;2015 Plan&rdquo;) as of the Effective Date, which shall also be the maximum number of Shares that may
be delivered pursuant to the exercise of Incentive Stock Options granted hereunder. In the event that any outstanding award under either
the Plan, the 2021 Plan or the 2015 Plan for any reason expires or is terminated prior to the exercise thereof, the Shares allocable to
the unexercised portion of such option shall continue to be reserved for Awards under the Plan and may be awarded hereunder. Immediately
upon the approval of the Plan by the Company&rsquo;s shareholders, no further grants will be permitted under the 2021 Plan, the 2015 Plan
or the and the Nonemployee Director Compensation Plan (the &ldquo;Nonemployee Director Plan&rdquo;). The total number of Shares reserved
for Awards under this Plan (including those from the 2021 Plan and the 2015 Plan) and the limit on annual grants shall be subject to adjustment
as provided in Section&nbsp;4.2 and except as provided in Section&nbsp;5.6(b).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If any Shares subject to an Award granted hereunder (other than a Substitute
Award granted pursuant to Section&nbsp;5.6(b)) are forfeited or such Award otherwise terminates without payment or delivery of such Shares,
the Shares subject to such Award, to the extent of any such forfeiture or termination, shall again be available for grant under the Plan.
For avoidance of doubt, however, if any Shares subject to an Award granted hereunder are withheld or applied as payment in connection
with the exercise of an Award or the withholding or payment of taxes related thereto (&ldquo;Returned Shares&rdquo;), such Returned Shares
will be treated as having been delivered for purposes of determining the maximum number of Shares available for grant under the Plan and
shall not again be treated as available for grant under the Plan. Moreover, the number of Shares available for issuance under the Plan
may not be increased through the Company&rsquo;s purchase of Shares on the open market with the proceeds obtained from the exercise of
any Options granted hereunder. Upon settlement of an SAR, the number of Shares underlying the portion of the SAR that is exercised will
be treated as having been delivered for purposes of determining the maximum number of Shares available for grant under the Plan and shall
not again be treated as available for issuance under the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Shares delivered pursuant to the
Plan may be, in whole or in part, authorized and unissued Shares, or treasury Shares, including Shares repurchased by the Company for
purposes of the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments
in Authorized Shares and Awards; Corporate Transaction, Liquidation or Dissolution</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
in Authorized Shares and Awards</U>. In the event that the Committee determines that any dividend or other distribution (whether in the
form of cash, Shares, or other property), recapitalization, forward or reverse stock split, subdivision, consolidation or reduction of
capital, reorganization, merger, consolidation, scheme of arrangement, split-up, spin-off or combination involving the Company or repurchase
or exchange of Shares or other securities of the Company or other rights to purchase Shares or other securities of the Company, or other
similar corporate transaction or event affects the Shares such that any adjustment is determined by the Committee to be appropriate in
order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the
Committee shall, in such manner as it may deem equitable, adjust any or all of (i)&nbsp;the number and type of Shares (or other securities
or property) with respect to which Awards may be granted, (ii)&nbsp;the number and type of Shares (or other securities or property) subject
to outstanding Awards, (iii)&nbsp;the Exercise Price</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 11 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">with respect to any Option or SAR or, if deemed appropriate, make provision for a
cash payment to the holder of an outstanding Award, and (iv)&nbsp;the number and kind of Shares of outstanding Restricted Shares, or the
Shares underlying any other form of Award. Notwithstanding the foregoing, no such adjustment shall be authorized with respect to any Options
or SARs to the extent that such adjustment would cause the Option or SAR to violate Section&nbsp;424(a) of the Code or otherwise subject
(in the determination of the Committee) any Grantee to taxation under Section&nbsp;409A of the Code; and <I>provided further</I> that
the number of Shares subject to any Award denominated in Shares shall always be a whole number.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Merger, Consolidation or Similar Corporate Transaction</U>. In the event of a merger or consolidation of the Company with or into another
corporation or a sale of substantially all of the stock of the Company (a &ldquo;Corporate Transaction&rdquo;), unless an outstanding
Award is assumed by the Surviving Company or replaced with an equivalent Award granted by the Surviving Company in substitution for such
outstanding Award, the Committee shall cancel any outstanding Awards that are not vested and nonforfeitable as of the consummation of
such Corporate Transaction (unless the Committee accelerates the vesting of any such Awards) and with respect to any vested and nonforfeitable
Awards, the Committee may either (i)&nbsp;allow all Grantees to exercise such Awards of Options and SARs within a reasonable period prior
to the consummation of the Corporate Transaction and cancel any outstanding Options or SARs that remain unexercised upon consummation
of the Corporate Transaction, or (ii)&nbsp;cancel any or all of such outstanding Awards in exchange for a payment (in cash, or in securities
or other property) in an amount equal to the amount that the Grantee would have received (net of the Exercise Price with respect to any Options or SARs) if
such vested Awards were settled or distributed or such vested Options and SARs were exercised immediately prior to the consummation of
the Corporate Transaction. Notwithstanding the foregoing, if an Option or SAR is not assumed by the Surviving Company or replaced with
an equivalent Award issued by the Surviving Company and the Exercise Price with respect to any outstanding Option or SAR exceeds the Fair
Market Value of the Shares immediately prior to the consummation of the Corporation Transaction, such Awards shall be cancelled without
any payment to the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Liquidation
or Dissolution of the Company</U>. In the event of the proposed dissolution or liquidation of the Company, each Award will terminate immediately
prior to the consummation of such proposed action, unless otherwise provided by the Committee. Additionally, the Committee may, in the
exercise of its sole discretion, cause Awards to be vested and non-forfeitable and cause any conditions on any such Award to lapse, as
to all or any part of such Award, including Shares as to which the Award would not otherwise be exercisable or non-forfeitable and allow
all Grantees to exercise such Awards of Options and SARs within a reasonable period prior to the consummation of such proposed action.
Any Awards that remain unexercised upon consummation of such proposed action shall be cancelled.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Deferred
Compensation</U>. Notwithstanding the forgoing provisions of this Section&nbsp;4.2, if an Award constitutes deferred compensation within
the meaning of Code Section&nbsp;409A, no payment or settlement of such Award shall be made pursuant to Section&nbsp;4.2(b) or (c), unless
the Corporate Transaction or the dissolution or liquidation of the Company, as applicable, constitutes a Change in Control.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 12 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 5.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Eligibility and General Conditions of Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>.
The Committee may in its discretion grant Awards to any Eligible Person, whether or not he or she has previously received an Award; provided,
however, that all Awards made to Non-Employee Directors shall be determined by the Board in its sole discretion.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Agreement</U>. To the extent not set forth in the Plan, the terms and conditions of each Award shall be set forth in an Award Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Terms and Termination of Affiliation</U>. The Committee may impose on any Award or the exercise or settlement thereof, at the date of
grant or, subject to the provisions of Section&nbsp;15.2, thereafter, such additional terms and conditions not inconsistent with the provisions
of the Plan as the Committee shall determine, including terms requiring forfeiture, acceleration or pro-rata acceleration of Awards in
the event of a Termination of Affiliation by the Grantee. Except as may be required under applicable state law, Awards may be granted
for no consideration other than prior and future services. Except as set forth in an Award Agreement or as otherwise determined by the
Committee, (a)&nbsp;all Options and SARs that are not vested and exercisable at the time of a Grantee&rsquo;s Termination of Affiliation,
and any other Awards that remain subject to a risk of forfeiture or which are not otherwise vested at the time of the Grantee&rsquo;s
Termination of Affiliation shall be forfeited to the Company and (b)&nbsp;all outstanding Options and SARs not previously exercised shall
expire three months after the Grantee&rsquo;s Termination of Affiliation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nontransferability
of Awards</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Award and each right under any Award shall be exercisable only by the Grantee during the Grantee&rsquo;s lifetime, or, if permissible
under applicable law, by the Grantee&rsquo;s guardian or legal representative or by a transferee receiving such Award pursuant to a domestic
relations order.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Award (prior to the time, if applicable, Shares are delivered in respect of such Award), and no right under any Award, may be assigned,
alienated, pledged, attached, sold or otherwise transferred or encumbered by a Grantee otherwise than by will or by the laws of descent
and distribution (or in the case of Restricted Shares, to the Company) or pursuant to a domestic relations order, and any such purported
assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate;
provided that the designation of a beneficiary to receive benefits in the event of the Grantee&rsquo;s death shall not constitute an assignment,
alienation, pledge, attachment, sale, transfer or encumbrance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
herein shall be construed as requiring the Committee to honor a domestic relations order except to the extent required under applicable
law.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cancellation
and Rescission of Awards</U>. Unless the Award Agreement specifies otherwise, the Committee may cancel, rescind, suspend, withhold, or
otherwise limit or restrict any unexercised Award at any time if the Grantee is not in compliance with all applicable provisions of the
Award Agreement and the Plan or if the Grantee has a Termination of Affiliation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 13 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stand-Alone,
Tandem and Substitute Awards</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards
granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution
for, any other Award granted under the Plan unless in the determination of the Committee such tandem or substitution Award would subject
the Grantee to a tax imposed under Section&nbsp;409A of the Code. If an Award is granted in substitution for another Award or any non-Plan
award or benefit, the Committee shall require the surrender of such other Award or non-Plan award or benefit in consideration for the
grant of the new Award. Awards granted in addition to or in tandem with other Awards or non-Plan awards or benefits may be granted either
at the same time as or at a different time from the grant of such other Awards or non-Plan awards or benefits; provided, however, that
if any SAR is granted in tandem with an Incentive Stock Option, such SAR and Incentive Stock Option must have the same Grant Date, Term
and the Exercise Price of the SAR may not be less than the Exercise Price of the Incentive Stock Option.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee may, in its discretion and on such terms and conditions as the Committee considers appropriate in the circumstances, grant Awards
under the Plan (&ldquo;Substitute Awards&rdquo;) in substitution for stock and stock-based awards (&ldquo;Acquired Entity Awards&rdquo;)
held by current or former employees or non-employee directors of, or consultants to, another corporation or entity who become Eligible
Persons as the result of a merger or consolidation of the employing corporation or other entity (the &ldquo;Acquired Entity&rdquo;) with
the Company or an Affiliate or the acquisition by the Company or an Affiliate of property or stock of the Acquired Entity immediately
prior to such merger, consolidation or acquisition in order to preserve for the Grantee the economic value of all or a portion of such
Acquired Entity Award at such price as the Committee determines necessary to achieve preservation of economic value.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Rule 16b-3</U>. The provisions of this Section&nbsp;5.7 will not apply unless and until the Company has a class of stock that is
registered under Section&nbsp;12 of the Exchange Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Six-Month
Holding Period Advice</U>. Unless a Grantee could otherwise dispose of or exercise a derivative security or dispose of Shares delivered
under the Plan without incurring liability under Section&nbsp;16(b) of the Exchange Act, the Committee may advise or require a Grantee
to comply with the following in order to avoid incurring liability under Section&nbsp;16(b) of the Exchange Act: (i)&nbsp;at least six
months must elapse from the date of acquisition of a derivative security under the Plan to the date of disposition of the derivative security
(other than upon exercise or conversion) or its underlying equity security, and (ii)&nbsp;Shares granted or awarded under the Plan other
than upon exercise or conversion of a derivative security must be held for at least six months from the date of grant of an Award.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reformation
to Comply with Exchange Act Rules</U>. To the extent the Committee determines that a grant or other transaction by a Section&nbsp;16 Person
should comply with applicable provisions of Rule 16b-3 (except for transactions exempted under alternative Exchange Act rules), the Committee
shall take such actions as necessary to make such grant or other transaction so comply, and if any provision of this Plan or any Award
Agreement relating to a given Award does not comply with the requirements of Rule 16b-3 as then applicable to any such grant or transaction,
such provision will be construed or deemed amended, if the Committee so determines, to the extent necessary to conform to the then applicable
requirements of Rule 16b-3.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule
16b-3 Administration</U>. Any function relating to a Section&nbsp;16 Person shall be performed solely by the Committee or the Board if
necessary to ensure compliance with applicable requirements of Rule 16b-3, to the extent the Committee determines that such compliance
is desired. Each member of the Committee or person acting on behalf of the Committee shall be entitled to, in good faith, rely or act
upon any report or other information</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 14 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">furnished to him by any officer, manager or other employee of the Company or any Affiliate, the Company&rsquo;s
independent certified public accountants or any executive compensation consultant or attorney or other professional retained by the Company
to assist in the administration of the Plan.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Deferral
of Award Payouts</U>. The Committee may permit a Grantee to defer, or if and to the extent specified in an Award Agreement require the
Grantee to defer, receipt of the payment of cash or the delivery of Shares that would otherwise be due by virtue of the lapse or waiver
of restrictions with respect to Restricted Stock Units, the satisfaction of any requirements or goals with respect to Performance Units
or Performance Shares, the lapse or waiver of the deferral period for Deferred Stock, or the lapse or waiver of restrictions with respect
to Other Stock-Based Awards or Cash Incentive Awards. If the Committee permits or requires such deferrals, the Committee shall establish
rules and procedures for making such deferral elections and for the payment of such deferrals, which shall conform in the Committee&rsquo;s
determination in form and substance with applicable regulations promulgated under Section&nbsp;409A of the Code so that if the Committee
is correct in such determination the Grantee is not subjected to taxes under Section&nbsp;409A of the Code with respect to such deferrals.
Except as otherwise provided in an Award Agreement, any payment or any Shares that are subject to such deferral shall be made or delivered
to the Grantee as specified in the Award Agreement or pursuant to the Grantee&rsquo;s deferral election.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 6.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stock Options</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Options</U>. Subject to and consistent with the provisions of the Plan, Options may be granted to any Eligible Person in such number,
and upon such terms, and at any time and from time to time as shall be determined by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Agreement</U>. Each Option grant shall be evidenced by an Award Agreement that shall specify the Exercise Price, the Term of the Option,
the number of Shares to which the Option pertains, the time or times at which such Option shall be exercisable and such other provisions
as the Committee shall determine.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Option
Exercise Price</U>. The Exercise Price of an Option under this Plan shall be determined in the sole discretion of the Committee but may
not be less than 100% of the Fair Market Value of a Share on the Grant Date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Incentive Stock Options</U>. At the time of the grant of any Option, the Committee may in its discretion designate that such Option
shall be made subject to additional restrictions to permit it to qualify as an Incentive Stock Option. Any Option designated as an Incentive
Stock Option:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
be granted only to an employee of the Company or a Subsidiary Corporation;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
have an Exercise Price of not less than 100% of the Fair Market Value of a Share on the Grant Date, and, if granted to a person who owns
capital stock (including stock treated as owned under Section&nbsp;424(d) of the Code) possessing more than 10% of the total combined
voting power of all classes of capital stock of the Company or any Subsidiary Corporation (a &ldquo;More Than 10% Owner&rdquo;), have
an Exercise Price not less than 110% of the Fair Market Value of a Share on its Grant Date;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 15 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
be for a period of not more than 10 years (five years if the Grantee is a More Than 10% Owner) from its Grant Date, and shall be subject
to earlier termination as provided herein or in the applicable Award Agreement;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
not have an aggregate Fair Market Value (as of the Grant Date) of the Shares with respect to which Incentive Stock Options (whether granted
under the Plan or any other plan of the Company or Affiliate (&ldquo;Other Plans&rdquo;)) are exercisable for the first time by such Grantee
during any calendar year (&ldquo;Current Grant&rdquo;), determined in accordance with the provisions of Section&nbsp;422 of the Code,
which exceeds $100,000 (the &ldquo;$100,000 Limit&rdquo;);</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall,
if the aggregate Fair Market Value of the Shares (determined on the Grant Date) with respect to the Current Grant and all Incentive Stock
Options previously granted under the Plan and any Other Plans which are exercisable for the first time during a calendar year (&ldquo;Prior
Grants&rdquo;) would exceed the $100,000 Limit, be, as to the portion in excess of the $100,000 Limit, exercisable as a separate option
that is not an Incentive Stock Option at such date or dates as are provided in the Current Grant;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
require the Grantee to notify the Committee of any disposition of any Shares delivered pursuant to the exercise of the Incentive Stock
Option under the circumstances described in Section&nbsp;421(b) of the Code (relating to holding periods and certain disqualifying dispositions)
(&ldquo;Disqualifying Disposition&rdquo;) within 10 days of such a Disqualifying Disposition;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall
by its terms not be assignable or transferable other than by will or the laws of descent and distribution and may be exercised, during
the Grantee&rsquo;s lifetime, only by the Grantee; provided, however, that the Grantee may, to the extent provided in the Plan in any
manner specified by the Committee, designate in writing a beneficiary to exercise his or her Incentive Stock Option after the Grantee&rsquo;s
death; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall,
if such Option nevertheless fails to meet the foregoing requirements, or otherwise fails to meet the requirements of Section&nbsp;422
of the Code for an Incentive Stock Option, be treated for all purposes of this Plan, except as otherwise provided in subsections (d)&nbsp;and
(e) above, as an Option that is not an Incentive Stock Option.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Exercise Price</U>. Except as otherwise provided in an Award Agreement, Options shall be exercised by the delivery of a written notice
of exercise to the Company, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full
payment for the Shares made by any one or more of the following means:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cash,
personal check or wire transfer;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
the approval of the Committee, delivery of Common Stock owned by the Grantee prior to exercise, valued at Fair Market Value on the date
of exercise;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
the approval of the Committee, Shares acquired upon the exercise of such Option, such Shares valued at Fair Market Value on the date of
exercise; or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
the approval of the Committee, subject to applicable law (including the prohibited loan provisions of Section&nbsp;402 of the Sarbanes
Oxley Act of 2002), through the sale of the Shares acquired on exercise of the Option through a broker-dealer to whom the Grantee has
submitted an irrevocable notice of exercise and irrevocable instructions to deliver promptly to the Company the amount of sale proceeds
sufficient to pay for such Shares, together with, if</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 16 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">requested by the Company, the amount of federal, state, local or foreign withholding
taxes payable by Grantee by reason of such exercise.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 7.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Stock Appreciation Rights</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance</U>.
Subject to and consistent with the provisions of the Plan, the Committee, at any time and from time to time, may grant SARs to any Eligible
Person either alone or in addition to other Awards granted under the Plan. Such SARs may, but need not, be granted in connection with
a specific Option granted under Article 6. The Committee may impose such conditions or restrictions on any SAR as it shall deem appropriate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Agreements</U>. Each SAR grant shall be evidenced by an Award Agreement in such form as the Committee may approve and shall contain such
terms and conditions not inconsistent with other provisions of the Plan as shall be determined from time to time by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SAR
Exercise Price</U>. The Exercise Price of a SAR shall be determined by the Committee in its sole discretion; provided that the Exercise
Price shall not be less than 100% of the Fair Market Value of a Share on the date of the grant of the SAR.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
and Payment</U>. Upon the exercise of a SAR, a Grantee shall be entitled to receive payment from the Company in an amount determined by
multiplying:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
excess of the Fair Market Value of a Share on the date of exercise over the Exercise Price; by</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of Shares with respect to which the SAR is exercised.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SARs shall be deemed exercised
on the date written notice of exercise in a form acceptable to the Committee is received by the Secretary of the Company. The Company
shall make payment in respect of any SAR within five (5)&nbsp;days of the date the SAR is exercised. Any payment by the Company in respect
of a SAR may be made in cash, Shares, other property, or any combination thereof, as the Committee, in its sole discretion, shall determine
or, to the extent permitted under the terms of the applicable Award Agreement, at the election of the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 8.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Restricted Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Restricted Shares</U>. Subject to and consistent with the provisions of the Plan, the Committee, at any time and from time to time,
may grant Restricted Shares to any Eligible Person in such amounts as the Committee shall determine.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Award
Agreement</U>. &nbsp;Each grant of Restricted Shares shall be evidenced by an Award Agreement that shall specify the Period(s) of Restriction,
the number of Restricted Shares granted, and such other provisions as the Committee shall determine. The Committee may impose such conditions
and/or restrictions on any Restricted Shares granted pursuant to the Plan as it may deem advisable, including restrictions based upon
the achievement of specific performance goals, time-based restrictions on vesting with or without &nbsp;the attainment of the performance
goals, and/or restrictions under applicable securities laws; provided that such conditions and/or restrictions may lapse, if so determined
by the Committee, in the event of the Grantee&rsquo;s Termination of Affiliation due to death, Disability, or involuntary termination
by the Company or an Affiliate without &ldquo;Cause&rdquo;. For purposes of the Plan,</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 17 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&ldquo;<U>Cause&rdquo; means (i)&nbsp;conviction</U>
of, or the entry of a plea of guilty or no contest to, a felony or any other crime that causes the Company or its Affiliates public disgrace
or disrepute, or materially and adversely affects the Company&rsquo;s or its Affiliates&rsquo; operations or financial performance or
the relationship the Company has with its customers, (ii) gross negligence or willful misconduct with respect to the Company or any of
its Affiliates, including, without limitation fraud, embezzlement, theft or dishonesty in the course of his or her employment; (iii) alcohol
abuse or use of controlled drugs other than in accordance with a physician&rsquo;s prescription; (iv) refusal to perform any lawful, material
obligation of fulfill any duty (including any duty or obligation of the type described in clause (vi) below) to the Company or its Affiliates;
(v) material breach of any agreement with or duty owed to the Company or any of its Affiliates; &nbsp;(vi) any breach of any obligation
or duty to the Company or any of its Affiliates (whether arising by statute, common law or agreement) relating to confidentiality, noncompetition,
nonsolicitation or proprietary rights; or (vii) the occurrence of a &ldquo;Forfeiture Event&rdquo; as defined in section 18.5, below.
&nbsp;Notwithstanding the foregoing, if an Eligible Person and the Company (or any of its Affiliates) have entered into an employment
agreement, consulting agreement or other similar agreement that specifically defines &ldquo;cause&rdquo;, then with respect to that Eligible
Person &ldquo;Cause&rdquo; shall have the meaning as defined in such employment, consulting or other agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consideration
for Restricted Shares</U>. The Committee shall determine the amount, if any, that a Grantee shall pay for Restricted Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect
of Forfeiture</U>. If Restricted Shares are forfeited, and if the Grantee was required to pay for such shares or acquired such Restricted
Shares upon the exercise of an Option, the Grantee shall be deemed to have resold such Restricted Shares to the Company at a price equal
to the lesser of (x)&nbsp;the amount paid by the Grantee for such Restricted Shares, or (y)&nbsp;the Fair Market Value of a Share on the
date of such forfeiture. The Company shall pay to the Grantee the deemed sale price as soon as is administratively practical. Such Restricted
Shares shall cease to be outstanding and shall no longer confer on the Grantee thereof any rights as a stockholder of the Company, from
and after the date of the event causing the forfeiture, whether or not the Grantee accepts the Company&rsquo;s tender of payment for such
Restricted Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Escrow;
Legends</U>. The Committee may provide that the certificates for any Restricted Shares (x)&nbsp;shall be held (together with a stock power
executed in blank by the Grantee) in escrow by the Secretary of the Company until any applicable conditions or restrictions respecting
such Restricted Shares are satisfied or such Restricted Shares are forfeited and/or (y)&nbsp;shall bear an appropriate legend restricting
the transfer of such Restricted Shares under the Plan. If any applicable conditions or restrictions respecting such Restricted Shares
shall lapse, the Company shall cause certificates for such shares to be delivered without such legend.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 9.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Performance Units and Performance Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Performance Units and Performance Shares</U>. Subject to and consistent with the provisions of the Plan, Performance Units or Performance
Shares may be granted to any Eligible Person in such amounts and upon such terms, and at any time and from time to time, as shall be determined
by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Value/Performance
Goals</U>. The Committee shall set performance goals in its discretion which, depending on the extent to which they are met, will determine
the number or value of Performance Units or Performance Shares that will be paid to the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 18 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance
Unit</U>. Each Performance Unit shall have an initial value that is established by the Committee at the time of grant.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance
Share</U>. Each Performance Share shall have an initial value equal to the Fair Market Value of a Share on the date of grant.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Earning
of Performance Units and Performance Shares</U>. After the applicable Performance Period has ended, the holder of Performance Units or
Performance Shares shall be entitled to payment at the time specified in the Award Agreement based on the level of achievement of performance
goals set by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At the discretion of the Committee,
the settlement of Performance Units or Performance Shares may be in cash, Shares of equivalent value, or in some combination thereof,
as set forth in the Award Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If a Grantee is transferred
to a different business unit of the Company during a Performance Period, then, to the extent the Committee determines that the Award,
the performance goals, or the Performance Period are no longer appropriate, the Committee may adjust, change, eliminate or cancel the
Award, the performance goals, or the applicable Performance Period, as it deems appropriate in order to make them appropriate and comparable
to the initial Award, the performance goals, or the Performance Period.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At the discretion of the Committee,
a Grantee may be entitled to receive any dividends or Dividend Equivalents declared with respect to Shares deliverable in connection with
vested Performance Shares which have been earned, but not yet delivered to the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 10.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Deferred Stock and Restricted Stock Units</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Deferred Stock and Restricted Stock Units</U>. Subject to and consistent with the provisions of the Plan, the Committee, at any time
and from time to time, may grant Deferred Stock and/or Restricted Stock Units to any Eligible Person, in such amount and upon such terms
as the Committee shall determine. The Committee may conform such grant(s) in accordance with applicable regulations promulgated under
Section&nbsp;409A of the Code.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">10.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting
and Delivery</U>. Delivery of Shares subject to a Deferred Stock or a Restricted Stock Unit
grant will occur upon expiration of the deferral period or upon the occurrence of one or more of the distribution events described in
Section&nbsp;409A (a) (2) of the Code as specified by the Committee in the Grantee&rsquo;s Award Agreement. Such Award may be subject
to such substantial risk of forfeiture conditions as the Committee may impose, which conditions may lapse at such times or upon the achievement
of such objectives as the Committee shall determine. Unless otherwise determined by the Committee, to the extent that the Grantee has
a Termination of Affiliation while the Deferred Stock remains subject to a substantial risk of forfeiture, such Deferred Shares shall
be forfeited, unless the Committee determines that such substantial risk of forfeiture shall lapse in the event of the Grantee&rsquo;s
Termination of Affiliation due to death, Disability, or involuntary termination by the Company or an Affiliate without &ldquo;Cause.&rdquo;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting
and Dividend Equivalent Rights Attributable to Deferred Stock and Restricted Stock Units</U>. A Grantee awarded Deferred Stock or Restricted
Stock Units will have no voting rights with respect to such Deferred Stock or Restricted Stock Units prior to the delivery of Shares in
settlement of such Deferred Stock and/or Restricted Stock Units. Unless otherwise determined by the Committee, a</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 19 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Grantee will have no rights to receive Dividend Equivalents
in respect of Deferred Stock and/or Restricted Stock Units. Dividend Equivalents, if any, shall be deemed reinvested in additional Shares
of Deferred Stock or Restricted Stock Units, as applicable, which shall remain subject to the same forfeiture conditions applicable to
the Deferred Stock or Restricted Stock Units to which such Dividend Equivalents relate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 11.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Dividend Equivalents</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Committee is authorized to
grant Awards of Dividend Equivalents alone or in conjunction with other Awards. The Committee may specify the time or times that
Dividend Equivalents shall be paid or distributed and the extent to which they shall be deemed to have been reinvested in additional
Shares or additional Awards or otherwise reinvested subject to distribution at the same time and subject to the same conditions as the
Award to which they relate; provided, however, that any Dividend Equivalents granted in conjunction with any Award that is subject
to forfeiture conditions shall remain subject to the same forfeiture conditions applicable to the Award to which such Dividend Equivalents
relate. The Committee may determine whether the timing of payment or distribution of Dividend Equivalents should comply with the requirements
of Section&nbsp;409A of the Code.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 12.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Bonus Shares</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subject to the terms of the Plan,
the Committee may grant Bonus Shares to any Eligible Person, in such amount and upon such terms and at any time and from time to time
as shall be determined by the Committee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 13.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Other Stock-Based Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Committee is authorized, subject
to limitations under applicable law, to grant such other Awards that are denominated or payable in, valued in whole or in part by reference
to, or otherwise based on, or related to, Shares, as deemed by the Committee to be consistent with the purposes of the Plan, including
Shares awarded which are not subject to any restrictions or conditions, convertible or exchangeable debt securities or other rights convertible
or exchangeable into Shares, and Awards valued by reference to the value of securities of or the performance of specified Affiliates.
Subject to and consistent with the provisions of the Plan, the Committee shall determine the terms and conditions of such Awards. Except
as provided by the Committee, Shares delivered pursuant to a purchase right granted under this Article 13 shall be purchased for such
consideration, paid for by such methods and in such forms, including cash, Shares, outstanding Awards or other property, as the Committee
shall determine.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 14.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Non-Employee Director Awards</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subject to the terms of the Plan, the Board may grant Awards to any Non-Employee
Director, in such amount and upon such terms and at any time and from time to time as shall be determined by the Board in its sole discretion.
Except as otherwise provided in Section&nbsp;5.6(b), Non-Employee Directors may not be granted any Award with respect to Shares to the
extent the Fair Market Value (determined as of the date of grant) of such Shares, when combined with all other compensation payable to
such Non-Employee Directors in the calendar year the Award is made, exceeds $750,000 (or $1,000,000 in the case of a newly appointed Non-Employee
Director).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 20 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 15.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Amendment, Modification, and Termination</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment,
Modification, and Termination</U>. Subject to Section&nbsp;15.2, the Board may, at any time and from time to time, alter, amend, suspend,
discontinue or terminate the Plan in whole or in part without the approval of the Company&rsquo;s stockholders, except that (a)&nbsp;any
amendment or alteration shall be subject to the approval of the Company&rsquo;s stockholders if such stockholder approval is required
by any federal or state law or regulation or the rules of any stock exchange or automated quotation system on which the Shares may then
be listed or quoted, and (b)&nbsp;the Board may otherwise, in its discretion, determine to submit other such amendments or alterations
to stockholders for approval.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Awards
Previously Granted</U>. Except as otherwise specifically permitted in the Plan or an Award Agreement, no termination, amendment, or modification
of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the
Grantee of such Award.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Repayment</U>.
Notwithstanding anything to the contrary contained herein, any Awards granted under the Plan (including any amounts or benefits arising
therefrom) shall be subject to any clawback or recoupment arrangements or policies the Company has in place from time to time (including,
without limitation, any policy adopted to comply with Rule 10D-1 of the Securities Act of 1934, as amended, or any related stock exchange
rules), and the Committee may, to the extent permitted or shall, to the extent required, by applicable law and stock exchange rules or
by any applicable Company policy or arrangement, cancel or require reimbursement of such Award or any Shares issued or cash received
upon vesting, exercise or settlement of the Award or sale of Shares underlying the Award. In addition, to the extent that the receipt
of an Award subject to repayment under this Section 15 has been deferred (including pursuant to any other plan, program or arrangement
that permits the deferral of receipt of an Award) such Award (and any earnings credited with respect thereto) shall be forfeited in lieu
of repayment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 16.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Section&nbsp;409A</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.75pt">16.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Awards
Subject to Code Section&nbsp;409A</U>. <B>&nbsp;</B>Notwithstanding any provision of the Plan or an Award to the contrary, if any Award
or benefit provided under this Plan is subject to the provisions of Section 409A of the Code (&ldquo;Section 409A&rdquo;), such provision
or Award shall (if the Committee so determines) be administered, interpreted and construed in a manner necessary to comply with Section
409A or an exception thereto (or disregarded to the extent such provision cannot be so administered, interpreted or construed). In such
case, the following provisions shall apply, as applicable:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 28.85pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of Section 409A, and to the extent the Committee determines applicable to any Award or benefit under the Plan, it is intended
that distribution events qualify as permissible distribution events for purposes of Section 409A and shall be interpreted and construed
accordingly. With respect to payments subject to Section 409A, the Company reserves the right to accelerate and/or defer any payment whether
or not permitted and consistent with Section 409A. Whether a Grantee has separated from service or employment will be determined based
on all of the facts and circumstances and, to the extent the Committee determines applicable to any Award or benefit, in accordance with
the guidance issued under Section 409A.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 28.85pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent the Committee determines applicable, the grant of Non-Qualified Stock Options and other stock rights shall be granted under
terms and conditions consistent with Treas. Reg. &sect; 1.409A-1(b)(5) such that any such Award does not constitute a deferral of compensation
under Section 409A.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 21 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 28.85pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
no event shall any member of the Board, the Committee or the Company (or its employees, officers or directors) have any liability to any
Grantee (or any other Person) due to the failure of an Award to satisfy the requirements of Section 409A.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 28.85pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything herein or in any Award Agreement to the contrary, to the extent that distribution of a 409A Award is triggered by a Grantee&rsquo;s
Separation from Service, if the Grantee is then a &ldquo;specified employee&rdquo; (as defined in Treasury Regulation Section&nbsp;1.409A-1(i)),
no distribution may be made before the date which is six (6)&nbsp;months after such Grantee&rsquo;s Separation from Service, or, if earlier,
the date of the Grantee&rsquo;s death. &nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 17.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Withholding</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">17.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Withholding</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee in its sole discretion may provide that when taxes are to be withheld in connection with any Award (the &ldquo;Tax Date&rdquo;).
The Grantee may elect to make payment for the withholding of federal, state and local taxes, including Social Security and Medicare (&ldquo;FICA&rdquo;)
taxes by one or a combination of the following methods:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payment
of an amount in cash equal to the amount to be withheld;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;delivering
part or all of the amount to be withheld in the form of Common Stock valued at its Fair Market Value on the Tax Date;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requesting
the Company to withhold from those Shares that would otherwise be received pursuant to an Award, a number of Shares having a Fair Market
Value on the Tax Date equal to the amount to be withheld; or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;withholding
from any compensation otherwise due to the Grantee.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">The Committee in its
sole discretion may provide that the maximum amount of such tax withholding shall not exceed the minimum amount of taxes, including FICA
taxes, required to be withheld under federal, state and local law. An election by Grantee under this subsection is irrevocable. Any fractional
share amount and any additional withholding not paid by the withholding or surrender of Shares must be paid in cash. If no timely election
is made, the Grantee must deliver cash to satisfy all tax withholding requirements.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Grantee who makes a Disqualifying Disposition (as defined in Section&nbsp;6.4(f)) or an election under Section&nbsp;83(b) of the Code
shall remit to the Company an amount sufficient to satisfy all resulting tax withholding requirements in the same manner as set forth
in subsection (a).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">17.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notification
under Code Section&nbsp;83(b)</U>. If the Grantee, in connection with the &nbsp;grant &nbsp;of any publically traded Option, or the grant
of Restricted Shares, makes the election permitted under Section&nbsp;83(b) of the Code to include in such Grantee&rsquo;s gross income
in the year of transfer the amounts specified in Section&nbsp;83(b) of the Code, then such Grantee shall notify the Company of such election
within 10 days of filing the notice of the election with the Internal Revenue Service, in addition to any filing and notification required
pursuant to regulations issued under Section&nbsp;83(b) of the Code. The Committee may, in connection with the grant of an Award or at
any time thereafter, prohibit a Grantee from making the election described in this section 17.2.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 22 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Article 18.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Additional Provisions</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors</U>.
Subject to Section&nbsp;4.2(b), all obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding
on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation,
or otherwise of all or substantially all of the business and/or assets of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any part of the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity
shall not invalidate any other part of the Plan. Any Section or part of a Section so declared to be unlawful or invalid shall, if possible,
be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while
remaining lawful and valid.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Requirements
of Law</U>. The granting of Awards and the delivery of Shares under the Plan shall be subject to all applicable laws, rules, and regulations,
and to such approvals by any governmental agencies or national securities exchanges as may be required by the same. Notwithstanding any
provision of the Plan or any Award, Grantees shall not be entitled to exercise, or receive benefits under, any Award, and the Company
(and any Affiliate) shall not be obligated to deliver any Shares or deliver benefits to a Grantee, if such exercise or delivery would
constitute a violation by the Grantee or the Company of any applicable law or regulation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities
Law Compliance</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Committee deems it necessary to comply with any applicable securities law, or the requirements of any stock exchange upon which Shares
may be listed, the Committee may impose any restriction on Awards or Shares acquired pursuant to Awards under the Plan as it may deem
advisable. In addition, if requested by the Company or any underwriter engaged by the Company, Shares acquired pursuant to Awards may
not be sold or otherwise transferred or disposed of for such period following the effective date of any registration statement of the
Company filed under the Securities Act as the Company or such underwriter shall specify reasonably and in good faith. All certificates
for Shares delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer orders and other
restrictions as the Committee may deem advisable under the rules, regulations and other requirements of the SEC, any stock exchange upon
which Shares are then listed, any applicable securities or other law, and the Committee may cause a legend or legends to be put on any
such certificates to make appropriate reference to such restrictions. If so requested by the Company, the Grantee shall make a written
representation to the Company that he or she will not sell or offer to sell any Shares unless a registration statement shall be in effect
with respect to such Shares under the Securities Act of 1933, as amended, and any applicable state securities law.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Committee determines that the exercise or nonforfeitability of, or delivery of benefits pursuant to, any Award would violate any applicable
provision of securities or other laws or the listing requirements of any national securities exchange or national market system on which
are listed any of the Company&rsquo;s equity securities, then the Committee may postpone any such exercise, nonforfeitability or delivery,
as applicable, but the Company shall use all reasonable efforts to cause such exercise, nonforfeitability or delivery to comply with all
such provisions at the earliest practicable date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 23 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Forfeiture
Events</U>. Notwithstanding any provisions herein to the contrary, the Committee shall have the discretionary authority at any time to
determine &nbsp;that a Grantee&rsquo;s (including his or her estate&rsquo;s, beneficiary&rsquo;s or transferee&rsquo;s) rights , payments
and benefits with respect to any Award shall be subject to reduction, cancellation, forfeiture or recoupment &nbsp;in the event of the
Grantee&rsquo;s serious misconduct; violation of the Company&rsquo;s or an Affiliate&rsquo;s policies; breach of fiduciary duty; unauthorized
disclosure of any trade secret or confidential information of the Company or an Affiliate; breach of applicable noncompetition, nonsolicitation,
confidentiality or other restrictive covenants; or other conduct or activity that is in competition with the business of the Company or
an Affiliate, or otherwise detrimental to the business, reputation or interests of the Company and/or an Affiliate; or upon the Grantee&rsquo;s
termination for Cause or &nbsp;the occurrence of certain events specified in the applicable Award Agreement (in any such case, whether
or not the Grantee is then an Eligible Person). The determination of whether a Grantee&rsquo;s conduct, activities or circumstances are
described in the immediately preceding sentence shall be made by the Committee in its discretion, and pending any such determination,
the Committee shall have the authority to suspend the exercise, payment, delivery or settlement of all or any portion of such Grantee&rsquo;s
outstanding Awards pending any investigation of the matter.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights as a Stockholder</U>. No Grantee shall have any rights as a stockholder of the Company with respect to the Shares which may be
deliverable upon exercise or payment of such Award until such Shares have been delivered to him or her, except that Restricted Shares,
whether held by a Grantee or in escrow by the Secretary of the Company, shall confer on the Grantee all rights of a stockholder of the
Company, except as otherwise provided in the Plan or Award Agreement. &nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nature
of Payments</U>. Unless otherwise specified in the Award Agreement, Awards shall be special incentive payments to the Grantee and shall
not be taken into account in computing the amount of salary or compensation of the Grantee for purposes of determining any &nbsp;benefit
under (a)&nbsp;any pension, retirement, profit sharing, bonus, insurance or other employee benefit plan of the Company or any</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Affiliate, except as such plan shall otherwise expressly
provide, or (b)&nbsp;any agreement between (i)&nbsp;the Company or any Affiliate and (ii)&nbsp;the Grantee, except as such agreement shall
otherwise expressly provide.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Exclusivity
of Plan</U>. Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for approval shall be
construed as creating any limitations on the power of the Board to adopt other compensatory arrangements for Eligible Persons as it may
deem desirable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. The Plan, and all Award Agreements hereunder, shall be construed in accordance with and governed by the laws of the State of
Delaware, other than its laws respecting choice or conflicts of law rule or principles that might otherwise refer construction or interpretation
of the same to the substantive law of another jurisdiction. Unless otherwise provided in an Award Agreement, all Eligible Persons are
deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of the District of Delaware,
to resolve any and all issues that may arise out of or relate to the Plan or any related Award Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Unfunded
Status of Awards; Creation of Trusts</U>. The Plan is intended to constitute an &ldquo;unfunded&rdquo; plan for incentive and deferred
compensation. With respect to any payments not yet made to a Grantee pursuant to an Award, nothing contained in the Plan or any Award
Agreement shall give any such Grantee any rights that are greater than those of a general creditor of the Company; provided, however,
that the Committee may authorize the creation of trusts or make other arrangements to meet the Company&rsquo;s obligations under the Plan
to deliver cash, Shares or other property pursuant to any Award which trusts or other arrangements shall be consistent with the &ldquo;unfunded&rdquo;
status of the Plan unless the Committee otherwise determines.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 24 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%"><P STYLE="BREAK-BEFORE: ALWAYS"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Affiliation</U>.
Nothing in the Plan or an Award Agreement shall interfere with or limit in any way the right of the Company or any Affiliate to terminate
any Grantee&rsquo;s employment or consulting contract at any time, nor confer upon any Grantee the right to continue in the employ of
or as an officer of or as a consultant to, or Director of the Company or any Affiliate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Participation</U>.
No employee, officer, consultant, director or any other person shall have the right to be selected to receive an Award under this Plan
or, having been so selected, to be selected to receive a future Award.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.13<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Notices</U>.
Any notice to be given to the Company pursuant to &nbsp;&nbsp;the provisions of the Plan will be given by registered or certified mail,
postage prepaid, or by recognized overnight delivery service, and addressed, if to the Company to its Secretary (or such other person
as the Company may designate in writing from time to time) at its principal executive office, and, if to an Eligible Person, to the address
given beneath his or her signature on his or her Award Agreement, or at such other address as such Eligible Person may hereafter designate
in writing to the Company. Any such notice will be deemed duly given on the date and at the time delivered via recognized overnight delivery
service or, if mailed, on the date five (5) days after the date of the mailing.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Construction</U>.
The following rules of construction will apply to the Plan: (a)&nbsp;the word &ldquo;or&rdquo; is disjunctive but not necessarily exclusive,
and (b)&nbsp;words in the singular include the plural, words in the plural include the singular, and words in the neuter gender include
the masculine and feminine genders and words in the masculine or feminine gender include the neuter gender.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings of articles and sections are included solely for convenience of reference, and if there is any conflict between such headings
and the text of this Plan, the text shall control.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Obligations</U>.
Unless otherwise specified in the Award Agreement, the obligation to deliver, pay or transfer any amount of money or other property pursuant
to Awards under this Plan shall be the sole obligation of a Grantee&rsquo;s employer; provided that the obligation to deliver or transfer
any Shares pursuant to Awards under this Plan shall be the sole obligation of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Right to Continue as Director</U>. Nothing in the Plan or any Award Agreement shall confer upon any Non-Employee Director the right to
continue to serve as a director of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">18.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder
Approval</U>. All Incentive Stock Options granted on or after the Effective Date and prior to the date the Company&rsquo;s stockholders
approve the Plan are expressly conditioned upon and subject to approval of the Plan by the Company&rsquo;s stockholders.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">- 25 -</P>

<HR ALIGN="CENTER" NOSHADE SIZE="2" STYLE="WIDTH: 100%">

</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>koru_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 koru_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  \ , # 2(  A$! Q$!_\0
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M!\5/"T[O^#N]BO\ P42^!K+PR?L2^#&4]>5^.7Q_(_45\+_MC_\ !/GX^_\
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M&SX=[W_@T\_:M\2?&/\ 8?\ B;^S=XQU:?6-1_9%^)MEH_@::Y9IKC3O@O\
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M9_M/7EU,Q Q'%\%/&QV1J2/,GF;;#;PKF2>>2.&-6DD52 ?Q'?\ !H7_ ,I
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D$/ACXH^,^O\ C[Q'X!\!+JFCZ+J(UWQO\3/%'CG[:HHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>proxy_chart-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_chart-1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '5 M # 2(  A$! Q$!_\0
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MM(^//VC?AI^T3^U5XM^#JW/P.\-^*=#^&_@?X(V7B^31]1U7QEI\FE:WXO\
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M]5+$ [_PG_P4$\7W_CC]G?3?B!^S!XP^&OPS_:;?2](^&7Q'U'QWX7UR^O\
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M !4U/7?C5\5Y;Z-8=1F\=_$R]/B"]AU"W54%K>Z7I<ND:-=6F"MK/ILL*!$
M1 #Y7_X*I>)G\.W/[)%GJ7Q/\<?"CP)XB^.$VD_$OQ/X(\>>(OA_=VO@B;3K
M,:W=WFL>'[N%Q%IEBUQ>V\EY;7]O9S1_:EM6=<'R?]D_XIVV@?M@>)O _P"S
MG\>?C1^U)^S#8?!'5_&?Q O/&.N:]\6&\(^/-.GDDTK3O!OBC4H;:[OM5UJ*
M"WM;72+!9!J<^H7U@L5W-HRSZ;]U_M>_LT^,?V@O&/[+FM>'+CP8-#^#/QKT
M[XA>.-.\87&H*-9\,6YL!>:;I%C:Z#KEEJM]/';SQFPU=],T^9'5);L*SX^B
M/'GPNM-=^%'Q%^''@&YM/A=>^-O"7B;0-/\ $/A32[?2Y- U?7='N=,MM?AM
M]*.FN]U8R313F2"XM;TK"!;WEM,(IXP#X@TC_@H+XST_QI\(-*^+O[,^K?"7
MP?\ '#QU8_#[P=J&I?%/POK7Q-T/6=<NY+'PY<?$7X00:1I^L^$+#4[J,Q74
M\>M:PVE$C[2CE[=;G-^'OQ[^&/PS^-W_  4C\;:YHOC[1[/X.2_#K7O'FK:G
M\3]9\=Z3XC6+PEJLNG6W@+X?:EI6F:=X FF:(:?_ &?;:UJT&IWUW: 7>E6%
MO';1_/GA/_@F]\=],M_V9K6[T;]D#PE_PH3XP?#WQ=XAU[X<:'XPLOB!\5=%
M\+ZA!=ZYXJ\9^.]3\-F_U+Q3J4=C;R)X3:P31[W6+JYU:Z\3VD-KIFEVOTR/
MV&_$_BGQ;_P4&'C?Q)X>L?!?[7MIX.LO!=YX<N]3U'Q'X;;P[H&H61U#Q'I5
M]I&D:>DEIJ\NGWEO9:=K.HI?VD,\,]W9-(I !\H_M _M5?'GXH67[&>O:K\%
M_B;^SCX5^(/[3WP?UKPCXFTGXL:?JNG?$/P'JU_ #H'C2U\'W6B:OH%UK6G:
MK8ZK!X5\26&H:-K6GQZB8[NX?3WC;]X*_&_5/V.?VW?'GAC]F+P;\2_'_P"S
ME/X;_9E^*_PMU_2;;PG:^/K/6?&'A'P!)9VO]MZ_KFJ:5>00^)[30[!;#2O#
M.DZ'8:3J-UJ-U?ZOXE5[2RCK]D* "BBB@ HHHH **** "BBB@ HHHH ****
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M/%.O0:S;>(TU*^DM!+#.WB*SEN+3Q!,M@]I%<:Y:W5W;ZM<1RW\-[>)<"YE
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_$RT\.S_  ZT7XA^(M*0WVB^"M4\3VOB'48VCBMK"2YFB@?X1_://[2OQ?\
MVF=,\&>*/V)/C1JW[(7PK^*7@CX@Z6_PN\1?LY6MY^T5\6/"&N:7J/A[XB?%
M34/%7Q@\,:_H?PB\ 7ECIVMZ-X)TG0K_ ,8>-]4T2ROO%-Y9Z986O@ZX\N\:
M?LD?M2W?Q=^)?P-TOX01ZA\*OBU_P4F^&/[=L?[4,'C7P=;:#X1\ >&[_P "
M>)_$O@B_\*W.J1_$)_B;I^K>!?\ A&/#$>F^'K[P[?:5J\=[<Z]IEO;21LP/
MTK\'?\%!OV2_'OQEF^ _A?XHM>^/!K?CKPOIMW<^#O'6E_#_ ,3>*?AA!<7/
MQ'\,>#OBIJGAJS^&WB_Q!X'AL[U_$VE>'?%.HW6EK979G0"%LVO@)^WS^RM^
MTQXUN/A]\'/B1=>(O$W_  CM[XRT&+5/!'C[P?I7CSP9IFL#0-2\8_#+Q!XQ
M\,:%H7Q)\+6.KLEC<ZYX)U#6["*21&:81$R#X,\/7O[3GQ1_:X\,?$[XZ?L(
M?'3PW\,?@CXE\>#]F+P3X,\2?LRGP/X;O?$WAG7M)\3?'#XO7O\ PNRV\1^)
M?B1XSLKW4?#OA/PGH?A]/"/@.Q\37EUJ5YXCU[5+_P 2:7TO[)%K^TA\0?VK
M(/C=^U+^QY\6_A'XALO!?C+X;_!>WMO$7P"O/@)^SC\)KJXTW6'\/PGP?\5=
M7^(?CCXH?$NYT+18?%GBY_ VG>'M+-AIWAOPYI.C:#97.JZH ?LI0> 3Z44'
M@$^GIUH ^*?C#_P4+_91^ _Q"UKX6_$SX@ZKHWC;P]!I-QK.E6'@#X@>(8;%
M=<TNVUK34?4_#_AK4M,DFGTN]L[QH8+N5X([F)9@DA9%W=!_;>_9_P#&'P!^
M,'[2?@C7M?\ %WPU^!^C^,-8\<M8>%=:T7Q#&/!'A.+QKK-AI>B^,;;PR][?
M/H5Q;36#//;:?<SW"0-?PE)FB_%__@H-^Q+^U;\7OVN_BG\1?AG\&-9\7^"?
M$5KX!&C^(++Q+X!L+>\?1_A[X8T/4H_L>N^+=)U2![35-.O+5UN+&(.8A+"T
MD+H[>]_LX?LI_M$^"?\ @FU^W1\%_%'PMU/1_BM\5?#_ ,:;7X=^"[C6_!MW
M>>)[OQ'\#-&\*Z##!?V7B.\\/V?]I>(;2?38O[8U:QC1HS-=&*U99F /K)O^
M"G'@;2_AS/\ &/QQ^S'^V%\,_A%:1_#N_N_B7X\^&7@33O"MOX>^)?B/1O#>
MB^*VFTOXJZSJ4WAW39-?TS6/$-W:Z;/<Z9H,SZ@+.Y,4D"^H^-O^"@O[./PY
M\9?'?PKXTUKQ#HVE_LY6/PQ3XE^/TT%]7\&)XW^,,Z)\/_A%X470KK5/&'C7
MXLZW;7&GZ@O@_P ,>$=2D@M=5TU)KQ+VZ6S'.?L[?L5^"_!'[.4OP]\>7'QC
M\82_%7X!^$?AW\6OAY\7?CE\1OBUX7TJ1O!+Z5XE\->%/#_C#QAXF\*>"X5N
MM6U+2Y/^$)BL-/\ LUKIUO:RM8:9IPA^0_V:/AK^TS^QC_P3.\,V7@S]E/5_
MC'^V/KOC/Q%XD\3^ O%WC;P/?WD7Q U+Q)K.G>&OBAX_\6ZUXVCL=7TOPAX%
M\-^"+>VL/#?B>7Q'<VUMH>BV-QHS2:CK&D 'W=8_\% /V4;[X&^*/VB/^%ES
MZ?\ #CP5XQ_X5SXJBUKP5X]T3Q_HGQ)?4-/TJV^'%[\*=5\,6GQ+7Q]?ZAJN
MFV^F^$X_"LFLWXO8)[:U>V+S)DWW_!1K]D6P^%7A;XP'XD:K?>'O&GCO6?A;
MX:\,:1\-_B;K/Q;U'XF>&H;NZ\4^ #\%M,\'W7Q5L_%GA6QL+O4O$ND7WA&V
MN-$TN./4[\0V5W93W'YQVO[-_P ?M:_9YT3Q;H_[.WQBD_:(^&O[=OPB_;7^
M+&F_''Q+\!_#WBG]J[Q5X?A-CXY/P^C^&OQ(\<?#SX?Z=HGAZ:RTCX:^$O$6
MMZ)8Z/:>$=$TZXO;^_ENM>O=/3]'_;X^"WPO^,/CWX5_LF:O/\;?VO?VM?B=
M\88M/@\0?!7Q?KG[(OPSUKPQX \$KK^HZ7XD^(7A7P;XV^,GB?1?#][J>D^&
MM \7W'@D:A(B^-O$4EGISZ)K0!^@NO\ _!2#]C_0O!/PL\?Q?$S5/%FB?&?P
M_P"*?%WP]L/AU\-_B=\2/%VJ>$? =PEGX^\5ZGX&\#^#]=\8^&?#G@2^<:?X
MRU?Q+HFDV?AS4%FLM4EM[FWN(XOKKP'XZ\(?$_P5X3^(W@#Q!IWBOP1XY\/:
M3XK\)>)-)E:;3==\/:[90ZCI.J63ND<AM[RSN(9D66.*:/?Y<T4<JNB_BY>?
M#/XJ>%_V4O!?P$\#_L+?M/I\*M<\ _$[POXDG\-_M(_"7X>?MG:#\4=1\:7/
MBP^)?&OBWPS\4=,\":O\,OC7K.H:CXK\;W/A?XAZI)#J,UUHFM_"+4?#LUKH
MLOZ=_L=> OB3\+OV6/V?_AS\8+?PA9?$OP1\*?!_ACQE8^ K'3M-\(V&L:/I
M-O926&BV>CV6FZ/%#8P0P6EPVD6%GI,][#<W&F6\=E+ H /I2BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\L^,7QI^&_P%\$:C\0?BCXDM/#?AVQ<6T#2GSM2U
MK4WM[BZ@T3P_I41-[K6M7-O:75S#IUA%+,+2TO+Z?R;&RO+F#U.O@[_@H)X;
MU'7/@];ZE8_#WQWXN3PM/XIUD^+/A)XL/A_XK_"R^N? 7B;0]/\ %?AC1':W
MMO'?A_6#JMQX'^(7A*YNKA9_!_B;4=3'AWQ&FG2VD0![OXA_:C_9V\*>&_!O
MC'Q#\9_AWIGA;XA1W=SX+\02>)]/FTGQ!8:<T,6KZM:7EM)-%'HF@SW-M;>(
M]<NC;Z1X=N;FVM];O;">XAC?OO'WQ/\ A_\ "WPK-XW^(7BW0_"?A2*XTRS7
M6]7ODAM+J_UN[AL-%T[3@@DFU34]9OKFWL](TS3HKK4-3N9HH;*VGDD53^2.
ML_#/]JG1YK+XE7.B_'%M>\8?!/Q_\/-"L_AMX2_9>N/&5KXAM/C;\4/'?PSC
M_:!\.Z]H^H^ [%_BIX/\:>&KSXN7GP[M[#P=<>,] UO_ (3&73A<:'M^D?'W
MB/Q_XFU#X07,?PD\4^*?$'['OQB^&^N?%[P_X#L?#B^&O&$OC7]FWQIX:UO4
M?@M;7OBRV;64^%NO_$W3-3O?"NO'1_$5MI&FS/HNF:Q>7'ATZD ?3_B']J+]
MGCPIX:\#>,O$7QE^'>D>%/B7%<W/@3Q!=^)]/&E^)K&PC@EU;5=/N8Y)$&C:
M"MU:_P#"2:S<^1I7AMKFW37;S3GGB5]S5/CY\&M$^)&C_"#5_B5X/T_XFZ_;
MV-SI/@JYUJT37+M-6CU&;1HO(W&*WN]=@T?5Y] L+J:"]UZ'2M2ETBWO([&Z
M:+\TM)^&/QG^'=QKWQ$OOV>/%WCRT^.'PV_:P\)Z;\+-&O?!%SJGPOUKXU?M
M#^,/B_X.\.>/TU'QA8Z%I.B?$3PYXKL(?B+K6@W^O:/X1\3>&S8:G,^GM8ZC
M<V-*^!'QH\'Z/J_[/=W\-_$/BW4_''Q9_8H^)%C\=]/NM"D^'VAZ'\!?"W[-
MFD^/Y-?U.^\0VGBS3O$?AN^^ 7B27PEI4'AV63Q))XS\*/;7$GF^,;O1 #]+
M/B?\<_A%\%;71+SXL_$3PG\/[?Q'=W=EH;>)=7M[!M2DTZT%_JMQ;Q/F8Z=H
MM@1?Z[JSQKI>AV+1WFKWEE;21R-7UGX_?!;P[X_\-_"W7/B=X+TOX@^+[33+
MWPWX4N]>LX]4U6VUV:]MO#LD*!S#$?$UUIFIVGA>.ZF@E\37>FW]KH,>H3V=
MS'%\8^,?&/B[Q7\2M+_:#\*_ 'XI?$KP?=?"K]I']F-O!=M!X#_MNR\7V'Q7
MT&#2O$;P7WCRVT*?X5_%P> [ZW_X3"QU/4/[,LK+PG<^)++1[2[U-]-\4\-_
ML_?&[X?>#=1_9ZO?AAK?B_6?B/<_L+:O8?&30[[0;CX?>#(_@#X4^!'A;XAP
M>)=5U/Q!IOB;3K[P%J'P9U[QUX)@L_#MY_PEM_XPT*UTN>75G\2RZ4 ?IYX=
M^//P<\6_$'Q'\*?#'Q)\'Z[\1O"7VY?$7@_3-;M+K6--DTF6P@UR!X8V:.XN
MO#MQJNEVWB6TLY+BZ\.7.I:?;:W#87%[:Q2^N5^8'P<^&?Q4L?'_ , ? &N?
M"CQ)H47[.7QH_:=^(WBSXPZQ<^'?^$3\>>'_ (IQ?&*S\(_\(3=Z=XCU/7=:
MUCX@3?%?2/%_B_3]4T725\,:MX/UJUU@6UT?#)UC]/Z "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^T"?!7A+Q'\(O#_ (YU/PMX5U+X5>*O%'PMTRX\9^*/'V@6%GXZL])U_0?
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M/"VIW/A-K#4P#]&Z*09QR03DYQ]>G?\ Q]<4M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5\4?MA_M2_%']F>'X?3?#7]DCXU_M4MXTN/$
M\.LP_!Z$3'P)'H$6AR6,_B,MI&IK%%XB;5KJ/2R3 &;1K\YD )7[7KSKXF)X
M/U_PKXB^'/BOQ58>&T^(7@[QIH?SZY8Z-K;Z))H%Q:>)M6T3[5/%.[>'M-U
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M1X?GU[3]7T/4M(TSQ-I/B;3]4L]+BTW\B/\ B('T[_HU"_\ _#V6?_SKJ/\
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M ..CO#__  <4^7_-(YWO:U_G?[]3^CG ]_S/^-&![_F?\:6BOVX_W=$P/?\
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M@>_YG_&EHH 3 ]_S/^-&![_F?\:6B@!,#W_,_P"-&![_ )G_ !I:* $P/?\
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M)_U]S&MS^#_]M_\ Y/(_:E_[+W\4?_4NU2OEROJ/]M__ )/(_:E_[+W\4?\
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M147F'^Z/^^C_ /$T>8?[H_[Z/_Q- $M%1>8?[H_[Z/\ \31YA_NC_OH__$T
M2T5%YA_NC_OH_P#Q-'F'^Z/^^C_\30!+147F'^Z/^^C_ /$T>8?[H_[Z/_Q-
M $M%1>8?[H_[Z/\ \31YA_NC_OH__$T 2T5%YA_NC_OH_P#Q-'F'^Z/^^C_\
M30!+147F'^Z/^^C_ /$T>8?[H_[Z/_Q- $M%1>8?[H_[Z/\ \31YA_NC_OH_
M_$T 2T5%YA_NC_OH_P#Q-'F'^Z/^^C_\30!+147F'^Z/^^C_ /$T>8?[H_[Z
M/_Q- $M%1>8?[H_[Z/\ \31YA_NC_OH__$T 2T5%YA_NC_OH_P#Q-'F'^Z/^
M^C_\30!+147F'^Z/^^C_ /$T>8?[H_[Z/_Q- $M%1>8?[H_[Z/\ \31YA_NC
M_OH__$T 2T5%YA_NC_OH_P#Q-'F'^Z/^^C_\30!+147F'^Z/^^C_ /$T>8?[
MH_[Z/_Q- $M%1>8?[H_[Z/\ \31YA_NC_OH__$T 2T5%YA_NC_OH_P#Q-'F'
M^Z/^^C_\30!+147F'^Z/^^C_ /$T>8?[H_[Z/_Q- $M20_ZT?[K?^RU6\P_W
M1_WT?_B:E@<F905 RK#KGL#Z#TH T**** "BBB@ KC?B+JFL:)X \<:UX=N_
M#FGZ_H_@_P 3:KH=_P",;TZ;X1L=8T_1+Z[TN\\5:B'C-AX;MKZ*";7+T.IM
M=,2ZGW+LW#LJ^5/VSOV=-8_:D^ WB?X3:#\6_'_P9U741<7UGXG^'WB!_#DV
MJ31:)K.GQ>%/&%U%97\U[\/->EU-(?&>D06_GZEI,,EO%(CD&@#\<OCOI'_!
M6[]IW]F;Q5X8^+/B_P#X)L^ /V<OB9X2TG4_&/QV\,>/_&M_H_A_X?M=:9X@
M/CSPWXBU&.[\-26]M#:VVL:1K)N8[<B."YLM4T^<V^H0_P!#7A6)8/#'AR!-
M;;Q,L.@Z1$OB1Y8IF\0+'I]NBZXTT,LT,IU8*+\R132QN;C<DCJ0Q_E]\$?L
M>?LAWO[+GPRD^-/_  56_:/\4? ;5?''AK]ECQ?X>\&_%>]MOV7]5^*FC0O'
MJ'PJ\,Q:[X$GAL/A@NHZ%<:;H&L7\2Z&NEPV-U#KULTMM>0_U(:3IECHNEZ;
MHVEVJ66F:186FEZ=9Q%VCM+#3X([2SMHVD9Y&2"WACB1G=F94!9B220#0HHH
MH **** "BBB@ HHHH **** "BBB@#/NO]:O_ %S_ /9C5>K%U_K5_P"N?_LQ
MJO0 4#[Z_C_-:*!]Y?\ /=:3Z>OZ,:W1_"%^V_\ \GD?M2_]E[^*/_J7:I7R
MY7U'^V__ ,GD?M2_]E[^*/\ ZEVJ5\N5_.^*_P![Q?\ V&8S_P!3,8?\V'B-
M_P G#X^_[+GC+_UJ^) HHHK ^-"OZ,?^" G^K_:O^OP+_P#0?BS7\YU?T8_\
M$!/]7^U?]?@7_P"@_%FOHN$_^2@P'_<W_P"H6(/ZD^AA_P I'^'W^#BK_P!8
M_/#^BY>@^@_E2TB]!]!_*EK]N/\ =P**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MI;?_ %\?T?\ ]!J*I;?_ %\?T?\ ]!H TZ*** "BBB@ KC/B-X4F\=_#_P <
M>"+?5+G0YO&/@_Q/X5BUJS:1;O1Y/$.AW^CQZI:M%)%*MQI[WBW<!CECD$D*
ME)$8!AV=?EC_ ,%2?VNOVF_V2OA]\/M=_9V^$-KXWM?%FL>([#XC_%'6/"/C
MGQ[X9^!NA:7:Z.;#Q+K_ (3\ HFJW=O>_P!IZIJ"7][?0Z;;1^&;BPDM;RYU
M>S%N ?F'??#[_@H->?L7VO\ P2RN_P#@GWX(\/:?8>%-/^&>I?M82?$WPE#\
M$[/PMHNIP&^^.JZ,FFQZA%XRNK*W?QA/*=6/BZ3Q!<7.I2>&$OFETR#^FKPE
MIL6C^%?#.D0:FVM0Z5X?T;38=8>03/JT5CIUM:QZFTHEG$K7Z1"Z,@FF$AEW
M"60'>?Y!-%71?^"@7[6'[+OPB^.'_!1OQ'^V+\*?CGHOQDU7XM> /A?8^(?V
M</ ?PVUKP#X3AUWP;X+;P%=_V5J3/K^H+(IN?%7A?2_%5Q%HK!)GU OJ=?V$
M:+I&G^']'TK0=)MQ:Z5HFFV.D:9:B6686VGZ;;165E;^=.\L\ODVT$4?F322
M2OMW2.SDL0#3HHHH *^./VX?B)\9OAI\%;SQ#\'-/O4G%W?0^-?&.C^#+SXE
M>(?AYX4C\,Z]>0^*=$^'>F^(?#6J>)G?Q3;>'="U.[TV\U2Y\)Z/J^H>+G\+
M^(+/1;JVC^QZ\"_:$_9\\-_M!^$HM#U+7?$G@KQ-HPUJ;P9\0?!U^UCXD\)7
MWB#0-0\+ZUY,;[].UK1M<T#5;[2->\.:Y;7FD:I9SI(T$&I66F:C8 'RIX^_
M:,^/VG?L]:1\>?!?BGX.:]HF@>'_ !M)XIG\,?!OXT^-IO%?C;PQXCUO2K#1
MM3\+W/B'P7K?[/GA73].\/WB?%W6/B%<^([SX4>*I-2T;6&;3_"EQJWB+Z&^
M-7Q7\>:1I?P&\.?"Z]\#6/C?]H'XA:;X,TGQ9K]G?>.O!'A?2H/AKXV^*_B7
MQ'::=HVO^#;CQFTOA_P)?Z1X4B@\0Z+;7FHZSIVM737&G65UI]USFH?L1_"J
MYTK3M-TCQ1\7O",Y\.>)/"7C;7O"WQ)U:P\2?%?P[XT\6:QXZ\86/Q(UB[@O
MY]6O->\8>)?%.O#Q'HP\/^*O#]SXI\16OA'7?#NFZI-8C8U/]E#P_K@\0V=_
MX[\?Z5H\'BKX;>*?@QIWA#7[K0?^&>[KX9>!;?P)IH^&+7<FM65BNNZ7+KMM
MXKTVZTV7PKXBTG7M0TG5/#-TE[J]UJH!\V6'[3W[2?CRXOO 7@>7X-^'OB3\
M)_!'Q\\5?%+6/$?A'Q1KG@[Q[K7P>^,?B;X/>$]"\%Z;9_$70-4\":-\09O!
MNM^*?$>M:KJOCF]\ P7>E>'XK#Q!<F;5GL:?^V!\7/%UM?\ QK\+V7@#3/@3
MX1\?_LP?#OQ#\/\ 6M"UF_\ B=K\G[0GASX)^(-<\3:;X\MO&&G>'M!_X01/
MC]X4CTGP]<^ ]8'BK_A$_$HDUO3QXAT6?1O==:_8A^#^J^'O#'AZRU?XG^%V
MT'0_'_A?7/$?A;X@ZOIGB[XD^&OBUK[>+OBMHWQ)\02K>7GB)?B!XPEN?%>K
M:O;G3/$FCZ]>ZC>>#M:\,KJ%[#/T%]^R%\)+SQS8^,(#XNT?1X-3^''B#5/A
M9HGBB[T[X2^)O%/P>M-,L/A9XI\0>#8XF6?6/ UKX?\ "D>F1Z??Z=H^HMX+
M\%R>(M*UJ3PKHCV8!A?&[XG_ !H7XL:!\&O@=J/PX\.Z_%\'_'WQJ\1:]\3?
M"NO>+M+U&S\,:[X<\+>%O!.EZ?H'C;P/<:6?$.M:W?7?B+Q9+>:N/#VE:3;P
M6N@WMYK4%S8_.^C_ +9?QB\=Z#<?&[PEIGP]T#X.^!I?V4]/\;?#[7=&UG6O
MB#XENOVA_"_PF\<^+K_0?'EIXOT70_#D'P]\+_&GPPGANPNO ?B ^,M<\/>(
M;6YU'2[35M+GTOZ'U/\ 8_T7Q3I.FKXS^*_QAO?&.G:K\8HQ\0/#7CC5/#7B
M>?X<_&?Q9-XD\0?!N>_FEUN[G^'>FVT'AO1_#T4UV_B+PRGA71]1\(Z_X;O8
M04U+W]C;X-7/BK1=?L(O%?AW0-*C^%O]H?"[PYXGO-+^%?BV[^"#V,GPAU'Q
M7X36.3[?>^ SI&@16)LK_3K76[+PSX8TWQ=:^(M,\/:196@!Y1\*OVC?C)XH
M\;?"7Q%XE'P[N/@]^T/\3_CE\-/ ?AG1O#VMZ5X_^'Y^%=K\2-8\)Z_XF\57
M?C+6='\8_P#"9:#\)O$\OB71['P=X4E\)ZQKOA[3;6\U&/2]5N-1_02OFKP?
M^RK\-/!/Q'_X6/I5[XTO)=.USQYXH\%^"M9\4W>I_#SX;>*/BG<7%Y\2/$/@
M+PU+$IT?4/%UU?ZS).MW?:E9:%%XB\2V/A&S\.Z=XBUFSO?I6@#*OL^<G)'[
MKL2/XSZ$54Y_O-_WTW^-6[[_ %Z?]<O_ &<U4H .?[S?]]-_C0"=R\D_4D]U
M]2:*!]]?Q_FM)_Y_DQK='\)7[;__ ">1^U+_ -E[^*7Z^+M4KY<KZC_;?_Y/
M(_:E_P"R]_%'_P!2[5*^7*_G?%?[WB_^PS&?^IF,/^;#Q&_Y.'Q]_P!ESQE_
MZU?$@4445@?&A7]%_P#P0'XA_:OQZ_ K^7Q8K^="OZ+_ /@@/_J?VL/K\"OY
M?%BOH^$O^2@R_P#[FO\ U"Q!_4GT+_\ E)#P^_P<5?\ K'YZ?T4#.!RW0?Q-
M_C2\_P!YO^^F_P :1>@^@_E2U^VG^[@<_P!YO^^F_P :.?[S?]]-_C110 <_
MWF_[Z;_&CG^\W_?3?XT44 '/]YO^^F_QHY_O-_WTW^-%% !S_>;_ +Z;_&CG
M^\W_ 'TW^-%% !S_ 'F_[Z;_ !HY_O-_WTW^-%% !S_>;_OIO\:.?[S?]]-_
MC110 <_WF_[Z;_&CG^\W_?3?XT44 '/]YO\ OIO\:.?[S?\ ?3?XT44 '/\
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M^L?GA_1&&? Y'0?P_P#UZ7<_]X?]\_\ UZ:O0?0?RI:_;3_=P7<_]X?]\_\
MUZ-S_P!X?]\__7I** %W/_>'_?/_ ->C<_\ >'_?/_UZ2B@!=S_WA_WS_P#7
MHW/_ 'A_WS_]>DHH 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->C
M<_\ >'_?/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_WS_]>DHH 7<_]X?]\_\ UZ-S
M_P!X?]\__7I** %W/_>'_?/_ ->C<_\ >'_?/_UZ2B@!=S_WA_WS_P#7HW/_
M 'A_WS_]>DHH 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->C<_\
M>'_?/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_WS_]>DHH 7<_]X?]\_\ UZ-S_P!X
M?]\__7I** %W/_>'_?/_ ->C<_\ >'_?/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_
MWS_]>DHH 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->C<_\ >'_?
M/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_WS_]>DHH 7<_]X?]\_\ UZ-S_P!X?]\_
M_7I** %W/_>'_?/_ ->C<_\ >'_?/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_WS_]
M>DHH 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->C<_\ >'_?/_UZ
M2B@!=S_WA_WS_P#7HW/_ 'A_WS_]>DHH 7<_]X?]\_\ UZ-S_P!X?]\__7I*
M* %W/_>'_?/_ ->C<_\ >'_?/_UZ2B@!=S_WA_WS_P#7HW/_ 'A_WS_]>DHH
M 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->K=DS?:4!((*R=L=!G
MU]A5.K5E_P ?4?\ NR?^@T ;U%%% !1110 5RGCK6?#?AOP5XN\1>,A;MX0T
M#PQX@UOQ4MW:)?VK>&]*TB\OM=6YL)$E2^MVTJ"[6>S>*1;F(O"T;*Y%=77S
M_P#&#X\_L^^ M<T7X/\ QA\<^&]&UWXJ>"OB?K6D>"]:CO[FX\6>!OAYX3O/
M$'Q0NEM[*RND.GZ+X234+Z^BN)()[VTM[Q-.BNY;>>- #\"3^T/^TM9?"RV_
M;5UO_@EU^Q5;?L*7-E8?$.73(=(\)2?M#6?P#U62"2S\>21F1O#5Q?KH-U!X
MEET=/"<<LEHZV36UI:F;7H/Z7O#U]I.IZ!HFI:"83H6HZ1IM]HOV>#[+;_V1
M>6<-QIOD6VR+[/#]CDA\J 1QB%-L81-NT?R-K!^P.?#]M\$=2_X+<>/M0_8;
ML;Z"XB_9GN?"FKK</X&T_5EU>P^&=U\35T'^UY_!=K;Q0Z>;$Z*MJUE"D4.E
M6UPD-U#_ %Q^')]&NO#VA77APVY\.W.CZ9/H)M(VBM#HLUE!)I1M8F2-XK<V
M+0&"-HT9(MJLBD$  V:*** "BBODW]L3]I*[_9D^%\'C#2]!T35]:U_6)_#.
MAW_C7Q(G@GX:^'M6_P"$=US7[2^\>^,I;+41HUEJ3Z(?#_AVQALY+SQ3XRU;
MP_X6LI;&?5_[0M@#ZRHKXD\;_M5?$;PIX M/B#:_LW^(;O2-$^%WB/XP?%&]
MU;XC^#])\,^%_"/AF_N[:>R\#^.-)B\4>%/B7XI\0Z3I>I>-/".E)J?A32[K
MP6-*U+Q1KWA#5-<T_0Y/7OBO\;;KP'X>^&LOA+P;<^.O''QF\7Z+X*^&W@_4
M-9B\%6MWJFI>&=<\=:I?^*]>O-.UJ;PQHGACP/X5\2Z_K$UMH'B#5FFTR+1M
M-T2_U/4+6$@'OM%? -Q^VSKVI:?I]IX#^!.N^+?B!HGA?XM>,/C#X!NO'6A:
M!<?#G3O@EX[U+X8^,-(T;7#IFK:=X]\4>(_&VAZ]:?#"Q@C\.Z'XMT?29];U
MWQ)X+@GLX+C7/[:UC?ZVNM>%_AQJ?B'X$:5XF^"'@?QA\83XFT[3M0T3Q;^T
M'I'@?6? J:5\.9M/FU+7_#.D6GQ4^%W_  G>NS:_H=]H#^+YCI?A_P 1Q^&O
M$#V(!]ST5\R?&KX^>)OA[XNT#X=_#?X67'Q=\>:AX&\:?%/6]#7QEIW@>VT3
MX>>!KG1=,O+J'5=1TK6$U7Q?XFUW7[#1/!'AC[-8:?JMU!J]SK_BCPMIFFF^
MG\E3]N33M9N[3Q/X*^&FM>)?@;IQ^ EMX^^*EQXALM$U;PEJ7[1FG>$M;\%0
MZ?\ #R?3KR_\26/ACP]\0_A_X@^)5\^OZ%/X=TOQ0K:%8>+;_1]9L+$ ^]:*
M^-OA]^UC=>-OB#X8T2Z^&&HZ#\,OBAXS^*WP]^#?Q1_X2G3]6F\9^*/@\?$4
MGB :_P"#(-,MKGP7HWB>Q\$^.M7^'NJ/KNO3:WI/A>6;Q!IWA*^U;1-/O_LF
M@#"U4GSX@"1^Y)XQ_?/M69EO[[?F/\*TM5_X^(O^N)_]#-9M !EO[[?F/\*5
M68.OS$_7'8K[#\:2@??7\?YK2?\ 7W,:W1_"S^V]_P GC_M2_P#9?/BG_P"I
M?JM?+M?47[;W_)X_[4O_ &7SXI_^I?JM?+M?SOBO][Q?_89C/_4S&'_-AXC?
M\G#X^_[+GC+_ -:OB0****P/C0K^BK_@@82(/VKR#CGX%C\T^+7^%?SJU_15
M_P $#?\ CW_:O_WO@7_Z!\6J^CX2_P"2AR__ +F__4'$G]2?0P_Y2/\ #[_!
MQ5_ZQ^>']#H+8'S-T'I_A2Y;^^WYC_"D!P%^@%*#GD5^VG^[@9;^^WYC_"C+
M?WV_,?X4F1^5&0/\_P _3ZT +EO[[?F/\*,M_?;\Q_A29'7MZ_3_ #UHR/7_
M #_]?MZ]J %RW]]OS'^%&6_OM^8_PI,CU_\ U^GU]NM+0 9;^^WYC_"C+?WV
M_,?X444 &6_OM^8_PHRW]]OS'^%%% !EO[[?F/\ "C+?WV_,?X444 &6_OM^
M8_PHRW]]OS'^%%% !EO[[?F/\*,M_?;\Q_A110 9;^^WYC_"C+?WV_,?X444
M &6_OM^8_P *,M_?;\Q_A110 9;^^WYC_"C+?WV_,?X444 &6_OM^8_PHRW]
M]OS'^%%% !EO[[?F/\*,M_?;\Q_A110 9;^^WYC_  HRW]]OS'^%%% !EO[[
M?F/\*,M_?;\Q_A110 9;^^WYC_"C+?WV_,?X444 &6_OM^8_PHRW]]OS'^%%
M% !EO[[?F/\ "C+?WV_,?X444 &6_OM^8_PHRW]]OS'^%%% !EO[[?F/\*,M
M_?;\Q_A110 9;^^WYC_"C+?WV_,?X444 &6_OM^8_P *,M_?;\Q_A110 9;^
M^WYC_"C+?WV_,?X444 &6_OM^8_PHRW]]OS'^%%% !EO[[?F/\*,M_?;\Q_A
M110 9;^^WYC_  HRW]]OS'^%%% !EO[[?F/\*,M_?;\Q_A110 9;^^WYC_"C
M+?WV_,?X444 &6_OM^8_PJ[IY/VN,%B<K)UQ_=SZ?Y_.J57-/_X_(O\ =E_]
M - '24444 %%%% !7PY^WUX]'P6^!GB#XUZ'^SA/^T-\0/"NB^+/#?AQ-)\&
M>&_%>L_#_1O&/A36;?Q1XNU%]<@,]O\ #NSM-.ME^(FGV-W -;T(_8;J*ZB9
M8:^XZX+XJ^(;SPC\,?B+XLT_1$\37WA?P)XO\16?AN5#)'X@N]$\.ZEJ5MH<
MD:AFDCU:>VCL'C"L76<KM.<$ _F3\-_'OQ[\4/V7_"4/PH_X(HZ;XC^-_CKX
M6^%$\*_':7]F;X*I^S_KGB[7=*TY/^%C6VE-I22)\/-0DFGUO3K"?4(DBTJ:
MVAN;](0UT?ZBO"=IJ%AX6\-V.KQ:;!JUEH&CVFJ0:- EMH\.HVVGV\-]#I5M
M&J1V^FQW*2I80(B)%:K%&BJJ@#^1^Z_:%_;ZN/A1J_Q:M?\ @J)X.T;3++]D
M;X=_M<V_@SP)\*?@K;Z+;^&?$WC#Q-X3\?\ PD\!/>Z"T#^+_@Q_PCL.CQ:-
MJ$ANM3\4:EHWA;5(](>:75E_K9\%7IU+P;X2U$ZM/KYO_#&@WIUVZL8],N=:
M-UI5I.=6N--A_<Z?/J/F?;)K&+]W:23- GRQB@#IJ*** "OFG]J/X2_$;XN?
M#R\T7X7>/;3P;XFALO$=J^D>)=#_ .$G^'?CS2_$7AG4_#]WX:\<:'#J6BZ@
MT%O+?6^NZ!K6E:U8WV@^(-*L;N6#5]+EU'1M0^EJ* /SBG_8K^*FG>'/AOX'
M\+?&?X6K\-_!6J^+O'VN?"[Q7\ /$.H_#WQ9\6_%OQ'UWXCVVO\ _"/>$OCO
MX(32OAMX!U+6A;_#CX,W,^N>'=$N;+3_ !'XAU/Q5XAT;0-0TCUOQU\'/CE\
M2?$DFO7GQ%\$^%-4^%OQ/\#_ !"_9XUJ/X>7NNV5A<V_PKU+P)\5=.^(?AR+
MQ]I-YXD\+>-O^$S\:VFB6ECXK\->(/#<<^GW;ZCJ$FCVLVH_85% 'Y[G]BWQ
MYH=I!J?P^^/%KX:^(_BCPE\8O"'QE\;ZS\+3XBL_&L7QK^(>K?%/6?$'@WPU
M:?$#P\GP_P#$7@;Q=XC\1#X9G4=5\=Z)I&@:I_8WB?1O%]Q;1:G6G'^Q1<:3
MJ;>%O"7Q.70_V?-8\6? ?QUXO^%UYX*?5O&.I>)?V?-'^'NB>%[?0/B>OBW3
M[;0?#'BBU^$/PR;QUI5[X!U_5M2?0]=_L;Q#HC^++F33_O6B@#X7U;X!?M#>
M,-1T[XE'XP^"_AU\8K?2_C?\+[[5X/A9<^,-!O\ X'^/?'BZ]\/+-M#A^(_A
MQ=/^*/P]TO1/#MU8^+$UG5O#MWJMWXEBU?PAJ=IJMO'IN)#^PY/H!B\$^!?B
MG+H/P'UA_P!GJ\^('P]UCP:WB#QKXBU+]G/2_!7AW0'\/_$J#Q;HEEX9T_QS
MX7^&?P]T#XB6=]X"\3W=_;:%J-UX;U/PY?\ B"YN;;] Z* /BWX=_LI^(/!7
MCSP7J&I?%*#7?A/\(_''Q<^(?P<^'%GX&DT/7O#OB'XO#Q1:WEKXQ\=OXQU>
MT\9Z!X(T?Q]X[T3P+86'@SPA=VNG:[8GQ!J/B"^T"UO+G[2HHH YW6"1<Q '
M'[C/0?\ /1O4&LK<W]X_DO\ \36IK'_'S%_UP_\ :C5E4 +N;^\?R7_XFC>X
M(.<X('('<CT'M_GH4I#T_%?YBD^GK%?>TG^#8?U^9_#%^VZ<_MC_ +4O_9?/
MBF/R\8:J/Z5\NU]0_MN?\GC_ +4W_9??BI_ZF.K5\O5_/.,5L9C4MEC<9_ZF
M8L_YL?$;_DX?'_\ V7/&7_K5\2!1117,?&A7]$__  0/8BW_ &KP.!N^!9_\
M<^+?^?6OYV*_HE_X((?ZC]J[Z_ O_P! ^+=?1\(_\E#EW_<W_P"H&*/ZD^AA
M_P I'^'W^#BK_P!8_/#]SOC)/\0(/A?XVNOAGXE\/>$?&-CX=U;4M/\ $OB;
MPK/XTL-'@TW3+R^O;FT\,P:]X;@U+6!! 4T@ZIJ3Z+;7K1W.K:7K=G%+I-WQ
MOPV^+UK:?LJ_#/X\?%[Q-:Z=9-^S_P##WXG_ !)\77EK9V=HMUJ?P\T3Q)XB
MU(V.EV=G9)<ZAJ%W<FRT?1["V6XN[FWT[2=.0RVUK7N5_86FJZ=?:7J$"W6G
MZG87FFZA:L\D:W-AJ%K+9WELTD,D4T:SVT\L1>&6*5 Y:.2-PKKX]+^S[\-9
M=1^%[G2)6\,?"'X9>(?A+X1\ 7-U<:GX*F\'>(+/P?I9T_Q1H^KSZA%XMCTC
M2O!&C66C+XA&I26LGVC4)9KB]F>1OVT_W</D_P"'/[7/C&RT_P#:"UCXH:MX
M-U'Q>_Q9^''A;X"_!VQU?PGIO_"/7GQ3^%?A?Q#X/^%OB+Q7IT\W]J7^CWL^
MJ^)?BUXXNKK5;30(]-\?3^'!/X;\+Z=9/Y1X=_:/_: \8>#_ ((>!+;QW\0?
M%/CO6/"7[37B[X@?$G]F_P"$_P (/%'B?Q/J?P?^-D'PS\.:7HGAWXC07/PK
M\(^"[72O$-GXCUBTOED\=^(;*T\)Z%X?U2?7-<U?4;_]"=+_ &;/V>]%G\47
M&E_ WX3VK>--1TC5_$]N? /AFYT[5-2T#28]"T:Z&DW>GW&E6#:?I<9@@BTR
MRL8/.GO;V2.6_P!0O[NYP+G]DO\ 9VF\+:%X,LOAAIWAC0/#&L^,-?\ #J>
MM>\8?#?6='U+XA3S3^.A9>*_A_XC\,^*X]+\7F<0^(=";6VT+4[.RT?3KG2W
MT[0M%M=/ )+CQ9XD^(?[.?@WX@?#[XR^$/#%MXF\)^ _&6O_ !ZOO",6@:'8
M?#[[+IVM?$;QQX<\'^-_^$ATGPEKUUH$6IR>'])^(3:]H'@B^NQ)XGCUV+1V
MM;[YD\%>/?VB_B7J_P (?A3%\7_%?P_M?']M^TW\2/#'QJO_ (5?#BR^*OQ
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M!7.Z,'8W3E3@ <#P+5/V7_@%K&O^'_$EW\,=%BO?#.F^"-(T[3-)U+Q)X?\
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M:G^LG_$9LW_Z$V5?^#\R_P C]LO^%X_!_P#Z*I\/O_"JT?\ ^2J/^%X_!_\
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MZ\U:WN[F7Z7H 7<_]X?]\_\ UZ-S_P!X?]\__7I** %W/_>'_?/_ ->C<_\
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M.:#:WFI:C?/9V.I:I>.L4=CI6BZ7JFMZO>6&DZ;?7MO\LR? SXTZI^SQ\)_
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M .$C\)I=O9R^+O#*:M\A:?\ L[?M+?#V?4?B+X3\*_#'Q9X]^,?@C]H/PO\
M$#PCJ7CJYT;P[\,-=^,?QI\5?&/P1JNFZY-X.O9/&WAGPA'XSU3PO\1XK33-
M$UCQ'=:;IFOZ#IE^MQ-8V4VG?LG_ !E\&V&H? 70;+PAKWP@\9?$/]E7XBZO
M\7=2\2G3O$GAFW_9[\-? G0O%7AMO !T&[DU?5?%9_9[T.3P;JEKXB_LS1T\
M:ZD^J"R_X0VPMO$P!]K?&']HGX>?!"XT.P\81^,-3U;7M,\2^(K?0_ 7@/Q;
M\0M:L?!_@N/39?&/C;6--\):5JESI7A3PU_;.C6VH:K>)%Y^HZOINEZ7!J.I
MWD%F_,ZC^UY\#]/\8:%X0CU_6=737(OAR[^-?#OA'Q/X@^&?AZ;XQ7%O:?"6
MQ\5_$32M,N/"OA[4/B+<7NF1^&K2_P!125X];\.W6HC3K/Q)H%QJ7AGB+3?V
MD/$_CC3?V@?!?P9\+1^)I/ WQY_9WO?A[XU^(MUX?6W\/2?$ZQO_ (4?&6WU
M*_\ A_\ ;'T#Q#:^$VU3QEX+N=$TW7[32O$VDRZ1)XFDT%(]3\ST3]D/XV>
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MV_,?X49;^^WYC_"BB@ RW]]OS'^%&6_OM^8_PHHH ,M_?;\Q_A1EO[[?F/\
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MA1EO[[?F/\*** #+?WV_,?X49;^^WYC_  HHH ,M_?;\Q_A1EO[[?F/\***
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MMO$EF+B2*#[5H4TR:I;^=+%#YUJGFRI'N8 '\T#_ !I_;0\/^"K7_@J?J'[
M/_!/9?@I?:9I_P 9[E=&T9W_ &L;;X3ZW>1:O:>.6\?II[:=)XR/AV^75[C4
MX#/JCF^+WGA:V>.XL;#^G#0-8M?$.A:-K]DEQ%9ZYI6GZS:17D7V>\CM=4M(
MKZW2[@WR>3<I%.BW$0=Q','0,0,U_&_X@\"?L1^&O!]_\#]:_P""]'Q3D^'7
MAK6I;V[^'^F>!_%6N_#6/5].\12^*9KC3]-\.SZCX.U#3X_%2R>(;:VTA[SP
M]_:@2]L;<E(67^EK]B7]G?XC? ;POXKO/'G[7OQ;_:YL_B/+X8\2^$]>^*T;
M13>%='CTF<BV\/QOJVJ2)9:^E_:ZC=)(MDZ2VT > MN*@'V[1110 48!ZC-%
M% "8'H.F.G;T^E&U?0>G0=/2EHH 3 ]!^5! /4 _44M% "8'H/R%&!G.!GUQ
MS2T4 &!Z"BBB@#C_ !'S=6XYQ]G8]2/^6A]*Y[ ]_P S_C70^(_^/NW_ .O=
MO_1AKGZ $P/?\S_C3EX8$$YR.Y]0?7UI*5>H^H_G1U7JOSB-;KU1_#Q^V]_R
M>/\ M2_]E\^*?_J7ZK7R[7U%^V]_R>/^U+_V7SXI_P#J7ZK7R[7\[XS_ 'S&
M_P#8;C/_ %,Q9_S8>(W_ "<3C_\ [+GC+_UJ^) HHHKG/C0K]>_V)?\ DA1_
M['_Q1_Z;?#=?D)7Z]_L2_P#)"C_V/_BC_P!-OANOB>/_ /D0+_L883_TC%G]
M%_1>_P"3FS_[)?/?SRL^O%Z#Z#^5+2+T'T'\J6OQ4_T-"BBB@3V?H_R9]D?L
M2<_$GQD.W_"O9?\ U*?#O^3ZU^DP&0.O0=S_ (U^;/[$?_)2?&7_ &3V7_U*
M?#M?I.O0?0?RK^T? W_DWV#_ .QMGG_J=2/ZB\*?^2-PG_8PS;_U,I!@>_YG
M_&C ]_S/^-+17Z^?HXF![_F?\:,#W_,_XTM% "8'O^9_QHP/?\S_ (TM% "8
M'O\ F?\ &C ]_P S_C2T4 )@>_YG_&C ]_S/^-+10 # (/S$ @D!RI.#GY6Y
MVMQPV#@]0RY4_(-U^S=\1_$5_I^I^-?VC-8NM9\"_#SX@> ?A#XO\ _#/PY\
M,_&_A&Y^(5WX8NM2\;^+-2T[7=7\->,O$UG'X.T.S32_#7@WX8^!]1@DUB34
MO"=Q<7UC)I'UZW0G&<8/Y'-?EQ^U]_P4^\*_LC?%X_"+5/@WXE\>7Z>$?#GB
MR77-.\::5X=L@GB1M1,%E#8W7A[69Y'M8[(&:XDN(5=Y_+C@*PM+)QX[,,'E
MM#ZSCJRH4'4C2]HXU)KVD^9P@HTH59MRY)6]QQ]UWDK:_'\<<?<(^&^1OB3C
M;.J.0Y(L;A<N^OU\/C<3#Z[C77^JT%2P&$QN(<JJPU?E:H\D>3]Y4IJ47+Z7
MT;X#_%G2==\9_$J#XZ^&+7XQ^--8^'=WJ>JZ/\"--L/A->:%\--#\5Z)I6BZ
MQ\+[_P"(FM>*;O5M9'C/4]1U_P <Z+\8/#?BQI='\(:/I=[IGA30[OP[JZ>&
M?@C\4_!UG_PAOAWXLV-IX9\867Q\\:?%CQA'X"\,?\)+J'QP^+OB_3_%6A>)
MO 7A?6_^$E\-:!X6\,7%UXICF\(>(8?%-GJ^FW&G0ZWJNLZ^]_KD_P"8O_#]
MWP/_ -&S^,O_  Z6@?\ S$4?\/W? _\ T;/XR_\ #I:!_P#,17C_ .MW#G_0
MRC_X38[_ .8C\=_XF]^CE_T<W+__  S<3?\ SA/TFOOV4M1\<>)=4\?_ !:^
M,WB/4/B'>:G\)[NQUKX,>&M(^$'A_3K/X*#X@77@2WNO"GB>_P#C/'XEOK;Q
M!\3/$GBJXU'Q)JNH0VFO6?A6Z\,Z;X;;PQ9&7E_"_P"QSXL^&^@>#8_AI^T5
MXAT_QYX8T'XT^!]2\>^/?A_HGCPZYX!^-7C:#Q[=Z7!X?TSQ#X%ATCQ/X&\2
MV%AK'@OQ1)JNL62:E<^(GU_PQK&DZW;:+I'P#_P_=\#_ /1L_C+_ ,.EH'_S
M$4?\/W? QZ_LS^,O_#I:!U'(_P"9(]:/];^'/^AE'H_]VQJT3N]?J32T3=[=
M&-?2]^CE=?\ &S<OO=6OD_$Z5[JUW_8&BO:[Z*[Z'U-^U!X(T+X9V?P'^''A
M@78\-_#_ .$&F>!] _M"<7>H/HWA-[;0M.FU"[6*%;N_FMK&.2^NEAA6XNFF
ME6*,-L7Y5J27]LS2?VTS%XQT?X?ZI\/(/ JMX3DT_5?$=GXDEU)]1/\ ;:WD
M5S9:/HR6R0AC 89()7<XD$H'RU'7\5>).)H8SCKB;%86I[7#U\PA.E4Y9PYX
MK 9;"_)4C"<?>IR34X1E=.Z6A^=YSQ/D/&>:8SBCAC,(9KD&<U8XK*\QITL1
M0IXO#PI4<+*K&CBZ&%Q--*O@\13:K4*4G*E*2CR2IN11117Q!Y@5ZC\&=2^(
M>D>/[74_AJGA%-;L="\2W>K:GXUTGQIXFTK0?"5II,UYXAUFQ\%?#V)?%_CW
MQ##!!#9Z'X,T?5?#T^L75ZS+K44EM'9WOEU>K_ KP!_PL+XN>$K2W\9>-/A]
MK?AN/7O%GAKQCX"O=&MM>TC5]/T.\T]TELO$NA^)_"VO:1J6EZKJ6G:KH7B7
MP]J^EW<%REPEO#J%G97MK]=P!;_7CA+F=E_K!ENT>=W]K6LK*4=W97O>.]I6
MY7]%PA;_ %JX=YFTO[8P.T>;7GK65KJ]W9;JU[]#VW4?VPOBS?\ @WX2>*M(
MTKPKH.E^*/!_QM\3>/?&5I\ _P!HCX[^&M-'PK^)&C>!=$NE\+_#/Q#X:\4_
M#"+7]%E\0>,_$GASXE75YXI\#OIDGA'5K4:]H^IA=#QM^W!=^#_B->6,VH?"
M9O VD>,?@EX;T[PLT/C:7XK_ !@\$?&72_ ;Q_'[X1ZO:ZA/X+'PPT#7?'@L
MH;.]TGQ);W\/@_Q+9:UX[\*Z_<Z7IS^[P_LM6>D^'%\.^%/CC^T!X-DU(^/9
M?B!KV@>*?!DNH_%#4_B;K][XG\:>)?%&EZY\/M9\):'XOU#5M1O1IOBOX<^&
M_ ^M^'M*F30M#N[/2K/3[2VTI?V8O";WWAO3HO'?Q7M/A)X8N_A=J.G_ +/R
M>)]*OOA']O\ @W::#;> &B@U;PYJ'CS3=%TR?PMX:UC4_!FB>.M)\%>)?$>C
M+X@U[P_>ZEJNOR:I_H&]WZO>_=]TG]Z3\C^QN_J_S?F_S9PW[3?[2VI?![QO
MX4^&7AS7OA;X2\0ZUX$\9_$S5/%/Q<TWQYXC\.P>'_">LZ-X:M=!TOPM\-+N
MS\6W=]K6KZM+?Z]XP:>;P_\ #OPOH5[J^LZ7K4NH:=9KTVI?&SXCVWQ7_9=\
M+0^$?AP_PT^/%GK4>M>/-'^(5]XTNAX@L/@QXK^*<-G\.HM*T+1](U;P9;S>
M'885\?ZU=F7Q1IE_;2Z/X-TU9WU.W?+^SMXDUF/2_$&N_'OXLZ1\5=(U#XO6
M%E\3?!$O@6#7(OA?\5?%[>)8_A+>VGBWX?\ B7PYK'A_P=;V'AFV\+:[/X:M
MO%>BWOA^.[TW6K<7^J+J?>:=\!_ .BQ_L\6>A1:QHVC_ +,<5U:_#71+2_BE
ML);"X^%^K_"1;#Q-+?V=YJ.JPV_AK6KJZCN+6^TR]EUM(KZ[N;FW,UI*@/-M
M#^+7QJM_CKX/^'?C[PO\-=-T/XDP?%W5]%\(^&=1UW5OBC\-_ WPYN6M_"?Q
M)^(FOP:SJW@G6?#WQ+E%AIPT_2M&\+3>%/$OBG1O#EKJOC"\TGQ%+:?5X /K
M_P!]'\N"1Q7S?\,_V>+KX9>/O%_CZW^./Q?\977C_P 0W_B+QII'C;3_ (,7
MT'B*22WO;3PYHMYXDT7X2:%X]M_"OP]M+M;3P#X9T_Q;9:/H5M;!&M[PZAKL
MNK?2"]!^?'3GZ\_B>3U/- !@>_YG_&C ]_S/^-+10 F![_F?\:,#W_,_XTM%
M "8'O^9_QHP/?\S_ (TM% "8'O\ F?\ &C ]_P S_C2T4 )@>_YG_&C ]_S/
M^-+D>HHH 3 ]_P S_C1@>_YG_&EHH 3 ]_S/^-&![_F?\:6B@!,#W_,_XT8'
MO^9_QI<CU%% "8'O^9_QHP/?\S_C2T4 )@>_YG_&C ]_S/\ C2T9'K0 F![_
M )G_ !HP/?\ ,_XTM% "8'O^9_QHP/?\S_C2T4 (1P>2./[Q_P :\/\ VD_C
M!^S]\!?@#\7?BQ^U9J&B:=^S?X5\#ZI#\9I?$W@_5?B'X>N? WB>6V\'ZII.
MO>!-$T'Q3J7B[1M<;Q##HNIZ#;^'=834;+4)K>[L)[.2<#W ]#GI@YJM=^'_
M  [XLT[5_"_B_1-%\3^%O$.CZGI'B/P[XETRPUKP[KFC7]G+!J&EZYI&J0W.
MF:GI-Y;/)!?66H6\UE/;NZ3Q.A.8F[0GK!>XU[^L+:7YEVM=-W2C?F;5N:+C
M;FBY*346G:#M-ZI6@]E.[BX-_:CRV?/I_--^R!_P6M_X-COV"?AIKOP=_9,_
M:1A^$7PS\1_$+Q%\4M2\*67P-_;G\46?_":^*K#1-+UK4;*[\:?"7Q)JNGV<
M]AX;T:TM=%M;Z+1M,M[**#3+"TA+1G[#_P""/'C/_@B1\4/C!^V1\4_^"1%_
MI$7BKQO!\'M0_:?\.>#O 'QS^&'P]L+M]0^*L_P[U7PQX$^+/@WP?X8\,/JL
MUSXZBO\ 1_A9967AV%;"UGO="TV\N8;K4? _V6/V&_\ @DA^P'X _:R_:S\1
M?'/]B3XP?\$W/C#\6I_'OP2MOB1\)_@G\1/"W[-GB^"[U7P;\4OAM\,/VC;C
M6_'.J?%KPQXA\:: -&\(?"S2?#]I=^#;CPG_ &3HL/B'Q%?^+=>\1?K]^PEX
MT_X)V?%_X>:S\9?^"=D7[,>H^ _$^HV?ASQEXG_9R\'>!_!T\NM^'(7U'3O"
M_P 1=-\,Z%X?\0Z1K^B67B5]7T_PYXWTVQU;3]-\21ZK:V,5CKT-Q=Z)Q<G*
M\Y25"G&I+[='VM*#5*MJWR6II*UX3A&C4ARQ>F<DDN5)1A]8ERN2?)5=&M.3
MJTXZ-U4Y3LM9TJJJPG=Q:/NQ>G;CTZ'(!S^M.IB'(STYZ>@P,?I3Z7I9KRV_
MK_@E]O1;:ZV5]>NM]>N_4*\T^,Z^$W^#_P 54\>RWT/@5_AOXZ7QI/I@E.I0
M^$V\+:L/$<NG+"&F:^CT<WC6BP@RFX$8C!;%>EURGCK2];USP5XNT3PS?Z;I
M7B/6/#'B#2O#^IZUID.MZ/IVMZCI%[::3?ZMHMPKP:OIEG?S6]Q?Z7,CQ7]K
M'+:R*T<K @'\L/[(WQW\2>#/V7_A-X;\,?\ !$+Q+^T;X6T;P9':^$_C?%X$
M\ Z9=?&?PI UPOA?Q_KEAJGP[\7SQ>)O%V@+IU_XD:+Q-XBTVZUJ:]NM(U&?
M2Y[."'^JSPO.]UX9\.W,FB-X9DN=#TFX?PVZQHWAYYK"WD;0V2&&WB0Z26-@
M5B@AC4V^$BC4!!_-Q\*OA)^WC\'1H'[)7PK_ ."RO[%_A_Q)X.-WX4\)_!5?
M /PQUWQCX8G\^ZO8?!>E>&=<O=4\8Q6N@F:2WT/PE/\ :)_#^@6]GI%A;6VB
MZ?8VT'])OA^#5;70M%M=>OXM5URVTK3[?6M4@MTLX=2U:"TABU+4(;2-4CM8
MKR\2:YCMT1%@241*BA0H ->BBB@ HHHH **** "BBB@ HHKROXF_&_X1_!IO
M"B?%/XB^#_ +^-]?M_#/A5/%7B#2M$?6]8N"BBWL$U&[MFGCMC+ ;ZYC!M[!
M9[=KN2%9XV8 ]4HK@[[XI_#+2_'&D?#'4_B)X%T[XD^(-/?5M!^'M]XMT"T\
M<:WI2"]9]3TCPG<:A'KVI:>JZ;J3F\L[":WV:??-YFVTG,?>4 <;XD8+=VV0
M>;=N@S_RT-<[YJ^C?]\FN@\3?\?=M_U[M_Z,-<W0!)YJ^C?]\FG)(I=1R,D=
M1C_/^-0TY/OK_O+_ #%'5>J_]*B!_#_^V]_R>/\ M2_]E\^*?_J7ZK7R[7U%
M^V]_R>/^U+_V7SXI_P#J7ZK7R[7\[XS_ 'S&_P#8;C/_ %,Q9_S8^(W_ "<3
MC_\ [+GC+_UJ^) HHHKG/C0K]>_V)?\ DA1_['_Q1_Z;?#=?D)7Z]_L2_P#)
M"C_V/_BC_P!-OANOB>/_ /D0+_L883_TC%G]%_1>_P"3FS_[)?/?SRL^O%Z#
MZ#^5+301@<CH.XI<CU'YBOQ4_P!#1:*3(]1^8HR/4?F*!/9^C_)GV1^Q*=OQ
M)\9$@X_X5]*..?\ F:?#U?I()%P.&Z#^$U^;?[$__)1O&'_8@3_^I1X;K]'P
M0 ,D=!W]J_M/P.27A]@?/-<\_P#4ZB?U'X4_\D;A/^QAFW_J93)O-7T;_ODT
M>:OHW_?)J+(]1^8HR/4?F*_73]&)?-7T;_ODT>:OHW_?)J+(]1^8I<@]#0!)
MYJ^C?]\FCS5]&_[Y-1T4 2>:OHW_ 'R:/-7T;_ODU'10!)YJ^C?]\FCS5]&_
M[Y-1T4 2&12".02#C(//';BOY//^"SX4?MIS[>A^#GPP/TQ_;P Y]!@?A[U_
M5_7\G_\ P6?_ .3TY?\ LC?PP_GKU?&<=_\ (DI?]C+!_P#I.+/XK^GO_P F
M%_[OKA3_ -)SP_)^BBBOR(_Q3"BBBE+X9?X9?^D3 _4?]@;_ )$3X@?]CGIO
M_I@2OO&O@[]@?_D0_B!_V.>F_P#I@2OO#(]1^8K\"XM_Y*3-_P#L*7_IC#G^
MHO@E_P FHX(_[%-7_P!6V<BT4F1ZC\Q1D>H_,5\Z?J8I. 3Z#-</XE_:A\2_
MLI^(?!_CSPMX2\/^+]1U5/%>B/8>([[4[&Q@MOL%BLLR/I0%P\SBYPN76-%0
M@JQD5XNV)!!P1T/?VKXN_;*_Y _PZ_["OB[_ -(M%K]!\*L/1Q7B%PM2KTU4
MIK'UZRBW)+VF%RW,<30G[KB[TZ]*$TKV;C:2E%N+^R\/J%+$<9Y!3K052"QE
M6JHMM+VF'P&-Q%&6C3O"M3A-*]FXVDG%M/ZC/_!:/XRDY'P*^$O(SSXC\='D
M\]1=XI/^'T7QE_Z(5\)/_"B\=_\ R77XV@ XR ?E7K^-.P/0?D*_NY;+^NS_
M %9_6J;:3>[U?J]7^9^R'_#Z+XR_]$*^$G_A1>.__DNC_A]%\9?^B%?"3_PH
MO'?_ ,EU^-^!Z#\A1@>@_(4QG[H_"7_@KG\5?B%\5OAA\/\ 5O@M\,M/TSQ[
M\0_!?@F_U'3/$/C)M1TZU\6>(]-T"74+%+R::UENK%=0^UPPW$9BG>$0L4#[
MU_=TNJDC#<$@_*>H)S].>W:OXN_V:@!^TE^SM@ ?\7Z^#G;_ *J-X;K^T!OO
M/_OO_P"AF@!_FKZ-_P!\FCS5]&_[Y-1T4 2>:OHW_?)H\U?1O^^34=% $GFK
MZ-_WR:/-7T;_ +Y-1T4 2>:OHW_?)H,JX/#?]\G_ .M418#J?\_A2;E]?YT
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MHJ@2[O9A[D #\23@#W/% $WFKZ-_WR:/-7T;_ODU'10!)YJ^C?\ ?)K\^?\
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M94_:4W[LU%*3LCYK_P"&&_A7_P!!KQ#_ .!,W];NC_AAOX6?]!KQ#_X$R_\
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M)PF%QM/V.+P]'$TE.%2-.O352"J0YN6?+)I<R4VD]U=M;M'@\1<+\-\7Y?\
MV1Q5D&3\295]8HXO^S<\R^AF6!^M8?VGU?$_5L1^[]O15:JJ53XJ:JU.6SDV
MOS3_ .'*O[%7_0/\=_\ A<^)?_EK1_PY5_8J_P"@?X[_ /"Y\2__ "UK],O[
M5NO5_P#OL4?VK=>K_P#?8K@_L')?^A5EW_A)2_\ DCX7_B _@E_T:+PW_P#$
M1RO_ .2/S-_X<J_L5?\ 0/\ '?\ X7/B7_Y:T?\ #E7]BK_H'^.__"Y\2C]?
M[5X^M?IE_:MUZO\ ]]BC^U;KU?\ [[%']@Y+URG+FNJ^J4M5V?O=0_X@-X(_
M]&B\./EPCE:?R?-HSXH^'/\ P3(_9X^%6GZEI7@:;Q7IECJ]_#J-_'=ZWJ6J
M-)=P6PM(GCEO-1D:%1  &BB"HQ^=LN"3Z'_PPW\+/^@UXA_\"9O_ )+KZ4_M
M2Y[EOS4G\3D$CV_#M1_:MUZO_P!]BO.K<$\'XBK.OB.%\@K5JCYJE6KE>%G4
MG*R7-.<M9.R2V6B26Q]7@. N!\KP>'R_+>#^&L!@<+!T\-@\)DV#P^&P]-SJ
M57"C1I^Y3@ZE6I/ECIS3D^K/FO\ X8;^%G_0:\0_^!,O_P ET?\ ##?PL_Z#
M7B'_ ,"9?_DNOI3^U;KU?_OL4?VK=>K_ /?8K+_4/@G_ *)+AS_PT80Z_P#5
M'A3_ *)K(O\ PV8;_(^:_P#AAOX6?]!KQ#_X$R__ "77G'Q&_P"";/[/GCZT
MTR+Q;/XKU&+1YKR?3TM-<U33/*EU".WANFD:RU2#SO,2VA"K+E8R&( +DU]M
M_P!JW7J__?8J&6^FE&'W'/4$@CV[\X]\ XS@5UX'A'A;+,51QV7\.9)@L9AW
M*5#%87+</0KTI3A.E)TZM.TX.5.I4A*WQ0G*+T;OT87ASA_ UZ>*P61Y3A,3
M1;=+$8; T:-:FY1E"3A4A:4>:$I0E9ZQE*+T;3_,C_ATY^R0?^87XW.../&G
MBC'Z:YC\N/3BC_ATW^R3_P! OQQ_X6OBG_Y>5^EXDP -AX]Q1YA_N'\Q_C7T
M7_#?=HOP2^X]H_-#_ATW^R3_ - OQQ_X6OBG_P"7E'_#IO\ 9)_Z!?CC_P +
M7Q3_ /+ROTO\P_W#^8_QH\P_W#^8_P : /SO\*?\$POV8O!/BKPQXU\.67C*
MT\1>#O$>A>+/#]U<^*O$-_;VNN>&]4M-9TFXGL;O6I+6]@AU"RMY);2XC>"Y
MC5H95:-V!^[CI?B,DD^+Y,DD_P#(L:-W_P"!UT7F'^X?S'^-'F'^X?S'^- '
M.?V7XC_Z&Z3_ ,)?1O\ XNC^R_$?_0W2?^$OHW_Q=='YA_N'\Q_C1YA_N'\Q
M_C0!SG]E^(_^AND_\)?1O_BZ/[+\1_\ 0W2?^$OHW_Q=='YA_N'\Q_C1YA_N
M'\Q_C0!SG]E^(_\ H;I/_"7T;_XNC^R_$?\ T-TG_A+Z-_\ %UT?F'^X?S'^
M-'F'^X?S6@#S3Q'\-O$7BN2SF'Q;^(?AG[%%/'Y7@N;2O#MO=F5XV,M_'':W
M?VJ:$J5MY&,?EQLR -N);G3\"?$@X_X:"^/9QZ>*M./_ +A_YU[C'<O%]Q2/
MQ!]3W/7G_'-2?;I_?_QVLY4:,FY2I\S>[<ZRO\HUH16BZ)??J>7B,DRK%5IX
MC$8*-6O4:<ZCQ.9TW*T8QC[E#.\+1C912]S#TD[7:<KREX5_PHKQ)_T<#\?/
M_"JT[_Y3T?\ "BO$G_1P/Q\_\*K3O_E/7NOVZ?W_ /':/MT_O_X[4_5\/_SY
M7_@S$?\ S28?ZN9'_P!"^/\ X69S_P#1&>%?\**\2?\ 1P/Q\_\ "JT[_P"4
M]:FE_!WQ-I;S2#XW_%_5!,@3RM>UC2]2ABVMN+VZ-IT/DR-]UWR=R'9MP!7L
M/VZ?W_\ ':<+^8*1@Y/7[N#GCU]/;T]*4L+AIQ<945RR5G:KB5=73WCBX-;=
M)(TI9#D]&I"K2P,85(.\)?6\UERNS5^6KGU:F]&U:=*:LWHG9KS8?#CQ1V^*
MWCS'UT@_K]E-'_"N/%'_ $5;QY^>D?\ R)7H_P!NG]_S7_&C[=/[_P#CM8_V
M=@O^@=?^%&/_ /GD=OU+#?\ /I?^#,7_ /-YYQ_PKCQ1_P!%6\>?GI'_ ,B4
M?\*X\4?]%6\>?GI'_P B5Z/]NG]__':/MT_O_P".T?V=@O\ H'7_ (48_P#^
M>0?4\-_SZ7_@W%__ #>>4:C\+O$UY;>2?C%\2[$>8KF?2;W2;*Z(3/R&9;*1
MO+?.738-V!R .<+_ (5!XA_Z+U\;_P#PH-._^5M>Y->2N,,"><]5'.",\=\&
MH1)@ ;#Q[BNFE1IT8\E*"A"[ERJ56>KM=\U6K6GK9:>T:71*^N].G"E'EIQY
M8WO;FG)7=KM.I4JR5[+3G:O>R5SQ/_A4'B'_ *+U\;__  H-._\ E;1_PJ#Q
M#_T7KXW_ /A0:=_\K:]L\P_W#^8_QH\P_P!P_F/\:T+/$_\ A4'B'_HO7QO_
M /"@T[_Y6T^/X1^(8Y(Y?^%[_&N7RI(Y/*GUW3I()/+=7\N>+^SU\R%]NR6/
M<N^,LF1NS7M/F'^X?S'^-'F'^X?S'^- '.MIGB-F)_X2Z09).!X8T; R>@RY
MX'8=AQTI/[+\1_\ 0W2?^$OHW_Q=='YA_N'\Q_C1YA_N'\Q_C0!SG]E^(_\
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M_#:WFL^)O^$8T#Q/X;OO'7W-_P &[>G>%O'_ ,9?^"HW[7?[+OP"\8?LP_\
M!.#]IOXL? %_V0?ACXC\+6_P\T'7/$?PR^'?B30/V@?B=\.?AQ8:C>:%X6\$
M>+_&6I:.UC<>$=_A6:6UD\#V,EA>_#74O#7AWX?^$/C+_@Z^NOVN/VXM2O\
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M;=KW4?!'C>PL[BR9+W3UNK"34O#VLVLP@U:Q@OK28RV]A>![B*SET^]^X:*
M/P>O?^"<W_!0G]H^]\/^ _V[_P!N[PU\1?V<-%\1Z)KWB3X8_"7X:Z5X*U;X
MN1^&]2L=3TK3/&>N:;X>\*-I>F7EU:++J=A&WB.UC=5N-/A@U6'3M7TS]V[>
M"&U@AMK>&&WM[>)(+>WMXTA@@@B41PPPQ1A4BBBC58XXT541%"J H J:B@ H
MHHH **** "BBB@ HHHH **** "BBB@#A/%/_ !_6_P#U['_T8:YJNE\4_P#'
M];_]>Q_]&&N:H **** "BBB@ HHHH **** "BBB@ HHHH _GU_X+0_\ )4_V
M??\ LE_C7_U-K:OQIK]EO^"T/_)4_P!GW_LE_C7_ -3:VK\:: "BBB@ K]#O
M^"6'_)Z?@7_L1_BO_P"H1J-?GC7Z'?\ !+#_ )/3\"_]B/\ %?\ ]0C4: /Z
MDJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6A_Y*G^S[_V2_P :_P#J;6U?C37[+?\ !:'_ )*G^S[_ -DO\:_^IM;5^--
M!1110 5^AW_!+#_D]/P+_P!B/\5__4(U&OSQK]#O^"6'_)Z?@7_L1_BO_P"H
M1J- ']25%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8_QIE% #_,/]P_F/\:/,/]P_F/\ &F44 /\ ,/\ </YC_&CS#_</YC_&F44
M/\P_W#^8_P :/,/]P_F/\:910 _S#_</YC_&CS#_ '#^8_QIE% #_,/]P_F/
M\:/,/]P_F/\ &F44 /\ ,/\ </YC_&CS#_</YC_&F44 /\P_W#^8_P :/,/]
MP_F/\:910 _S#_</YC_&CS#_ '#^8_QIE% #_,/]P_F/\:/,/]P_F/\ &F44
M /\ ,/\ </YC_&CS#_</YC_&F44 /\P_W#^8_P :/,/]P_F/\:910 _S#_</
MYC_&CS#_ '#^8_QIE% #_,/]P_F/\:/,/]P_F/\ &F44 /\ ,/\ </YC_&CS
M#_</YC_&F44 /\P_W#^8_P :/,/]P_F/\:910 _S#_</YC_&CS#_ '#^8_QI
ME% #_,/]P_F/\:/,/]P_F/\ &F44 /\ -Q_ ?S%?G#_P5^^-?Q"_9Y_X)>?M
MT?&'X3>(M5\'_$CPC^S]XFM_!_B_0=1N=(\0^$]5\5ZGHO@D^)_#FL63+?:1
MXCT&S\27.IZ!JUA+;WVF:O:V=]97-I=6\-S%^C1Z'Z&OD_\ ;I^"GP1_:+_8
MY_:2^#/[2OQ'U'X0? 'QE\+=8;XN_%#2M:\/^'+WP%X'\,WVF>,]7\2)KOBO
M2->\.:7#8)X>0WEWJVD7]NEDTZI#Y[1.N.(3>'KQB[2E3<8W=HW;@I.3Z>XJ
MB3O\3LKN23VP[C&O1<TY0C4C*24>=M+F:M'[34U3=NT;[)G\/VG?LL?M2?\
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MP\E_8"TOPM\,='U2Y\/^ _$MO\>O"OP4UOQT/$GPPA1=/\4WOQ;\4_$KX@^
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M_P".5Z:-AZ;?T]Q_,$?4'TI<+G&%SZ<9_*@#S'_A'M8_Y]4_\"K;_P".4?\
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MRO31M/0#\A_GO2X7T'Y"@#S'_A'M8_Y]4_\  JV_^.4?\(]K'_/JG_@5;?\
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M\_C'\;_&_P"SAH/Q5\$_!G3-%_:F_9D\1_'[P$_PC\:>)/$WB'P7<_#R_P#
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MVA^!Y;F;P=I'C 75E(/$.G>%I;RZDT"SU,7-OI37$ILXXM[9[WQ'X8\.^,-
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M/Q1U/PA)-+X5U/Q]%=:7*GBK4?#LMQ/+HM_K(N[O3I9II;66-Y78T;O]D/\
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M\/Z[X2\ V6L6G@?5&M-_CKQ'-83V][T'PM_;L\=^%OAI\(]'\477A/Q-.O\
MP29M_P!LK4/'WC/79H=;\6_%#PQ9^&],OM,U:]CO+73;C2-4GU!M0\07%I&F
MJ6]]<J%E@CD1#^B^G?LL?LTZ/X^N?BII/P ^#.F?$V\\17_BZZ^(.G_#3PA9
M^,Y_%&K:/J/A_5O$$OB2#24U9]7U;1-8U72]4OC=_:-1L]1O(;QYUGDW<L/V
M0?V-?$&@>$O#9_9O_9SUWPQ\,+GQG8>"-#;X5_#[5-#\!W?C"\N[GQY8^'=.
M;2+BQ\/3:_J-]=W/B2TL8;5[R_GDGO8S<L' !^;WB/\ X*C_ !T@US0E\'?
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M&N>#?A5X>\1?'O\ :0\"?&[2?!GBKQ)-HWQ%\4_LDZSJD'C*7PIXWMM!DO\
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M)?[1WAW]AC2/VF?B+X@_;8U'4_%_@S]D6>Q\5?$_]H_X1W?PQ\?ZC\2OC/\
M"ZU\2:_\*]&^$TU]\5? UO<6%W.9M/\ B+IVDS7_ (/UV\\*W\<U]/?3VWV;
MXF_X*7_$'P3\:OVH?A?K7@#X=Z_I7[(_@;X]_&'QOKOACQ!JWF?$WP-X*\*^
M%?$OPY\"?#*.>2[6#XK>'7\86%C^T>-1CU71OAHMOI-Y:V4X\:Z/!8?HU9>"
MOV;-:\">'?@9I_A_X-:K\./#]OX<L?"WPGL[/PAJ'A32+;P'>66K^%K31?!\
M/FZ=:Q^$[[1M/U'1H[.P0:/<Z9;75JL#VJ,L.D_"7]F6R2VUO1/ /P7MT\"^
M*OB'XL@UG3M!\'H/"_C/XIPZE;_%779M2@ASIVN_$&WUK4H?'-W<SQW?B2*]
ME36VO%9 H!^9^C_\%+_CWX?^#/QO\9?%/X%>$K#QEX+\+_L^^)_AI<VFI>(?
M!'@;7(_VBO'UC\,-(7QE9>,6O?&VE^%O /B/4K'6]7^).F:=-X5\:>%VOGT
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M@O;J:W\-Z+:W,S32KING.9;&V_4"D(R#VR,9[_Y% '\G_P 3?"/@C7_V&O\
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M%^,VD6-U\3?V5_@%:^,]('A>:'6=:\.6OPV\2:9\.[>^O[#4?%4MO=K'I_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>proxy_chart-2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_chart-2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'P M # 2(  A$! Q$!_\0
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M1U/3IKC2+G5Y(UPB2:S)IW]JNL86(/>$1*L>Q1^'6I:S\5/@G^V=^VG^UO\
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M=>B-\%?VB/A[\9?B-JWQ'^(/[4>O0>+/BC\2],T2P\,_9/$6E70U+PS<>$]
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MPTT[P)>:MK?A^&&V\.:K\0M<M]5U*36[C2X[+3I)(K:"$WC0W,<TZC4-1>^
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MV5F&>[LTA#EKU=.]W^#,48_X*Y_MA2"-!(_P$^%(>0(H=@NE?#C:&8#+!<<
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MW,-VD?U/X_\ VOO&]]\(O@3\2O@-\-="U^U^.5A;ZI-XM^+'C:Q\ ?#/X2V
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MM>KX>\YH99)UN61Y&54\G],Z "BBB@ HHHH **** "BBB@!,#.>^,?A_DT
M'/?ZD_S^E+10 4444 %%%% !1110 4450U75=,T+2]2UO6]1L='T;1["\U75
M]6U2[@L-,TO3-/MY+N_U'4;ZZDBM;*PL;2&:YN[NYEB@MK>*2::1(T9@ 7Z*
M^-_A'_P4#_8\^.VN:'X>^%/QP\->+=1\4^-/%'P\\)M;67B"PT_Q9XR\&^$]
M-\=>(M$\,ZMJVD6&EZY/9>$M6L]<BGT^[GM-1LS<'3+B\DL[J.'[(H ****
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M2]OK9X;"YEL]0T_N?@/^R[^T-X5_:_\ %_[4'QK\<_"SQ5+XW^"5MX"U#3_
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MV6\]\L8N9H$$486&25HU$: * JXT0,<4 ?%VN_LZ^.-3_;L\#_M/6^I^%D\
M^&?@3KWPQO\ 1YKW5AXOFU_4]<N]3M[NSL4T5]&?2$@FC26>;78+P2A@EBZ
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M#\5E>6;I>?V/;1R"SA_I]H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\,_:(^/7AC]FGX.
M^-_C9XWTS7=8\,>!X=*EO].\+6MG=Z[>2:UXATKPSI]M96^I:CI=@TC:CK-G
MYTESJ%M#%;">X9\1^6?S T'_ (+I_LR:_KNB:#!\+/CU:SZYK&EZ+#=7.A^
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M V/A#6M1T.5K'6'TW4=%U'4OL6@ HHHH **** "BBB@ HHHH **** "BBB@
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M+O=3T[1+>\;1/B+X1\27Z-JFJ2P6-JZZ5H]\T)N9X8YI@D6]'D5J_FQ\'_\
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ME)XM\4?\)!XBM_">F^%OTT(!Z@'ZCUZ_G1@>@_(4 ?E'!^SY^T,MSI7[.A\
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M5Z]>2Z?'X=FD^V36&W;/HEY%/<W.F_KW0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %?-/[9'C[XA?"O]E3]H7XD_"?3%U?XD>"/A)X
MV\2>#[1M.76!'K6E:)=7-OJ7]CO#<1:L=&6-]873)8)H=0:P%I-%)%,ZGZ6K
MXM_:UU#]O+3[CP9/^QE8_LLW>D16'B>?XG3?M(7_ ,0[&6TEB;16\,R>%Y/
M\B6ZV0MO^$ADU^35B/+,6FFV.UKF@#\/OV7?VG-3E_:#^$G@#X._MU?$[]K+
MQ#X@_;'\' Z=XDU^?Q!_PM/]G+Q_^R5X&\0?''Q=X@\,16-MIW@/PM\'?B-%
MJ\WA73H(-'30/$UA?Z$8+_4(]69?ZDZ_F8_8K_:9_:^\?_MDW'@/X3?LZ?\
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M%-5\93:;8B62YN?%6OZ=K+I;R>&K!Y?YY8_^"^'QM>.-S\ /A1ET4L!XE\8
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M_;\;?^B ?"G_ ,*;QA_\31_KMD'_ #_Q/_A!BO\ Y(7_ !.]]'7_ **K.O\
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M6P/?\S_C1@>_YG_&@"S15; ]_P S_C1@>_YG_&@"S15; ]_S/^-&![_F?\:
M+-%5L#W_ #/^-&![_F?\: +-%5L#W_,_XT8'O^9_QH LT56P/?\ ,_XT8'O^
M9_QH T:^=OVN/@YK/[0G[,GQT^"7AS5[30?$'Q.^&?BGPCH6J:BUPFEV^KZI
MILT>FQZP]I#<72Z+=WBPV>LFVM[B?^R[B[\FWGDVQ/\ 1-? '[>'[0O[4_[-
MOA6R^(OP(^!/PP^*_P .?#7A7QQXM^-'BKXD_&&U^%T/P_TWPQ;Z3>Z5)IUG
M)8:A>>)CJ]D^OF2VTZWEO8[O3["RM8+JZU." @'Y_>"?V/?VM]&_:2^!FL_\
M,O\ [+7P^\*GXQ?"']I?X@_%_P"&^H^'(#\([W1_@-IOPI^,W[.O@WPU=:-%
MXEUSP_XFU[1VUKP?KME##I-H?$#:Q<Q6GB*TFU6T_H K\4O G[<__!11/B-^
MS)H_Q[_8C^$_P:^&'[1OCOP]X0L_'-U\>QJ>IZ&==T.Z\3QZ5>:%%HI?3/'6
MH>'['4Y?#OA37)-/EUG5]/N_#ZW$.LB&RN/VMH **** "BBB@ HHHH ****
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M)_>%'F)_>% #Z*9YB?WA1YB?WA0 ^BF>8G]X4>8G]X4 /HIGF)_>%'F)_>%
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M3^\*/,3^\* 'T4SS$_O"CS$_O"@!]%,\Q/[PH\Q/[PH ?13/,3^\*/,3^\*
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M:<6FE8.Y).<_08P,  #           &****ZSH"BBB@ HHHH **** "BBB@
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M<W.N^,+;0;JSTZVTQP#]/B,\&O%/'?P!^''COPS\<?#EUIDVC2?M$Z%#X?\
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M::EIM]IAF@74-(O-/U.Y /?J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M_LP7,G@)O$$'@/PMJ_P$U+4O 6FW'@?P_/KMUHMUIVF:#-%!X6U76[+5=?\
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MU3X<KXPE\,KI-U8K/H3:S_PD']FW=W,+ZX< _7BBBB@ HHHH **** "BBB@
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MI$VDZG8>+=)U/_A(-:T'7_"LN@7_ (<U37#:^%QH6C6-I9P?R5_\/,OVZO\
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MKUO<KSDH5J?.HWC%?>'_  WEXV_Z)SX3_P#!UK/_ ,9H_P"&\O&W_1.?"?\
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MZ#D\?X4S;)_=?_OEO_C= F[=+CMS_P!X?]\__7HW/_>'_?/_ ->F[9/[K_\
M?+?_ !NC;)_=?_OEO_C= K^3_KY#MS_WA_WS_P#7HW/_ 'A_WS_]>F[9/[K_
M /?+?_&Z-LG]U_\ OEO_ (W0%_)_U\AVY_[P_P"^?_KT;G_O#_OG_P"O2^7-
M_P \F'X-_P#$T>7+_P \V_)O_B:"A-S_ -X?]\__ %Z-S_WA_P!\_P#UZ7RY
M?^>;?DW_ ,31Y<O_ #S;\F_^)H 3<_\ >'_?/_UZ-S_WA_WS_P#7I?+E_P">
M3_@K?U4#]:;M?_GFW_?+_P#Q% "[G_O#_OG_ .O1N?\ O#_OG_Z])A_[C?\
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MK6C^#7PFACCBA^'^@00PQI%##!!=0PPQ1J$CABBBG2.**)%5(XT141 %554
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MQ^5 ']'7_"!>$/\ H%WG_A0>)OZ:P11_P@7A#_H%WG_A0>)__EO7844 <?\
M\(%X0_Z!=Y_X4'B?_P"6]'_"!>$/^@7>?^%!XG_^6]=A10!Q_P#P@7A#_H%W
MG_A0>)__ );T?\(%X0_Z!=Y_X4'B?_Y;UV%% ''_ /"!>$/^@7>?^%!XG_\
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M _X-:>KIIWPT\*Z<DK!Y8]-TUM.CED50BR2I920)+($ 022*7" *"% 46_\
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MS/\ Z&68_P#A?C/_ )I/Y3_XC3XO_P#1U?$C_P 3CB?_ .>Y]G_\/$_VU/\
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M5/%OAFYT2_=GU*RT^'3=&&EV=Q#9"TC$0#?97_!._P 6?LK_  U^(NL>$?\
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MCC/_ )*#$_\ 8-@O_3-0_P 1?IV_\I"YM_V2'!/_ *J\S"BBBOEC^.@KV_\
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M^8_QIE% #_,/]P_F/\:/,/\ </YC_&F44 /\P_W#^8_QH\P_W#^8_P :910
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MH_,49'J/S%>J_P#"A/CM_P!$1^,W_AK?'G_S/T?\*$^.W_1$?C-_X:WQY_\
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M ##_ '1_WT?_ (FCS#_='_?1_P#B:910 _S#_='_ 'T?_B:/,/\ ='_?1_\
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MR_X0<]NVO^$7-];M6_X3,<TNJLFHNS3NXJ[TU\-HHHK_ #L/XL"BBB@!\/\
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M&GAJT\7^%-!L]6TV:VU#4]>\.7VHZ3:ZEIUM8/<O,LNJ:>;?Y;R.\MY;=)5
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M_9C_ &N?&O[0O@V#QK^Q?X%_9*^%_@+]I[X6_M)ZKXJT'QYX"US2_#3?!_\
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M:T\+>(_&-\^IZ[I?A6_>VTO2=5OH8&T^_P#$EYX?M?$<&G+)H\U_#IQ>S;]
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M!,#T'Y"C ]!^0I:* /8*\"_:I^('Q ^%/[-WQQ^)?PJ\*6WCCXB^!/ACXO\
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MUT_3+9+CP3XNL]*AM]-GL6AE.KM/=:E<R16%O9R_K30 4444 %%%% !1110
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M\A0!8R/4?F*,CU'YBJ^!Z#\A1@>@_(4 6,CU'YBC(]1^8JO@>@_(48'H/R%
M%C(]1^8HR/4?F*KX'H/R%&!Z#\A0!8R/4?F*,CU'YBJ^!Z#\A1@>@_(4 6,C
MU'YBC(]1^8JO@>@_(48'H/R% %C(]1^8HR/4?F*KX'H/R%&!Z#\A0!8R/4?F
M*,CU'YBJ^!Z#\A1@>@_(4 6,CU'YBC(]1^8JO@>@_(48'H/R% %C(]1^8HR/
M4?F*KX'H/R%&!Z#\A0!8R/4?F*,CU'YBJ^!Z#\A1@>@_(4 6,CU'YBC(]1^8
MJO@>@_(48'H/R% %C(]1^8HR/4?F*KX'H/R%&!Z#\A0!8R/4?F*,CU'YBJ^!
MZ#\A1@>@_(4 6,CU'YBC(]1^8JO@>@_(48'H/R% %C(]1^8HR/4?F*KX'H/R
M%&!Z#\A0!8R/4?F*,CU'YBJ^!Z#\A1@>@_(4 6,CU'YBC(]1^8JO@>@_(48'
MH/R% &C9$&\M ",FY@[C_GHM?PNW/_'W>_\ 7]??^E<U?W-60'VRTX'_ !\P
M=O\ IJM?PR7'_'U>?]?M[_Z534 14444 %%%% ']%_\ P1MX_9W^*N>_Q\U(
M_P#F,?AL*_7#(]1^8K\B?^".'/[//Q4!Y'_"^]3X/3_DF/PU[5^MV!Z#\A0!
M8R/4?F*,CU'YBJ^!Z#\A1@>@_(4 >TU^>_[<G[+'QC^,NL_!'X[?LP_$3PU\
M-OVFOV:]9\6:A\/KOQWIMQJGP\\:^&?B!I-GHGCOP!XW@L(+G5+;3=:L=-LI
M+:_L()9K:XA*1_8[F>WUK1_T(HH _&KX9_LS?\% _P!H?XZ_!7XN_M_^*/@+
MX1\ _LV>*KOXA_#?X,?L^6OB2Z'C#XI_V-=:+H_C+QSKOB:^U(0:=X;@U.]O
M-%L-/OYII+MI;>>PM$+ZA>_LK110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'CUU_Q]77_7S<?^CGJ"I[K_CZNO\ KYN/_1SU!0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ##[3_ORG^%']BZ3_P! ZT_[\I_A0!^2VJ_L7^(;V]\-_$K5HOV?OBQ\7/\
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MX^U6S\)>#]1UF;5IK;3#HWA_5-6C\3Z\E]<VUF=!T35&N;FW@22:/X]^!O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxy_internet.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_internet.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  6 !@# 2(  A$! Q$!_\0
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55-)O%U;1[O$]G<+?V4CB4HHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>proxy_mail.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_mail.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  2 !@# 2(  A$! Q$!_\0
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>proxy_mobile.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_mobile.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 !@# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#?_P""/?\
MP2B^%_\ P5K\!_ML_M1_M4?M._MQ6?Q3TS_@HE^T%\+&G^%O[0K>%=%U/P_X
M=\)?"7Q3IE]JEAK7A'Q7=3ZU%<^-M1TM;B'4+:Q@T'3="TJSTZU@TQ3+Z7_P
M4E_X)@_\$6/^"6OA/X=:S^U;^W!_P5A\/W_QGO?%>D_#30/A[\=8/&GBS6QX
M-M]!?Q?KEI$_PD3PUI]EX4/B[PL;I_$.I6YNKC7+"+3].U=$U".V^_\ _@T^
M_P"3-_V[O^TKO[3_ /ZJS]G.OO;]N?\ 9O\ @%^U)_P4O_X)T_#C]H[X._#K
MXX> ++]E;_@I/XJM?!OQ/\*Z1XQ\-P>)-,\<_P#!/#3].UQ-(UJVN[(:G8V6
ML:I;6MV83+!%?W*QLOFM0!^</["G_!1KX#?\$@_@W^S-_P $_P#]N'Q]^W+J
MOC7X@^/_ !1IGP=^-7[2_P"R7XC^$5IJ>A>+?&U@8]#O1<?&CXVZK/HO@;Q%
MXNAL[O5;;6KQ='TC6=(ADT;3=.MH)9BO:O\ @KG_ ,$Q?^"=OP"_X)W?M(?&
M;X*?L2_LQ_"SXK_#?2_A]XI\"?$+P-\&_!'AWQ7X5U_3_BYX :UU+1]8T[1X
M+NUF"M)!.BN8+NSFN+*[BGL[F>"0H ^ ?V"/AK_P7Z_X)2^'/VG_ (!?!?\
MX)4?#+]I?P3\2/VU/CK^T!H_Q?U+]LSX >"-.\1:-XSL? O@O07\.^%=8^(6
MB^*+#1;[2?AQ;>)[.?Q?I>A>)G@\2PZ=K/A3PYJ.DW5O<>B_M5_\%>_BU^PA
M\<O^"=?[7W_!6[]B[QQ^SGXRO?AW_P %+_@EIOP9_9U\??!W]H;6+[2-=UK_
M ()U>)_"7C^36E^*GAOPAI^F7\F@^+=%U+2G\87.O6-UI%C>#2VLM81K3^P:
MOPT_X. /^3-_AI_V<SX-_P#56?&:@#\@_P#@JG_P<%_LL_'O]ER3]BZU_9]_
M:U^&WQ4_;C^$'[/_ ,0/@5K7C[3/V9-4\!W'@#XO^._"GB7P!XM\9:M\)/VH
MOBEKWA"'5]*T>\ENO#.I>&3X\T*4P0:]X2TR29!17Y8_\$Q_^3R/A!_V?_\
+#_\ ]6GX!HH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>proxy_signature.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_signature.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B *@# 2(  A$! Q$!_\0
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MFOOA9XRGU>>(:4W[+7[<VHZ)K?BJ>_OKR[UN2Z_9S_:2\)>//C,FKZ/=:'X
MN_ GP%T#PAXX\3@'ZK5\W?M2_'B\^ WPU@OO"'AN+X@?&OXD^(;7X4_LZ?"I
M[N>Q'Q.^-OB32M9U+PUH.I7]G;7U]HO@;PWH^@^(OB5\8?&%GINJR_#SX*^!
M/B+\1'TK4X/"LUA<?._Q&_X*>_L^?!RWU#1OBWX6^-'@#XOVOA:3Q=8? F_\
M!V7B/QAKFCRWNDZ9I-[9?$KP%XC\7?LR:7H>I:AX@T*'4_''BOX^>'/AS\.;
M/49->^+_ (R^'7AK1?$>LZ-\T^$OVM_V<_AQ9?$G]N#]I#]H/X7_ !]^.5IX
M5N-,\%_!?]DS7X/VE4_9V^&GB*^T5?#_ , _@OHOP]34M9\4?$?XP^+HO"EM
M\1?C%X@TKP8_QM^(G_"&>'H4\*?#'P#\.?"_A8 ]*T3X(V(\?? []B6V\42_
M$=/AIKVC_MZ?MY?$Z_L$TO5?BW\6]3^(.L>+/@E#KVE1WTY\.M\7OVFO"OB3
MXW^'O#7AC6=6\,_"CX9?LHZ+\ SHNE_"SQ;X!T]O<? 6IK^U9^TN?B]I[+>_
ML\_LG:GXX\"?!S4OWZVGQ/\ VHKZWUWX;?&SXK:*ZG[/>^$/@7X.N_%7[.W@
MC7H+DP^(O'?C_P#:<L-2T,Z?X(^''BO6_P 7O ?AO_@HEIWCO0/%GQU@_;-\
M+_#']M>^^.7Q?_:@^%'P,^'?@:;QGJ?Q'U#P]\%-!^$?[+7PO\9_#7X>WWQ%
M_9O\/Q_#2T\-_ #3OVR?VB/VIOV>KZY\,?!_XFZJGA#]E#Q?K7@/XWP_8/PJ
M_:"_;SM?CYX]_9_^%G[/OP>\+>'?@)X-^ GPQ\!_LO>'O".O_#3]G?X3Z1KE
MKX#^(7C'5_''[5MOX<U73+SPK\*/V>7\(_"CX(Z9\ /@R7\2_'KXF^._ =O\
M!?$WPC_96\<_'] #]U**_#F+_@IC^UC;>-]&U^R_95\!_&3]GSXC_';X??LW
M_"+7O@)XX^(7B?QK\1_BG'H?Q9\1_&^;X17^N?#72?!_Q/\ @YX&TCX>FUL/
MVB?BHW[)WPAM_&6A>+M)U+7KOX7BU^.5AW7@+_@K&L/B#X8>&/VB/@/XB^!.
MK_%SQI\=;?17U>X\7Z?I.D>!_@ZNC:-H&D^&;'XG?#SX6?%W]HW]H+XM^*_$
M_@6V\)_ []G3X*^.-3TFX\>/X#UK6O\ A8_P_P!?T'5P#]C**^-)?VWO *7J
MZ'#\%OVR[KQ7J,<3^%?#T7[%W[2\-EXJ?4;);OP]"WQ)O?AK:?!CX?2:]))%
M82M\9?B7\,X/!-[(P^*$W@2UMKRZMOLN@#XP^(O[.?CVV_:7F_:U^$7Q$\!:
M1XRU'X)>'?@3XO\ "_QG^'E]X[\,VG@#PAXV\9?$&UOOA1XH\.>-/ ?B3X.Z
M_P")]<\;37'QCN+K_A8?AGXJZ9\./@S877AGPMJ?P[LO$]QR'[)GQ@_:?^._
MCKQ7X^U[5?@GJW[((\,6-I\(?''A#X4^/O"/BGXX>,+K4"^I_$/X=Z]XE^-G
MBJUU/]G+2M)LA:^!_B!JGPU\/S?'R_\ $,_C7X8#_A1WAKX>_%G]H?&^+5Q:
M?MA_M(^*_P!CF;4;5OV?_@)X6^'?C_\ ;"\,NBM-\<=9^*X\37WPB_9HU:,S
M>>_P>?1?"-]\2OVBM)N+2#1_BMX?U7X8?!>[O?%WPU\6_M#^ Y?JCPS\?_ G
MQ!\7S^$OA7+>?%*'1M1O=*\:>.?!7V/4OA?X$U/3+C4K+4O#^N?$)[R'P]JW
MC;3]2TFZTC6/A]X(N?%GCCPEJ5QH\OC_ $'P?H.M6&NR '._M0_M!G]GSP%H
M]]X>\(7?Q/\ C#\3_&.E?"7]G[X/Z=J":3??%+XO^)+#5M4TK1KS6FM-1;PS
MX&\)^&] \4?%#XP>.4TG7'^'7P9\!_$'Q['X?\1S>&XM U.M^SI^SI#\&X_%
M/CSQQXC_ .%I_M(_%T:+J'QU^-E[8W.G2>)[S1%U&3P_X"^'WAZ]U37&^&/P
M!^&4FN:[8?!_X0:9K&HV?ANVUCQ#XO\ %NM^//C)\0/BK\4_'_BGC35-'M?^
M"E?P@;XI7%CH.CVO[+/CCP_^RW?:W(]MHWC;XR^/OB'8:G^T+X:TB[NHET23
MXI>%OA5\*_A-JO@O13>+XWU7X>>)_CC?^#K"]\*Z!\5;C3MO]L[]LW0O@!\'
MOC@/A"O_  NW]JGP?\*_%WB3X;_LY_#'P[KGQD^)^J>+(O#E[<^#;[Q1\+?A
MN]WXRT?X?OKKZ/%KGBK77\*^&DBOK+23XJT[5]=T1+L H?M4?$W1_B=I_P 5
MOV8_!]E\/-?@T+P?%JG[4GQ#^+NK:UIW[.G[/GPZU'38/$SZ3\9V\/Z_X3N?
MB7XC\6>#5?Q/K'[-Z^,?"6A>(/@M<7>I?'WQK\.?AI\2OAW%\6?SWGT=OL_A
M?X[:9X>\2?%WXD_&+XK^$_!'[$.G?M*0ZE=>,?VG?CYIUEK.M^'?VR/VB_#^
MB6?A>'P)^S#^SAX3T?QY\>_@5^SCX#\-?#7P5\-?"&@_$3]H30O <_[47Q8^
M"6E_"7J_V?K/X/W_ (.\,>']:\8:+^UC=P>(KOXCZ%^RK^S3XL\,?'JS\:?%
M[4=1E\;WO[17[;7QBT'_ (1SX7>)OBWXT\50:C\1=+3XJZM\*/V4?AIXWGT7
MPC\)-!^)GC_X3_!KXG+\^_"+Q=^TW^T?^T=\:OCSK_QV\%2_&B35_BQ^R]\'
M_P!GC]ECP7<_$KQ_^SO^SG\-/CAJ/P^^*_B#PK\:OBWXQ\/_  9^#MU\>OCS
M\'=2E\:?'[]H7]GE=>^-/P]_9ST&P^ 7PYMO%>G>'?!OA4 _0ZR^#WABSTJ+
M]@WX;:I>?$R^\5Z]!\2?^"C7QR\50Z9?Z]XVTWQ79:7JOC?1?BE?Z?;1:=J/
MQB_:RT^TT/X=Z=\.-,M='T/X0_LG/JZ>#E^&OA#P7^SAX(\5?J4      !@
M<  = !V K\=_V$/VB?B3!\!1;:/^P=\9]'\0ZAXQ\9^)[_X;>$O#GC+P;=>
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
